spnt-20260930
000157601812/312026Q3falsehttp://fasb.org/us-gaap/2026#OtherAssetshttp://fasb.org/us-gaap/2026#OtherAssetshttp://fasb.org/us-gaap/2026#OtherLiabilitieshttp://fasb.org/us-gaap/2026#OtherLiabilitiesxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purespnt:segmentspnt:security00015760182026-01-012026-09-3000015760182026-11-0200015760182026-09-3000015760182025-12-310001576018us-gaap:SeriesBPreferredStockMember2026-09-300001576018us-gaap:SeriesBPreferredStockMember2025-12-3100015760182026-07-012026-09-3000015760182025-07-012025-09-3000015760182025-01-012025-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-06-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-06-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-12-310001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2024-12-310001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-07-012025-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-01-012026-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-01-012025-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-09-300001576018us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-09-300001576018us-gaap:CommonStockMember2026-06-300001576018us-gaap:CommonStockMember2025-06-300001576018us-gaap:CommonStockMember2025-12-310001576018us-gaap:CommonStockMember2024-12-310001576018us-gaap:CommonStockMember2026-07-012026-09-300001576018us-gaap:CommonStockMember2025-07-012025-09-300001576018us-gaap:CommonStockMember2026-01-012026-09-300001576018us-gaap:CommonStockMember2025-01-012025-09-300001576018us-gaap:CommonStockMember2026-09-300001576018us-gaap:CommonStockMember2025-09-300001576018us-gaap:AdditionalPaidInCapitalMember2026-06-300001576018us-gaap:AdditionalPaidInCapitalMember2025-06-300001576018us-gaap:AdditionalPaidInCapitalMember2025-12-310001576018us-gaap:AdditionalPaidInCapitalMember2024-12-310001576018us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001576018us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001576018us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-300001576018us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001576018us-gaap:AdditionalPaidInCapitalMember2026-09-300001576018us-gaap:AdditionalPaidInCapitalMember2025-09-300001576018us-gaap:RetainedEarningsMember2026-06-300001576018us-gaap:RetainedEarningsMember2025-06-300001576018us-gaap:RetainedEarningsMember2025-12-310001576018us-gaap:RetainedEarningsMember2024-12-310001576018us-gaap:RetainedEarningsMember2026-07-012026-09-300001576018us-gaap:RetainedEarningsMember2025-07-012025-09-300001576018us-gaap:RetainedEarningsMember2026-01-012026-09-300001576018us-gaap:RetainedEarningsMember2025-01-012025-09-300001576018us-gaap:RetainedEarningsMember2026-09-300001576018us-gaap:RetainedEarningsMember2025-09-300001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001576018us-gaap:AccumulatedTranslationAdjustmentMember2026-06-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2025-06-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310001576018us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001576018us-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2026-09-300001576018us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-06-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-06-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-12-310001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-07-012026-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-07-012025-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-01-012026-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-09-300001576018us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-09-300001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300001576018us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001576018us-gaap:ParentMember2026-09-300001576018us-gaap:ParentMember2025-09-300001576018us-gaap:NoncontrollingInterestMember2026-09-300001576018us-gaap:NoncontrollingInterestMember2025-09-3000015760182025-09-3000015760182024-12-310001576018spnt:VariableInterestEntityPrimaryBeneficiaryArcadianRiskCapitalLtdMember2025-10-032025-10-030001576018spnt:ArcadianHoldingsLimitedMember2025-10-032025-10-030001576018spnt:ArcadianHoldingsLimitedMember2026-01-012026-09-300001576018spnt:VariableInterestEntityPrimaryBeneficiaryArcadianRiskCapitalLtdMember2025-10-032025-12-310001576018spnt:AssistAmericaMember2026-01-012026-01-010001576018spnt:AssistAmericaMember2026-09-300001576018spnt:WorldNomadsMember2026-09-302026-09-300001576018spnt:WorldNomadsMember2026-09-300001576018spnt:InternationalMedicalGroupInc.Member2026-09-300001576018spnt:ArmadaCorpCapitalLLCMember2025-10-310001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018us-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018us-gaap:IntersegmentEliminationMember2026-07-012026-09-300001576018us-gaap:CorporateNonSegmentMember2026-07-012026-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018us-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001576018us-gaap:ServiceMemberus-gaap:IntersegmentEliminationMember2026-07-012026-09-300001576018us-gaap:ServiceMemberus-gaap:MaterialReconcilingItemsMember2026-07-012026-09-300001576018us-gaap:MaterialReconcilingItemsMember2026-07-012026-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018us-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018us-gaap:IntersegmentEliminationMember2025-07-012025-09-300001576018us-gaap:CorporateNonSegmentMember2025-07-012025-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018us-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001576018us-gaap:ServiceMemberus-gaap:IntersegmentEliminationMember2025-07-012025-09-300001576018us-gaap:ServiceMemberus-gaap:MaterialReconcilingItemsMember2025-07-012025-09-300001576018us-gaap:MaterialReconcilingItemsMember2025-07-012025-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018us-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018us-gaap:IntersegmentEliminationMember2026-01-012026-09-300001576018us-gaap:CorporateNonSegmentMember2026-01-012026-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018us-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001576018us-gaap:ServiceMemberus-gaap:IntersegmentEliminationMember2026-01-012026-09-300001576018us-gaap:ServiceMemberus-gaap:MaterialReconcilingItemsMember2026-01-012026-09-300001576018us-gaap:MaterialReconcilingItemsMember2026-01-012026-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018us-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018us-gaap:IntersegmentEliminationMember2025-01-012025-09-300001576018us-gaap:CorporateNonSegmentMember2025-01-012025-09-300001576018spnt:InsuranceAndServicesSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018spnt:ReinsuranceSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018us-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001576018us-gaap:ServiceMemberus-gaap:IntersegmentEliminationMember2025-01-012025-09-300001576018us-gaap:ServiceMemberus-gaap:MaterialReconcilingItemsMember2025-01-012025-09-300001576018us-gaap:MaterialReconcilingItemsMember2025-01-012025-09-300001576018us-gaap:FinancialStandbyLetterOfCreditMember2026-09-300001576018us-gaap:FinancialStandbyLetterOfCreditMember2025-12-310001576018spnt:ReinsuranceContractsMember2026-09-300001576018spnt:ReinsuranceContractsMember2025-12-310001576018spnt:ManagingGeneralUnderwritersMember2026-09-300001576018spnt:ManagingGeneralUnderwritersMember2025-12-310001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:FairValueInputsLevel1Member2026-09-300001576018us-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:FairValueInputsLevel3Member2026-09-300001576018us-gaap:FairValueInputsLevel12And3Member2026-09-300001576018us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2026-09-300001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:FairValueInputsLevel1Member2025-12-310001576018us-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:FairValueInputsLevel3Member2025-12-310001576018us-gaap:FairValueInputsLevel12And3Member2025-12-310001576018us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310001576018us-gaap:OtherLongTermInvestmentsMember2026-06-300001576018us-gaap:OtherLongTermInvestmentsMember2026-07-012026-09-300001576018us-gaap:OtherLongTermInvestmentsMember2026-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2026-06-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2026-07-012026-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2026-09-300001576018us-gaap:OtherLongTermInvestmentsMember2025-12-310001576018us-gaap:OtherLongTermInvestmentsMember2026-01-012026-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-12-310001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2026-01-012026-09-300001576018us-gaap:OtherLongTermInvestmentsMember2025-06-300001576018us-gaap:OtherLongTermInvestmentsMember2025-07-012025-09-300001576018us-gaap:OtherLongTermInvestmentsMember2025-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-06-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-07-012025-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-09-300001576018us-gaap:OtherLongTermInvestmentsMember2024-12-310001576018us-gaap:OtherLongTermInvestmentsMember2025-01-012025-09-300001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2024-12-310001576018us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-01-012025-09-300001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Memberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Memberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Memberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Memberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeriesBPreferredStockMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeriesBPreferredStockMemberus-gaap:FairValueInputsLevel2Member2026-09-300001576018us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeriesBPreferredStockMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeriesBPreferredStockMemberus-gaap:FairValueInputsLevel2Member2025-12-310001576018us-gaap:AssetBackedSecuritiesMember2026-09-300001576018us-gaap:ResidentialMortgageBackedSecuritiesMember2026-09-300001576018us-gaap:CommercialMortgageBackedSecuritiesMember2026-09-300001576018us-gaap:CorporateDebtSecuritiesMember2026-09-300001576018us-gaap:USTreasuryAndGovernmentMember2026-09-300001576018us-gaap:ForeignGovernmentDebtSecuritiesMember2026-09-300001576018us-gaap:AssetBackedSecuritiesMember2025-12-310001576018us-gaap:ResidentialMortgageBackedSecuritiesMember2025-12-310001576018us-gaap:CommercialMortgageBackedSecuritiesMember2025-12-310001576018us-gaap:CorporateDebtSecuritiesMember2025-12-310001576018us-gaap:USTreasuryAndGovernmentMember2025-12-310001576018us-gaap:ForeignGovernmentDebtSecuritiesMember2025-12-3100015760182025-01-012025-12-310001576018spnt:MortgageBackedAndAssetBackedSecuritiesMember2026-09-300001576018spnt:MortgageBackedAndAssetBackedSecuritiesMember2025-12-310001576018spnt:EquityMethodEligibleUnconsolidatedEntitiesMember2026-09-300001576018spnt:EquityMethodEligibleUnconsolidatedEntitiesMember2025-12-310001576018us-gaap:EquityMethodInvestmentsMember2026-09-300001576018us-gaap:EquityMethodInvestmentsMember2025-12-310001576018spnt:OtherUnconsolidatedInvestmentsAtFairValueMember2026-09-300001576018spnt:OtherUnconsolidatedInvestmentsAtFairValueMember2025-12-310001576018spnt:OtherUnconsolidatedInvestmentsAtCostMember2026-09-300001576018spnt:OtherUnconsolidatedInvestmentsAtCostMember2025-12-310001576018spnt:StrategicInvestmentsAndLimitedLiabilityCompaniesAndPrivateEquitySecuritiesMember2026-09-300001576018spnt:StrategicInvestmentsAndLimitedLiabilityCompaniesAndPrivateEquitySecuritiesMember2025-12-310001576018spnt:DebtSecuritiesAvailableForSaleMember2026-07-012026-09-300001576018spnt:DebtSecuritiesAvailableForSaleMember2025-07-012025-09-300001576018spnt:DebtSecuritiesAvailableForSaleMember2026-01-012026-09-300001576018spnt:DebtSecuritiesAvailableForSaleMember2025-01-012025-09-300001576018spnt:DebtSecuritiesTradingMember2026-07-012026-09-300001576018spnt:DebtSecuritiesTradingMember2025-07-012025-09-300001576018spnt:DebtSecuritiesTradingMember2026-01-012026-09-300001576018spnt:DebtSecuritiesTradingMember2025-01-012025-09-300001576018spnt:OtherShortTermInvestmentsMember2026-07-012026-09-300001576018spnt:OtherShortTermInvestmentsMember2025-07-012025-09-300001576018spnt:OtherShortTermInvestmentsMember2026-01-012026-09-300001576018spnt:OtherShortTermInvestmentsMember2025-01-012025-09-300001576018us-gaap:OtherLongTermInvestmentsMember2026-07-012026-09-300001576018us-gaap:OtherLongTermInvestmentsMember2025-07-012025-09-300001576018us-gaap:OtherLongTermInvestmentsMember2026-01-012026-09-300001576018us-gaap:OtherLongTermInvestmentsMember2025-01-012025-09-300001576018spnt:CashCashEquivalentsAndOtherMember2026-07-012026-09-300001576018spnt:CashCashEquivalentsAndOtherMember2025-07-012025-09-300001576018spnt:CashCashEquivalentsAndOtherMember2026-01-012026-09-300001576018spnt:CashCashEquivalentsAndOtherMember2025-01-012025-09-300001576018spnt:InvestmentsExcludingCashAndCashEquivalentsMember2026-07-012026-09-300001576018spnt:InvestmentsExcludingCashAndCashEquivalentsMember2025-07-012025-09-300001576018spnt:InvestmentsExcludingCashAndCashEquivalentsMember2026-01-012026-09-300001576018spnt:InvestmentsExcludingCashAndCashEquivalentsMember2025-01-012025-09-300001576018us-gaap:ForeignExchangeContractMember2026-09-300001576018us-gaap:ForeignExchangeContractMember2025-12-310001576018us-gaap:CreditRiskContractMember2026-09-300001576018us-gaap:CreditRiskContractMember2025-12-310001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2026-09-300001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2025-12-310001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2026-09-300001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2025-12-310001576018us-gaap:NondesignatedMemberus-gaap:CreditRiskContractMember2026-09-300001576018us-gaap:NondesignatedMemberus-gaap:CreditRiskContractMember2025-12-310001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2026-09-300001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2025-12-310001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2026-07-012026-09-300001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2025-07-012025-09-300001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2026-01-012026-09-300001576018us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2025-01-012025-09-300001576018us-gaap:NondesignatedMemberspnt:WeatherDerivativeMember2026-07-012026-09-300001576018us-gaap:NondesignatedMemberspnt:WeatherDerivativeMember2025-07-012025-09-300001576018us-gaap:NondesignatedMemberspnt:WeatherDerivativeMember2026-01-012026-09-300001576018us-gaap:NondesignatedMemberspnt:WeatherDerivativeMember2025-01-012025-09-300001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2026-07-012026-09-300001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2025-07-012025-09-300001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2026-01-012026-09-300001576018us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2025-01-012025-09-300001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2026-07-012026-09-300001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2025-07-012025-09-300001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2026-01-012026-09-300001576018us-gaap:NondesignatedMemberspnt:ReinsuranceContractMember2025-01-012025-09-300001576018spnt:VariableInterestEntityPrimaryBeneficiaryAlsteadReInsuranceCompanyMember2026-09-300001576018spnt:VariableInterestEntityPrimaryBeneficiaryAlsteadReInsuranceCompanyMember2025-12-310001576018us-gaap:ConsolidatedEntityExcludingVieMember2026-01-012026-09-300001576018us-gaap:ConsolidatedEntityExcludingVieMember2026-09-300001576018us-gaap:ConsolidatedEntityExcludingVieMember2025-12-310001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMemberus-gaap:DebtSecuritiesMember2026-09-300001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMemberus-gaap:DebtSecuritiesMember2025-12-310001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMemberus-gaap:OtherLongTermInvestmentsMember2026-09-300001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMemberus-gaap:OtherLongTermInvestmentsMember2025-12-310001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMember2026-09-300001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryExcludingInvestmentsInRelatedPartyInvestmentFundsMember2025-12-310001576018spnt:VariableInterestEntityNotPrimaryBeneficiaryTPEnhancedFundMemberspnt:ThirdPointEnhancedLPMember2026-01-012026-09-300001576018us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberspnt:ThirdPointAdvisorsLLCMemberspnt:ThirdPointEnhancedLPMember2026-01-012026-09-300001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundILPMember2026-09-300001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundILPMember2025-12-310001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundIILPMember2026-09-300001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundIILPMember2025-12-310001576018spnt:RelatedPartyFundThirdPointInsuranceSolutionsFundILLCMember2026-09-300001576018spnt:RelatedPartyFundThirdPointInsuranceSolutionsFundILLCMember2025-12-310001576018spnt:PallasReinsuranceCompanyLtdMember2026-09-300001576018us-gaap:CreditConcentrationRiskMemberspnt:AssetsWithinScopeOfCreditLossesMemberspnt:CreditRatingAgenciesMember2026-01-012026-09-300001576018us-gaap:CreditConcentrationRiskMemberspnt:AssetsWithinScopeOfCreditLossesMemberspnt:CreditRatingAgenciesMemberspnt:AOrBetterRatingMember2026-01-012026-09-300001576018us-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Member2026-09-300001576018us-gaap:SeniorNotesMemberspnt:SeniorUnsecuredNotesDue2029Member2025-12-310001576018us-gaap:SubordinatedDebtMember2026-09-300001576018us-gaap:SubordinatedDebtMember2025-12-310001576018us-gaap:StandbyLettersOfCreditMemberspnt:CommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:CashAndCashEquivalentsMemberus-gaap:StandbyLettersOfCreditMemberspnt:CommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:DebtSecuritiesMemberus-gaap:StandbyLettersOfCreditMemberspnt:CommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:StandbyLettersOfCreditMemberspnt:UncommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:CashAndCashEquivalentsMemberus-gaap:StandbyLettersOfCreditMemberspnt:UncommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:DebtSecuritiesMemberus-gaap:StandbyLettersOfCreditMemberspnt:UncommittedSecuredLetterOfCreditFacilityMember2026-09-300001576018us-gaap:StandbyLettersOfCreditMember2026-09-300001576018us-gaap:CashAndCashEquivalentsMemberus-gaap:StandbyLettersOfCreditMember2026-09-300001576018us-gaap:DebtSecuritiesMemberus-gaap:StandbyLettersOfCreditMember2026-09-300001576018us-gaap:RevolvingCreditFacilityMember2024-12-192024-12-190001576018us-gaap:RevolvingCreditFacilityMember2024-12-190001576018us-gaap:RevolvingCreditFacilityMember2026-09-3000015760182025-09-252025-09-2500015760182026-06-300001576018us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2026-01-012026-09-300001576018us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2025-01-012025-09-300001576018us-gaap:NonredeemablePreferredStockMember2026-09-300001576018us-gaap:SeriesBPreferredStockMember2026-01-290001576018us-gaap:SeriesBPreferredStockMember2026-01-292026-01-290001576018us-gaap:SeriesBPreferredStockMember2026-02-262026-02-260001576018us-gaap:SeriesBPreferredStockMember2026-02-260001576018us-gaap:SeriesBPreferredStockMember2026-01-012026-09-300001576018us-gaap:SeriesBPreferredStockMember2025-07-012025-09-300001576018us-gaap:SeriesBPreferredStockMember2025-01-012025-09-300001576018spnt:CMIGSecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-01-012025-09-300001576018spnt:CMIGSecuritiesPurchaseAgreementMember2025-01-012025-09-300001576018srt:DirectorMember2025-02-272025-02-270001576018spnt:RestrictedStockAndRestrictedStockUnitsRSUsMember2026-07-012026-09-300001576018spnt:RestrictedStockAndRestrictedStockUnitsRSUsMember2025-07-012025-09-300001576018spnt:RestrictedStockAndRestrictedStockUnitsRSUsMember2026-01-012026-09-300001576018spnt:RestrictedStockAndRestrictedStockUnitsRSUsMember2025-01-012025-09-300001576018us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001576018us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001576018us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001576018us-gaap:EmployeeStockOptionMember2025-01-012025-09-300001576018us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-300001576018us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001576018us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-300001576018us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001576018us-gaap:RelatedPartyMember2026-07-012026-09-300001576018us-gaap:RelatedPartyMember2026-01-012026-09-300001576018us-gaap:RelatedPartyMember2025-07-012025-09-300001576018us-gaap:RelatedPartyMember2025-01-012025-09-300001576018us-gaap:RelatedPartyMember2026-09-300001576018us-gaap:RelatedPartyMember2025-12-310001576018spnt:RelatedPartyFundThirdPointEnhancedLPMemberus-gaap:RelatedPartyMember2026-09-300001576018spnt:RelatedPartyFundThirdPointEnhancedLPMemberus-gaap:RelatedPartyMember2025-12-310001576018spnt:RelatedPartyFundThirdPointInsuranceSolutionsFundILLCMemberus-gaap:RelatedPartyMember2026-09-300001576018spnt:RelatedPartyFundThirdPointInsuranceSolutionsFundILLCMemberus-gaap:RelatedPartyMember2025-12-310001576018spnt:RelatedPartyFundThirdPointStructuredCreditOpportunitiesFundMemberus-gaap:RelatedPartyMember2026-09-300001576018spnt:RelatedPartyFundThirdPointStructuredCreditOpportunitiesFundMemberus-gaap:RelatedPartyMember2025-12-310001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundILPMemberus-gaap:RelatedPartyMember2026-09-300001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundILPMemberus-gaap:RelatedPartyMember2025-12-310001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundIILPMemberus-gaap:RelatedPartyMember2026-09-300001576018spnt:RelatedPartyFundThirdPointVentureOffshoreFundIILPMemberus-gaap:RelatedPartyMember2025-12-310001576018spnt:ManagementAndAdvisoryFeesMember2026-07-012026-09-300001576018spnt:ManagementAndAdvisoryFeesMember2025-07-012025-09-300001576018spnt:ManagementAndAdvisoryFeesMember2026-01-012026-09-300001576018spnt:ManagementAndAdvisoryFeesMember2025-01-012025-09-300001576018spnt:PerformanceFeesMember2026-07-012026-09-300001576018spnt:PerformanceFeesMember2025-07-012025-09-300001576018spnt:PerformanceFeesMember2026-01-012026-09-300001576018spnt:PerformanceFeesMember2025-01-012025-09-300001576018us-gaap:SubsequentEventMemberspnt:NationalMotorClubAndSpecializedAssociationServicesMember2026-10-022026-10-020001576018spnt:RiverStoneInternationalBermudaLimitedMember2026-06-300001576018us-gaap:SubsequentEventMemberspnt:RiverStoneInternationalBermudaLimitedMember2026-10-30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2026
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 001-36052
SIRIUSPOINT LTD.
(Exact name of registrant as specified in its charter)
Bermuda98-1599372
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
Point Building
3 Waterloo Lane
Pembroke HM 08, Bermuda
+1 441 542-3300
(Address of Principal Executive Offices) (Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Shares, $0.10 par valueSPNTNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    ☒    No    ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes    ☒    No    ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     ☐
As of November 2, 2026, the registrant had 115,032,060 common shares issued and outstanding.



SiriusPoint Ltd.
INDEX
Page
PART I. FINANCIAL INFORMATION
  Item 1. Financial Statements
Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025
Consolidated Statements of Income for the three and nine months ended September 30, 2026 and 2025 (unaudited)
Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025 (unaudited)
Consolidated Statements of Shareholders' Equity for the three and nine months ended September 30, 2026 and 2025 (unaudited)
Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (unaudited)
Note 1. Organization
Note 2. Significant accounting policies
Note 3. Significant transactions
Note 4. Segment reporting
Note 5. Cash, cash equivalents, restricted cash and restricted investments
Note 6. Fair value measurements
Note 7. Investments
Note 8. Derivatives
Note 9. Variable and voting interest entities
Note 10. Loss and loss adjustment expense reserves
Note 11. Allowance for expected credit losses
Note 12. Debt and letter of credit facilities
Note 13. Income taxes
Note 14. Shareholders' equity
Note 15. Earnings per share available to SiriusPoint common shareholders
Note 16. Related party transactions
Note 17. Commitments and contingencies
Note 18. Subsequent events
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  Item 3. Quantitative and Qualitative Disclosures About Market Risk
  Item 4. Controls and Procedures
  Item 1. Legal Proceedings
  Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
  Item 3. Defaults Upon Senior Securities
  Item 4. Mine Safety Disclosures
  Item 5. Other Information
  Item 6. Exhibits



PART I - Financial Information
ITEM 1. Financial Statements
SIRIUSPOINT LTD.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
As of September 30, 2026 and December 31, 2025
(expressed in millions of U.S. dollars, except per share and share amounts)
September 30,
2026
December 31,
2025
Assets
Debt securities, available for sale, at fair value, net of allowance for credit losses of $0.0 (2025 - $0.0) (cost - $5,523.9; 2025 - $5,118.3)
$5,364.8 $5,168.6 
Debt securities, trading, at fair value (cost - $80.6; 2025 - $114.6)
55.3 90.3 
Short-term investments, at fair value (cost - $16.6; 2025 - $28.4)
17.1 28.3 
Other long-term investments, at fair value (cost - $398.1; 2025 - $421.9) (includes related party investments at fair value of $215.8 (2025 - $216.1))
276.5 315.1 
Total investments5,713.7 5,602.3 
Cash and cash equivalents434.3 731.2 
Restricted cash and cash equivalents127.4 171.2 
Due from brokers6.5 7.5 
Interest and dividends receivable46.2 47.1 
Insurance and reinsurance balances receivable, net
2,558.9 2,260.3 
Deferred acquisition costs, net397.7 384.1 
Unearned premiums ceded649.2 487.4 
Loss and loss adjustment expenses recoverable, net1,966.4 2,102.3 
Deferred tax asset280.5 267.7 
Goodwill46.0 — 
Intangible assets158.8 121.2 
Other assets236.7 272.1 
Assets held for sale— 115.2 
Total assets$12,622.3 $12,569.6 
Liabilities
Loss and loss adjustment expense reserves$5,816.7 $5,782.5 
Unearned premium reserves2,050.6 1,855.4 
Reinsurance balances payable1,472.5 1,447.6 
Debt667.5 688.6 
Due to brokers48.9 5.5 
Deferred tax liability67.8 73.0 
Other liabilities268.9 246.1 
Total liabilities10,392.9 10,098.7 
Commitments and contingent liabilities (refer to Note 17)
Shareholders’ equity
Series B preference shares (2025 - par value $0.10; authorized and issued: 8,000,000)
— 200.0 
Common shares (issued and outstanding: 115,032,060; 2025 - 116,989,799)
11.5 11.7 
Additional paid-in capital869.2 967.7 
Retained earnings1,483.5 1,228.5 
Accumulated other comprehensive income (loss), net of tax(135.9)61.9 
Shareholders’ equity attributable to SiriusPoint shareholders2,228.3 2,469.8 
Noncontrolling interests1.1 1.1 
Total shareholders’ equity2,229.4 2,470.9 
Total liabilities, noncontrolling interests and shareholders’ equity$12,622.3 $12,569.6 
The accompanying Notes to the Consolidated Financial Statements are
an integral part of the Consolidated Financial Statements.

1


SIRIUSPOINT LTD.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
For the three and nine months ended September 30, 2026 and 2025
(expressed in millions of U.S. dollars, except per share and share amounts)
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Revenues
Net earned premium$767.6 $647.7 $2,046.8 $1,926.4 
Net investment income65.9 66.5 197.8 205.9 
Net investment gains (losses)3.3 6.2 22.6 6.6 
Other revenues30.8 35.5 119.1 92.5 
Total revenues867.6 755.9 2,386.3 2,231.4 
Expenses
Loss and loss adjustment expenses incurred, net415.9 372.9 1,137.0 1,147.3 
Acquisition costs, net195.2 139.8 499.8 410.4 
Other underwriting expenses53.0 43.6 155.3 133.0 
Net corporate and other expenses75.7 62.5 220.6 194.0 
Intangible asset amortization2.5 2.8 7.5 8.5 
Interest expense18.4 21.0 53.9 60.2 
Foreign exchange losses3.2 2.4 2.7 16.9 
Total expenses763.9 645.0 2,076.8 1,970.3 
Income before income tax expense103.7 110.9 309.5 261.1 
Income tax expense(16.7)(20.2)(51.7)(45.1)
Net income87.0 90.7 257.8 216.0 
Net (income) loss attributable to noncontrolling interests(0.2)0.1 (0.2)(0.4)
Net income available to SiriusPoint86.8 90.8 257.6 215.6 
Dividends on Series B preference shares— (4.0)(2.6)(12.0)
Net income available to SiriusPoint common shareholders$86.8 $86.8 $255.0 $203.6 
Earnings per share available to SiriusPoint common shareholders
Basic earnings per share available to SiriusPoint common shareholders$0.75 $0.74 $2.19 $1.75 
Diluted earnings per share available to SiriusPoint common shareholders$0.74 $0.73 $2.14 $1.71 
Weighted average number of common shares used in the determination of earnings per share
Basic115,135,159 116,726,540 116,191,819 116,412,996 
Diluted117,166,671 118,817,903 119,150,790 118,655,606 
The accompanying Notes to the Consolidated Financial Statements are
an integral part of the Consolidated Financial Statements.

2


SIRIUSPOINT LTD.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)
For the three and nine months ended September 30, 2026 and 2025
(expressed in millions of U.S. dollars)

Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Comprehensive income (loss)
Net income$87.0 $90.7 $257.8 $216.0 
Other comprehensive income (loss), net of tax
Change in foreign currency translation adjustment0.2 (3.3)(6.7)(0.1)
Unrealized gains (losses) from debt securities held as available for sale investments(104.9)2.2 (190.0)54.0 
Reclassifications from accumulated other comprehensive income (loss)(9.9)6.9 (1.1)2.5 
Total other comprehensive income (loss)(114.6)5.8 (197.8)56.4 
Comprehensive income (loss)(27.6)96.5 60.0 272.4 
Net (income) loss attributable to noncontrolling interests(0.2)0.1 (0.2)(0.4)
Comprehensive income (loss) available to SiriusPoint$(27.8)$96.6 $59.8 $272.0 
The accompanying Notes to the Consolidated Financial Statements are
an integral part of the Consolidated Financial Statements.
3


SIRIUSPOINT LTD.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED)
For the three and nine months ended September 30, 2026 and 2025
(expressed in millions of U.S. dollars)
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Series B preference shares
Balance, beginning of period$— $200.0 $200.0 $200.0 
Redemption of preference shares— — (200.0)— 
Balance, end of period— 200.0 — 200.0 
Common shares
Balance, beginning of period11.6 11.7 11.7 11.6 
Issuance of common shares, net— — 0.2 0.2 
Common shares repurchased and retired(0.1)— (0.4)(0.1)
Balance, end of period11.5 11.7 11.5 11.7 
Additional paid-in capital
Balance, beginning of period888.9 945.8 967.7 945.0 
Issuance of common shares, net— — 0.1 — 
Share compensation7.4 11.6 1.6 19.5 
Exercise of options and warrants— — — 0.6 
Common shares repurchased and retired(27.1)— (100.2)(7.7)
Balance, end of period869.2 957.4 869.2 957.4 
Retained earnings
Balance, beginning of period1,396.7 901.7 1,228.5 784.9 
Net income87.0 90.7 257.8 216.0 
Net (income) loss attributable to noncontrolling interests(0.2)0.1 (0.2)(0.4)
Dividends on preference shares— (4.0)(2.6)(12.0)
Balance, end of period1,483.5 988.5 1,483.5 988.5 
Accumulated other comprehensive income (loss), net of tax
Balance, beginning of period(21.3)46.5 61.9 (4.1)
Change in foreign currency translation adjustment
Balance, beginning of period(7.8)0.2 (0.9)(3.0)
Change in foreign currency translation adjustment0.2 (3.3)(6.7)(0.1)
Balance, end of period(7.6)(3.1)(7.6)(3.1)
Unrealized gains (losses) from debt securities held as available for sale investments
Balance, beginning of period(13.5)46.3 62.8 (1.1)
Unrealized gains (losses) from debt securities held as available for sale investments(104.9)2.2 (190.0)54.0 
Reclassifications from accumulated other comprehensive income (loss)(9.9)6.9 (1.1)2.5 
Balance, end of period(128.3)55.4 (128.3)55.4 
Balance, end of period(135.9)52.3 (135.9)52.3 
Shareholders’ equity attributable to SiriusPoint shareholders 2,228.3 2,209.9 2,228.3 2,209.9 
Noncontrolling interests1.1 1.1 1.1 1.1 
Total shareholders’ equity$2,229.4 $2,211.0 $2,229.4 $2,211.0 
The accompanying Notes to the Consolidated Financial Statements are
an integral part of the Consolidated Financial Statements.
4


SIRIUSPOINT LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the nine months ended September 30, 2026 and 2025
(expressed in millions of U.S. dollars)
20262025
Operating activities
Net income$257.8 $216.0 
Adjustments to reconcile net income to net cash provided by operating activities:
Share compensation24.0 24.1 
Net realized and unrealized gain on investments and derivatives(22.6)(6.6)
Amortization of premium and accretion of discount, net(18.5)(28.6)
Amortization of intangible assets7.5 8.5 
Other items, net(20.5)39.1 
Changes in assets and liabilities:
Insurance and reinsurance balances receivable, net
(297.5)(237.9)
Deferred acquisition costs, net(13.4)(53.6)
Unearned premiums ceded(161.8)(23.2)
Loss and loss adjustment expenses recoverable, net135.9 152.4 
Deferred tax asset/liability9.9 10.0 
Other assets36.9 (69.0)
Interest and dividends receivable0.9 0.1 
Loss and loss adjustment expense reserves33.9 157.8 
Unearned premium reserves194.9 228.7 
Deferred gain on retroactive reinsurance— (8.5)
Reinsurance balances payable24.0(289.5)
Other liabilities0.1 (6.0)
Intangible assets— 8.7 
Held for sale asset115.2 (19.5)
Held for sale liability— 25.8 
Net cash provided by operating activities306.7 128.8 
Investing activities
Purchases of debt securities, available-for-sale(1,853.7)(1,743.0)
Purchases of short-term investments(29.7)(101.6)
Purchases of other investments(5.4)(19.0)
Proceeds from sales and maturities of debt securities, available-for-sale1,453.2 1,832.0 
Proceeds from sales and maturities of debt securities, trading and short-term investments71.9 239.8 
Proceeds from sales and maturities of other investments62.7 16.0 
Change in due to/from brokers, net44.4 10.7 
Business acquisitions, net (cash and restricted cash acquired of $6.5)
(76.4)— 
Net cash provided by (used in) investing activities(333.0)234.9 
Financing activities
Redemption of preference shares(200.0)— 
Purchases of SiriusPoint common shares under share repurchase program(100.6)(490.8)
Net proceeds (payments) on deposit liability contracts11.4 (9.7)
Net proceeds from exercise of options— 0.8 
Cash dividends paid to preference shareholders(2.6)(12.0)
Taxes paid on withholding shares (22.4)(4.6)
Change in total noncontrolling interests, net(0.2)(0.7)
Net cash used in financing activities(314.4)(517.0)
Net decrease in cash, cash equivalents and restricted cash(340.7)(153.3)
Cash, cash equivalents and restricted cash at beginning of period902.4 894.6 
Change in cash, cash equivalents and restricted cash classified as assets held for sale— (23.6)
Cash, cash equivalents and restricted cash at end of period$561.7 $717.7 
 The accompanying Notes to the Consolidated Financial Statements are
 an integral part of the Consolidated Financial Statements.
5


SiriusPoint Ltd.
Notes to the Consolidated Financial Statements (UNAUDITED)
(Expressed in U.S. Dollars)
1. Organization
SiriusPoint Ltd. (together with its consolidated subsidiaries, “SiriusPoint” or the “Company”) was incorporated under the laws of Bermuda on October 6, 2011. Through its subsidiaries, the Company is a provider of global multi-line insurance and reinsurance products and services. 
These unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete annual financial statements. This Quarterly Report on Form 10-Q (“Form 10-Q”) should be read in conjunction with the audited financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”) filed with the U.S. Securities and Exchange Commission on February 24, 2026.
In the opinion of management, these unaudited consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of the Company’s financial position and results of operations as at the end of and for the periods presented. All intercompany balances and transactions have been eliminated.
The results for the nine months ended September 30, 2026 are not necessarily indicative of the results for the full calendar year.
Tabular amounts are in U.S. Dollars in millions, except share amounts, unless otherwise noted.
2. Significant accounting policies
Other than the items listed below, there were no significant updates to the Company’s significant accounting policies as described in its 2025 Form 10-K.
Business combinations
The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price of the acquisition is allocated to the assets acquired and liabilities assumed using the fair values determined by management as of the acquisition date.
Goodwill
Goodwill represents the excess of acquisition cost over the fair value of the identifiable assets acquired and liabilities assumed in connection with an acquisition. The Company will assess goodwill for impairment annually or more frequently if circumstances indicate that impairment may have occurred. In performing impairment tests, the Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit exceeds its carrying amount as a basis for determining whether it is necessary to perform quantitative goodwill impairment testing as described in the accounting guidance.
If goodwill is impaired, such assets are written down to their fair values with the related expense recorded in the Company’s results of operations.
Recently issued accounting standards
Issued and effective as of September 30, 2026
Management of Credit Losses for Accounts Receivable and Contract Assets
In July 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). The amendment provides guidance for estimating expected credit losses on current accounts receivable and current contract assets. ASU 2025-05 is effective for all entities for annual periods beginning after December 15, 2025, and

6


interim reporting periods within those annual reporting periods. The Company adopted this accounting standard effective January 1, 2026 and its adoption did not have a material impact on the Company’s consolidated financial statements.
Issued but not yet effective as of September 30, 2026
Expense Disaggregation Disclosures
In November 2024, the FASB issued Accounting Standards Update 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Management is in the process of reviewing this update to assess the impact on the Company’s consolidated financial statements and disclosures.
Internal-Use Software
In September 2025, the FASB issued Accounting Standards Update 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). The amendment updates accounting guidelines around capitalizing software costs. ASU 2025-06 is effective for all entities for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Management is in the process of reviewing this update to assess the impact on the Company’s consolidated financial statements and disclosures.
The Company considers the applicability and impact of all accounting standard updates ("ASUs") issued by the FASB. ASUs issued during the three and nine months ended September 30, 2026 and not listed above were assessed and either determined to be not applicable or expected to have minimal impact on the Company’s consolidated financial statements and disclosures.
Reclassifications
Certain comparative figures have been reclassified to conform to the current year presentation. These reclassifications had no impact on the previously reported net income (loss) or shareholders’ equity attributable to SiriusPoint shareholders.
3. Significant transactions
Sale of Arcadian
On October 3, 2025, the Company entered into an agreement to sell its 49% equity stake in Arcadian Risk Capital Ltd. (“Arcadian”) to Lee Equity Partners for total consideration of $140.4 million, inclusive of a pre-close dividend. The Company also renewed and extended its capacity agreement with Arcadian until the end of 2031. On January 30, 2026, the transaction closed following the satisfaction of customary closing conditions and the Company recognized a gain of $25.2 million in Other revenues in its consolidated income statement during the nine months ended September 30, 2026.
During 2025, the Company accounted for its 49% ownership in Arcadian under the equity method of accounting and recorded its share of net income in Other revenues in its consolidated income statement. As of December 31, 2025, a held for sale asset of $115.2 million was recorded in the Company’s consolidated balance sheet.
Acquisition of Assist America
On December 31, 2025, the Company, through its wholly owned subsidiaries, entered into an agreement to acquire Assist America Inc. and its affiliates (“Assist America”) for $44.0 million in cash and other contingent considerations. Pursuant to the agreement, Assist America became a consolidated subsidiary of the Company effective as of January 1, 2026 and the acquisition was accounted for as a business combination. The consideration was allocated to Assist America’s assets acquired and liabilities assumed based on their fair value as of the acquisition date. The consideration transferred is subject to customary post-closing adjustments, which could affect the preliminary goodwill recognized.
Goodwill of $18.6 million was recognized within the Insurance & Services segment and is primarily attributable to the Company’s third-party medical and travel assistance capacities and the synergies that can be achieved subsequent to the Assist America acquisition. A majority of the goodwill recognized is expected to be deductible for tax purposes.

7


Acquisition of World Nomads
On September 30, 2026, the Company, through its wholly owned subsidiaries, completed the acquisition of equity interests and assets comprising the World Nomads travel insurance business operated by nib Travel Pty Ltd. (collectively, “World Nomads”) for $48.0 million in cash, and the acquisition was accounted for as a business combination. World Nomads became a consolidated subsidiary of the Company as of the acquisition date. The purchase consideration was allocated to assets acquired and liabilities assumed based on their acquisition-date fair value. The consideration transferred remains subject to customary post-closing adjustments, which may affect the preliminary goodwill recognized.
The Company recognized goodwill of $27.5 million within the Insurance & Services segment, primarily attributable to the Company's travel insurance distribution capabilities and expected synergies resulting from the acquisition of World Nomads. A majority of the goodwill recognized is expected to be deductible for tax purposes.
4. Segment reporting
The determination of the Company’s business segments is based on the manner in which management monitors the performance of its operations. The Company reports two operating segments: Insurance & Services and Reinsurance. The Company’s segments each have managers who are responsible for the overall profitability of their segments and who are directly accountable to the Company’s chief operating decision maker (“CODM”), the Chief Executive Officer. The CODM assesses segment operating performance, allocates capital and makes resource allocation decisions accordingly. Further, the CODM does not manage the Company’s assets by segment; accordingly, total assets are not allocated to the segments, excluding goodwill recognized due to the Assist America and World Nomads acquisitions, which is allocated to the Insurance & Services segment. We continue to evaluate our segments as our business evolves and may further refine our segments and segment income (loss) measures.
Insurance & Services
In the Insurance & Services segment, the Company underwrites primary insurance in several sectors. The Insurance & Services segment includes Accident & Health, Property & Casualty, and Other Specialties.
Accident and Health (“A&H”) – the Company provides insurance products to meet the risk management needs of diverse populations in select markets. This includes employer groups, associations, affinity groups, higher education and other niche markets. The Company also owns 100% of International Medical Group, Inc. (“IMG”), who receive fees for services provided within the Insurance & Services segment and to third parties. IMG offers a full line of international medical insurance products, travel insurance programs, medical management services and 24/7 emergency medical and travel assistance. The Company owned 100% of ArmadaCorp Capital, LLC (“Armada”) through October 31, 2025, when it was sold to Octave Specialty Group, Inc (formerly known as Ambac Financial Group, Inc.) and deconsolidated as of November 1, 2025. SiriusPoint will continue its underwriting capacity partnership with Armada until the end of 2030. Armada operates as a supplemental medical insurance managing general agent (“MGA”).
Property & Casualty – the Company is a carrier for program administrators and MGAs. The majority of its P&C insurance business is written through partners in the Property & Casualty space, covering Financial and Professional Liability, General Liability, Environmental and Commercial Auto lines around the world, including Bermuda, Europe, London and the U.S.
Other Specialties – SiriusPoint’s business encompasses a broad range of worldwide insurance coverages. Other Specialties business lines in the Insurance & Services segment include Aviation, Marine & Energy, Credit, Surety and Mortgage.
Reinsurance
In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk bearing vehicles on a treaty or facultative basis. For reinsurance assumed, the Company participates in the reinsurance market with a global focus through the broker market distribution channel. The Company primarily writes treaty reinsurance, on both a proportional and excess of loss basis, and provides facultative reinsurance in some of its business lines. In the United States and Bermuda, the Company’s core focus is on distribution, risk and clients located in North America, while our international operation is focused primarily on distribution, risks and clients located in Europe.
The Reinsurance segment predominantly underwrites Casualty, Property and Other Specialties lines of business.

8


Casualty – the Company provides reinsurance to casualty insurers who underwrite a diverse range of casualty classes. The Company works with clients all over the world, including multi-national, nationwide and regional carriers, as well as risk retention groups and captives. The Company’s underwriting focus is on all major commercial casualty lines, including Financial and Professional Liability and General Liability lines, with an emphasis on specialty niche classes of business, including personal lines.
Property – the Company works with leading global brokers as well as large national writers and regional companies. Underwriting is focused on providing critical catastrophe protection and worldwide coverage for natural perils, underwriting residential, commercial, and industrial risks in the United States, Europe and Asia.
Other Specialties – the Company’s business encompasses a broad range of worldwide reinsurance coverages, including proportional and excess of loss, treaty and facultative. Other Specialties business lines in the Reinsurance segment include Aviation & Space, Marine & Energy and Credit.
Management uses segment income (loss) as the primary basis for assessing segment performance. Segment income (loss) is comprised of two components, underwriting income (loss) and net services income (loss). The Company calculates underwriting income (loss) by subtracting loss and loss adjustment expenses incurred, net, acquisition costs, net, and other underwriting expenses from net earned premium. Net services income (loss) consists of services revenues (fees for services revenues), services expenses, and services non-controlling (income) loss. This definition of segment income (loss) aligns with how business performance is managed and monitored. Certain items are presented in a different manner for segment reporting purposes than in the consolidated statements of income. These items are reconciled to the consolidated presentation in the segment measure reclass column below. Included in Insurance & Services segment income (loss) are services noncontrolling loss (income) attributable to minority shareholders on non-wholly-owned subsidiaries. In addition, services revenues and services expenses are reconciled to other revenues and net corporate and other expenses, respectively.
Segment results are shown prior to corporate eliminations. Corporate eliminations are included in the elimination column below as necessary to reconcile to underwriting income (loss), net services income (loss), and segment income (loss) to the consolidated statements of income.
Corporate includes the results of all run-off business, which represents certain classes of business that the Company ceased underwriting as part of fundamental changes to its business strategy, including the effect of the restructuring of the underwriting platform announced in 2022 and certain reinsurance contracts that have interest crediting features. Corporate results also include asbestos and environmental and other latent liability exposures on a gross basis, which have mostly been ceded, as well as specific workers’ compensation and cyber programs which the Company no longer writes. In addition, revenue and expenses managed at the corporate level, including realized and unrealized gains (losses) and other investment income, non services-related other revenues, non services-related net corporate and other expenses, intangible asset amortization, interest expense, foreign exchange (gains) losses and income tax (expense) benefit are reported within Corporate. The CODM does not manage segment results or allocate resources to segments when considering these items and they are therefore excluded from our definition of segment income (loss).

9


The following is a summary of the Company’s operating segment results for the three and nine months ended September 30, 2026 and 2025:
Three months ended September 30, 2026
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$673.0 $317.6 $990.6 $— $4.3 $— $994.9 
Net written premium403.5 275.2 678.7 — 1.7 — 680.4 
Net earned premium460.8 304.0 764.8 — 2.8 — 767.6 
Loss and loss adjustment expenses incurred, net263.6 154.0 417.6 (2.1)0.4 — 415.9 
Acquisition costs, net136.9 86.2 223.1 (28.7)0.8 — 195.2 
Other underwriting expenses27.3 20.9 48.2 — 4.8 — 53.0 
Underwriting income (loss)33.0 42.9 75.9 30.8 (3.2)— 103.5 
Services revenues61.5 — 61.5 (31.2)— (30.3)— 
Services expenses49.4 — 49.4 — — (49.4)— 
Net services fee income12.1 — 12.1 (31.2)— 19.1 — 
Services noncontrolling income(0.2)— (0.2)— — 0.2 — 
Net services income11.9 — 11.9 (31.2)— 19.3 — 
Segment income (loss)44.9 42.9 87.8 (0.4)(3.2)19.3 103.5 
Net investment income65.9 — 65.9 
Net investment gains (losses)3.3 — 3.3 
Other revenues0.5 30.3 30.8 
Net corporate and other expenses(26.3)(49.4)(75.7)
Intangible asset amortization(2.5)— (2.5)
Interest expense(18.4)— (18.4)
Foreign exchange losses(3.2)— (3.2)
Income before income tax expense$44.9 $42.9 87.8 (0.4)16.1 0.2 103.7 
Income tax expense— — (16.7)— (16.7)
Net income (loss)87.8 (0.4)(0.6)0.2 87.0 
Net (income) loss attributable to noncontrolling interest— — — (0.2)(0.2)
Net income (loss) available to SiriusPoint$87.8 $(0.4)$(0.6)$— $86.8 
Attritional losses$272.7 $163.2 $435.9 $(2.1)$1.9 $— $435.7 
Catastrophe losses— — — — — — — 
Prior year loss reserve development(9.1)(9.2)(18.3)— (1.5)— (19.8)
Loss and loss adjustment expenses incurred, net$263.6 $154.0 $417.6 $(2.1)$0.4 $— $415.9 
Underwriting Ratios: (1)
Attritional loss ratio59.2 %53.7 %57.0 %56.8 %
Catastrophe loss ratio— %— %— %— %
Prior year loss development ratio(2.0)%(3.0)%(2.4)%(2.6)%
Loss ratio57.2 %50.7 %54.6 %54.2 %
Acquisition cost ratio29.7 %28.4 %29.2 %25.4 %
Other underwriting expenses ratio5.9 %6.9 %6.3 %6.9 %
Combined ratio
92.8 %86.0 %90.1 %86.5 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.

10


Three months ended September 30, 2025
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$562.0 $309.6 $871.6 $— $2.8 $— $874.4 
Net written premium396.8 268.1 664.9 — 5.4 — 670.3 
Net earned premium381.2 262.3 643.5 — 4.2 — 647.7 
Loss and loss adjustment expenses incurred, net225.3 145.5 370.8 (1.5)3.6 — 372.9 
Acquisition costs, net98.3 64.7 163.0 (26.9)3.7 — 139.8 
Other underwriting expenses19.9 20.2 40.1 — 3.5 — 43.6 
Underwriting income (loss)37.7 31.9 69.6 28.4 (6.6)— 91.4 
Services revenues58.5 — 58.5 (32.7)— (25.8)— 
Services expenses48.5 — 48.5 — — (48.5)— 
Net services fee income10.0 — 10.0 (32.7)— 22.7 — 
Services noncontrolling loss0.1 — 0.1 — — (0.1)— 
Net services income10.1 — 10.1 (32.7)— 22.6 — 
Segment income (loss)47.8 31.9 79.7 (4.3)(6.6)22.6 91.4 
Net investment income66.5 — 66.5 
Net investment gains (losses)6.2 — 6.2 
Other revenues9.7 25.8 35.5 
Net corporate and other expenses(14.0)(48.5)(62.5)
Intangible asset amortization(2.8)— (2.8)
Interest expense(21.0)— (21.0)
Foreign exchange losses(2.4)— (2.4)
Income before income tax expense$47.8 $31.9 79.7 (4.3)35.6 (0.1)110.9 
Income tax expense— — (20.2)— (20.2)
Net income79.7 (4.3)15.4 (0.1)90.7 
Net loss attributable to noncontrolling interests— — — 0.1 0.1 
Net income available to SiriusPoint$79.7 $(4.3)$15.4 $— $90.8 
Attritional losses$234.8 $145.1 $379.9 $(1.5)$3.4 $— $381.8 
Catastrophe losses— — — — — — — 
Prior year loss reserve development(9.5)0.4 (9.1)— 0.2 — (8.9)
Loss and loss adjustment expenses incurred, net$225.3 $145.5 $370.8 $(1.5)$3.6 $— $372.9 
Underwriting Ratios: (1)
Attritional loss ratio61.6 %55.3 %59.0 %59.0 %
Catastrophe loss ratio— %— %— %— %
Prior year loss development ratio(2.5)%0.2 %(1.4)%(1.4)%
Loss ratio59.1 %55.5 %57.6 %57.6 %
Acquisition cost ratio25.8 %24.7 %25.3 %21.6 %
Other underwriting expenses ratio5.2 %7.7 %6.2 %6.7 %
Combined ratio90.1 %87.9 %89.1 %85.9 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.


11


Nine months ended September 30, 2026
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$2,002.2 $973.7 $2,975.9 $— $0.1 $— $2,976.0 
Net written premium1,287.0 798.0 2,085.0 — 0.9 — 2,085.9 
Net earned premium1,222.6 819.3 2,041.9 — 4.9 — 2,046.8 
Loss and loss adjustment expenses incurred, net 695.8 428.1 1,123.9 (5.7)18.8 — 1,137.0 
Acquisition costs, net349.1 225.7 574.8 (73.2)(1.8)— 499.8 
Other underwriting expenses 79.2 62.2 141.4 — 13.9 — 155.3 
Underwriting income (loss)98.5 103.3 201.8 78.9 (26.0)— 254.7 
Services revenues174.9 — 174.9 (84.1)— (90.8)— 
Services expenses145.1 — 145.1 — — (145.1)— 
Net services fee income29.8 — 29.8 (84.1)— 54.3 — 
Services noncontrolling loss0.4 — 0.4 — — (0.4)— 
Net services income30.2 — 30.2 (84.1)— 53.9 — 
Segment income (loss)128.7 103.3 232.0 (5.2)(26.0)53.9 254.7 
Net investment income197.8 — 197.8 
Net investment gains (losses)22.6 — 22.6 
Other revenues28.3 90.8 119.1 
Net corporate and other expenses(75.5)(145.1)(220.6)
Intangible asset amortization(7.5)— (7.5)
Interest expense(53.9)— (53.9)
Foreign exchange losses(2.7)— (2.7)
Income before income tax expense$128.7 $103.3 232.0 (5.2)83.1 (0.4)309.5 
Income tax expense— — (51.7)— (51.7)
Net income232.0 (5.2)31.4 (0.4)257.8 
Net income attributable to noncontrolling interests— — (0.6)0.4 (0.2)
Net income available to SiriusPoint$232.0 $(5.2)$30.8 $— $257.6 
Attritional losses$734.8 $449.6 $1,184.4 $(5.7)$4.3 $— $1,183.0 
Catastrophe losses1.3 5.4 6.7 — — — 6.7 
Prior year loss reserve development(40.3)(26.9)(67.2)— 14.5 — (52.7)
Loss and loss adjustment expenses incurred, net$695.8 $428.1 $1,123.9 $(5.7)$18.8 $— $1,137.0 
Underwriting Ratios: (1)
Attritional loss ratio60.1 %54.9 %58.0 %57.9 %
Catastrophe loss ratio0.1 %0.7 %0.3 %0.3 %
Prior year loss development ratio(3.3)%(3.3)%(3.3)%(2.6)%
Loss ratio56.9 %52.3 %55.0 %55.6 %
Acquisition cost ratio28.6 %27.5 %28.2 %24.4 %
Other underwriting expenses ratio6.5 %7.6 %6.9 %7.6 %
Combined ratio
92.0 %87.4 %90.1 %87.6 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.

12


Nine months ended September 30, 2025
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$1,757.5 $1,034.1 $2,791.6 $— $15.7 $— $2,807.3 
Net written premium1,273.1 843.6 2,116.7 — 1.0 — 2,117.7 
Net earned premium1,086.6 828.3 1,914.9 — 11.5 — 1,926.4 
Loss and loss adjustment expenses incurred, net644.4 497.2 1,141.6 (5.0)10.7 — 1,147.3 
Acquisition costs, net283.5 202.3 485.8 (83.1)7.7 — 410.4 
Other underwriting expenses61.4 60.4 121.8 — 11.2 — 133.0 
Underwriting income (loss)97.3 68.4 165.7 88.1 (18.1)— 235.7 
Services revenues178.7 — 178.7 (94.6)— (84.1)— 
Services expenses141.2 — 141.2 — — (141.2)— 
Net services fee income37.5 — 37.5 (94.6)— 57.1 — 
Services noncontrolling loss0.2 — 0.2 — — (0.2)— 
Net services income37.7 — 37.7 (94.6)— 56.9 — 
Segment income (loss)135.0 68.4 203.4 (6.5)(18.1)56.9 235.7 
Net investment income205.9 — 205.9 
Net investment gains (losses)6.6 — 6.6 
Other revenues8.4 84.1 92.5 
Net corporate and other expenses(52.8)(141.2)(194.0)
Intangible asset amortization(8.5)— (8.5)
Interest expense(60.2)— (60.2)
Foreign exchange losses(16.9)— (16.9)
Income before income tax expense$135.0 $68.4 203.4 (6.5)64.4 (0.2)261.1 
Income tax expense— — (45.1)— (45.1)
Net income203.4 (6.5)19.3 (0.2)216.0 
Net income attributable to noncontrolling interests— — (0.6)0.2 (0.4)
Net income available to SiriusPoint$203.4 $(6.5)$18.7 $— $215.6 
Attritional losses$661.3 $470.1 $1,131.4 $(5.0)$5.3 $— $1,131.7 
Catastrophe losses4.8 62.6 67.4 — — — 67.4 
Prior year loss reserve development(21.7)(35.5)(57.2)— 5.4 — (51.8)
Loss and loss adjustment expenses incurred, net$644.4 $497.2 $1,141.6 $(5.0)$10.7 $— $1,147.3 
Underwriting Ratios: (1)
Attritional loss ratio60.9 %56.7 %59.1 %58.8 %
Catastrophe loss ratio0.4 %7.6 %3.5 %3.5 %
Prior year loss development ratio(2.0)%(4.3)%(3.0)%(2.7)%
Loss ratio59.3 %60.0 %59.6 %59.6 %
Acquisition cost ratio26.1 %24.4 %25.4 %21.3 %
Other underwriting expenses ratio5.7 %7.3 %6.4 %6.9 %
Combined ratio91.1 %91.7 %91.4 %87.8 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.

13


5. Cash, cash equivalents, restricted cash and restricted investments
The following table provides a summary of cash and cash equivalents, restricted cash and restricted investments as of September 30, 2026 and December 31, 2025:
September 30,
2026
December 31,
2025
Cash and cash equivalents$434.3 $731.2 
Restricted cash securing letter of credit facilities (1)
23.0 69.1 
Restricted cash securing reinsurance contracts (2)
90.0 89.3 
Restricted cash held by managing general underwriters14.4 12.8 
Total cash, cash equivalents and restricted cash (3)
561.7 902.4 
Restricted investments securing reinsurance contracts and letter of credit facilities (1) (2) (4)
1,733.1 2,040.7 
Total cash, cash equivalents, restricted cash and restricted investments$2,294.8 $2,943.1 
(1)Restricted cash and restricted investments securing letter of credit facilities primarily pertains to letters of credit that have been issued to the Company’s clients in support of its obligations under reinsurance contracts. The Company will not be released from the obligation to provide these letters of credit until the reserves underlying the reinsurance contracts have been settled. The time period for which the Company expects each letter of credit to be in place varies from contract to contract but can last several years.
(2)Restricted cash and restricted investments securing reinsurance contracts pertain to trust accounts securing the Company’s contractual obligations under certain reinsurance contracts that the Company will not be released from until the underlying risks have expired or have been settled. Restricted investments include certain investments in debt securities and short-term investments. The time period for which the Company expects these trust accounts to be in place varies from contract to contract, but can last several years.
(3)Cash, cash equivalents and restricted cash as reported in the Company’s consolidated statements of cash flows.
(4)Restricted investments include required deposits with certain insurance state regulatory agencies in order to maintain insurance licenses.
6. Fair value measurements
U.S. GAAP disclosure requirements establish a framework for measuring fair value, including a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. The three-level hierarchy of inputs is summarized below:
•Level 1 – Quoted prices available in active markets/exchanges for identical investments as of the reporting date.
•Level 2 – Observable inputs to the valuation methodology other than unadjusted quoted market prices for identical assets or liabilities in active markets. Level 2 inputs include, but are not limited to, prices quoted for similar assets or liabilities in active markets/exchanges, prices quoted for identical or similar assets or liabilities in markets that are not active and fair values determined through the use of models or other valuation methodologies.
•Level 3 – Inputs are based all or in part on significant unobservable inputs for the investment, and include situations where there is little, if any, market activity for the investment. The inputs applied in the determination of fair value require significant management judgment and estimation.
Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including, but not limited to, assumptions about risk inherent in a particular valuation technique used to measure fair value such as a pricing model and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable.
Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources other than those of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the investment.

14


The following tables present the Company’s investments measured and reported at fair value, categorized by the level of the fair value hierarchy as of September 30, 2026 and December 31, 2025:
September 30, 2026
 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Total
 (Level 1) (Level 2) (Level 3)
Assets
Asset-backed securities$— $770.0 $— $770.0 
Residential mortgage-backed securities— 1,066.6 — 1,066.6 
Commercial mortgage-backed securities— 247.5 — 247.5 
Corporate debt securities— 2,380.1 — 2,380.1 
U.S. government and government agency880.8 — — 880.8 
Non-U.S. government and government agency— 19.8 — 19.8 
Total debt securities, available for sale880.8 4,484.0 — 5,364.8 
Asset-backed securities— 5.0 — 5.0 
Residential mortgage-backed securities— 24.9 — 24.9 
Commercial mortgage-backed securities— 19.5 — 19.5 
Corporate debt securities— 2.9 — 2.9 
U.S. government and government agency3.0 — — 3.0 
Total debt securities, trading3.0 52.3 — 55.3 
Short-term investments17.1 — — 17.1 
Other long-term investments— — 56.9 56.9 
Derivative assets— — 2.6 2.6 
$900.9 $4,536.3 $59.5 5,496.7 
Cost and equity method investments60.4 
Investments in funds valued at NAV159.2 
Total assets$5,716.3 
Liabilities
Derivative liabilities $— $— $24.6 $24.6 
Total liabilities$— $— $24.6 $24.6 

15


December 31, 2025
 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Total
 (Level 1) (Level 2) (Level 3)
Assets
Asset-backed securities$— $921.1 $— $921.1 
Residential mortgage-backed securities— 963.1 — 963.1 
Commercial mortgage-backed securities— 231.9 — 231.9 
Corporate debt securities— 2,198.2 — 2,198.2 
U.S. government and government agency835.7 — — 835.7 
Non-U.S. government and government agency— 18.6 — 18.6 
Total debt securities, available for sale835.7 4,332.9 — 5,168.6 
Asset-backed securities— 5.9 — 5.9 
Residential mortgage-backed securities— 45.0 — 45.0 
Commercial mortgage-backed securities— 31.9 — 31.9 
Corporate debt securities— 3.7 — 3.7 
U.S. Government and government agency3.8 — — 3.8 
Total debt securities, trading3.8 86.5 — 90.3 
Short-term investments28.3 — — 28.3 
Other long-term investments— 5.2 82.9 88.1 
Derivative assets— — 14.4 14.4 
$867.8 $4,424.6 $97.3 5,389.7 
Cost and equity method investments69.3 
Investments in funds valued at NAV157.7 
Total assets$5,616.7 
Liabilities
Derivative liabilities$— $— $9.0 $9.0 
Total liabilities$— $— $9.0 $9.0 
During the nine months ended September 30, 2026, the Company did not reclassify its assets or liabilities between Levels 2 and 3 (December 31, 2025 - no reclassifications).
Valuation techniques
The Company uses independent pricing services to assist in determining fair values for its investments. For investments in active markets, the Company uses the quoted market prices provided by independent pricing services to determine fair value. In circumstances where quoted market prices are unavailable or are not considered reasonable, the Company estimates the fair value using industry standard pricing models and observable inputs such as benchmark yields, reported trades, broker-dealer quotes, issuer spreads, benchmark securities, bids, offers, prepayment speeds, reference data including research publications, and other relevant inputs. Given that many debt securities do not trade on a daily basis, the independent pricing services evaluate a wide range of fixed maturity investments by regularly drawing parallels from recent trades and quotes of comparable securities with similar features. The characteristics used to identify comparable debt securities vary by asset type and take into account market convention.
The techniques and inputs specific to asset classes within the Company’s debt securities and short-term investments for Level 2 securities that use observable inputs are as follows:
Asset-backed and mortgage-backed securities
The fair value of mortgage and asset-backed securities is primarily priced by independent pricing services using a pricing model that uses information from market sources and leveraging similar securities. Key inputs include benchmark yields, reported trades, underlying tranche cash flow data, collateral performance, plus new issue data, as well as broker-dealer

16


quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including issuer, vintage, loan type, collateral attributes, prepayment speeds, default rates, recovery rates, cash flow stress testing, credit quality ratings and market research publications.
Corporate debt securities
Corporate debt securities consist primarily of investment-grade debt of a wide variety of U.S. and non-U.S. corporate issuers and industries. The corporate fixed maturity investments are primarily priced by independent pricing services. When evaluating these securities, the independent pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The independent pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk.
U.S. government and government agency
U.S. government and government agency securities consist primarily of debt securities issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. Fixed maturity investments included in U.S. government and government agency securities are primarily priced by independent pricing services. When evaluating these securities, the independent pricing services gather information from market sources and integrate other observations from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The fair value of each security is individually computed using analytical models which incorporate option adjusted spreads and other daily interest rate data.
Non-U.S. government and government agency
Non-U.S. government and government agency securities consist of debt securities issued by non-U.S. governments and their agencies along with supranational organizations (also known as sovereign debt securities). Securities held in these sectors are primarily priced by independent pricing services who employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for treasury, swap and high issuance credits. The independent pricing services then apply a credit spread for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the independent pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets.
U.S. states, municipalities, and political subdivisions
The U.S. states, municipalities and political subdivisions portfolio contains debt securities issued by U.S. domiciled state and municipal entities. These securities are generally priced by independent pricing services using the techniques for U.S. government and government agency securities described above.
Short-term investments
Short-term investments consist of U.S. treasury bills, certificates of deposit and other securities, which, at the time of purchase, mature within a period of greater than three months but less than one year. These investments are generally priced by independent pricing services using the techniques for U.S. government and government agency securities and Corporate debt securities described above.
Investments measured using Net Asset Value
The Company measures its investments in limited partnerships, including its investments in hedge funds and private equity funds, at fair value using the net asset value ("NAV") per share, or its equivalent, as a practical expedient. NAV represents the Company's proportionate interest in the partners' or members' equity of each fund, as reported by the fund's administrator or investment manager.

Since final fund valuations are generally not available as of the Company's reporting date, the Company records these investments on a lag of generally one to three months, using the most recent NAV or capital statement available. The reported NAV is adjusted for capital contributions and distributions during the lag period and for significant known events that

17


indicate a material change in value. Other changes in NAV are recognized in the period in which the capital statement is received.

These investments are included in investment in funds valued at NAV and excluded from the presentation of investments categorized by the level of the fair value hierarchy.
Level 3 Investments
Level 3 valuations are generated from techniques that use assumptions not observable in the market. These unobservable assumptions reflect the Company's assumptions that market participants would use in valuing the investment. Generally, certain securities may start out as Level 3 when they are originally issued but as observable inputs become available in the market, they may be reclassified to Level 2.
The Company employs a number of procedures to assess the reasonableness of the fair value measurements for its other long-term investments, including obtaining and reviewing the audited annual financial statements of hedge funds and private equity funds and periodically discussing each fund's pricing with the fund manager. However, since the fund managers do not provide sufficient information to evaluate the pricing inputs and methods for each underlying investment, the inputs are considered to be unobservable.
The fair values of the Company's investments in private equity securities, private debt instruments, certain private equity funds, and certain hedge funds have been classified as Level 3 measurements. Private equity securities and private debt instruments are initially valued based on transaction price and their valuation is subsequently estimated based on available evidence such as a market transaction in similar instruments and other financial information for the issuer.
For strategic investments carried at fair value, management either engages a third-party valuation specialist to assist in determination of the fair value based on commonly accepted valuation methods (e.g., income approach, market approach) as of the valuation date or performs valuation internally. In addition, investors’ fair value analyses prepared by third party valuation specialists working with strategic investment operating management are referenced where available. Where criteria to be accounted for under the equity method is not met, we have elected to value our strategic investments at the cost adjusted for market observable events less impairment method, a measurement alternative in which the investment is measured at cost and remeasured to fair value when determined to be impaired or upon observable transactions prices becoming available.
See Note 8 for additional information on the fair values of derivative financial instruments used for both risk management and investment purposes.
Underwriting-related derivatives
Underwriting-related derivatives include reinsurance contracts that are accounted for as derivatives. These derivative contracts are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair values of these derivatives are determined using internally developed discounted cash flow models. As the significant inputs used to price these derivatives are unobservable, the fair values of these contracts are classified as Level 3.
The following tables present the reconciliation of investments measured at fair value using Level 3 inputs for the three and nine months ended September 30, 2026 and 2025:
July 1,
2026
Transfers in to (out of) Level 3PurchasesSales & Settlements
Realized and Unrealized Gains (Losses) (1)
September 30,
2026
Other long-term investments$57.5 $— $— $— $(0.6)$56.9 
Net derivatives (2)
$(22.9)$— $— $3.4 $(2.5)$(22.0)
January 1, 2026Transfers in to (out of) Level 3PurchasesSales & Settlements
Realized and Unrealized Gains(Losses) (1)
September 30,
2026
Other long-term investments$82.9 $— $— $(22.7)$(3.3)$56.9 
Net derivatives (2)
$5.4 $— $— $2.1 $(29.5)$(22.0)

18



19


July 1,
2025
Transfers in to (out of) Level 3PurchasesSales & Settlements
Realized and Unrealized Gains (Losses) (1)
September 30,
2025
Other long-term investments$87.0 $— $— $— $1.1 $88.1 
Net derivatives (2)
$6.8 $— $— $— $(6.8)$— 
January 1, 2025Transfers in to (out of) Level 3PurchasesSales & Settlements
Realized and Unrealized Gains (Losses) (1)
September 30,
2025
Other long-term investments$86.6 $— $— $— $1.5 $88.1 
Net derivatives (2)
$(13.4)$— $— $5.4 $8.0 $— 
(1)Total change in realized and unrealized gains (losses) recorded on Level 3 financial instruments is included in net investment gains (losses) in the consolidated statements of income. Realized and unrealized gains (losses) related to underwriting related derivative assets and liabilities are included in other revenues, net of foreign exchange (gains) losses, in the consolidated statements of income. See Note 8 “Derivatives” for classifications of gains (losses) on derivatives.
(2)Derivative assets are presented within Other assets on the consolidated balance sheets and derivative liabilities are presented within Other liabilities on the consolidated balance sheets. The amounts are presented net in the tables above for the purposes of the rollforward.
For assets and liabilities that were transferred into Level 3 during the period, gains (losses) are presented as if the assets or liabilities had been transferred into Level 3 at the beginning of the period; similarly, for assets and liabilities that were transferred out of Level 3 during the period, gains (losses) are presented as if the assets or liabilities had been transferred out of Level 3 at the beginning of the period.
The following table includes financial instruments for which the carrying value differs from the estimated fair values as of September 30, 2026 and December 31, 2025. The fair values of the below financial instruments are based on observable inputs and are considered Level 2 measurements.
September 30, 2026December 31, 2025
Fair ValueCarrying ValueFair ValueCarrying Value
2024 Senior Notes$406.8 $396.9 $424.2 $396.0 
2017 SEK Subordinated Notes276.0 270.6 293.3 292.6 
Series B preference shares (1)
$— $— $202.2 $200.0 
(1)The Series B preference shares were fully redeemed on February 26, 2026. See Note 14 for further discussion on the redemption.
7. Investments
The Company’s invested assets consist of investment securities and other long-term investments held for general investment purposes. The portfolio of investment securities includes debt securities available for sale, debt securities held for trading, short-term investments, and other long-term investments. Realized investment gains and losses on debt securities are reported in pre-tax revenues. Unrealized investment gains and losses on debt securities are reported based on classification. Trading securities flow through pre-tax revenues, whereas securities classified as available for sale (“AFS”) flow through other comprehensive income (loss).
For debt securities classified as AFS for which a decline in the fair value between the amortized cost is due to credit-related factors, an allowance is established for the difference between the estimated recoverable value and amortized cost with a corresponding impact to the consolidated statements of income. The allowance is limited to the difference between amortized cost and fair value. A credit loss impairment assessment is performed on securities using both quantitative and qualitative factors. Qualitative factors include significant declines in fair value below amortized cost. Additionally, a qualitative assessment is also performed over debt securities to evaluate potential credit losses. Examples of qualitative indicators include issuer credit downgrades as well as changes to credit spreads.
Declines in fair value related to a debt security that do not relate to a credit loss are recorded as a component of accumulated other comprehensive income (loss).

20


Debt securities
The following tables provide the cost or amortized cost, gross unrealized investment gains (losses), net foreign currency gains, and fair value of the Company's debt securities as of September 30, 2026 and December 31, 2025:
September 30, 2026
Cost or
amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Net foreign
currency
gains (losses)
Fair value
Debt securities, available for sale
Asset-backed securities$782.2 $1.3 $(13.5)$— $770.0 
Residential mortgage-backed securities1,110.9 0.3 (44.6)— 1,066.6 
Commercial mortgage-backed securities253.4 0.2 (6.1)— 247.5 
Corporate debt securities2,453.9 1.5 (76.5)1.2 2,380.1 
U.S. government and government agency 903.8 — (23.3)0.3 880.8 
Non-U.S. government and government agency19.7 — (0.3)0.4 19.8 
Total debt securities, available for sale (1)
$5,523.9 $3.3 $(164.3)$1.9 $5,364.8 
Debt securities, trading
Asset-backed securities$7.7 $— $(2.7)$— $5.0 
Residential mortgage-backed securities30.7 — (5.8)— 24.9 
Commercial mortgage-backed securities23.0 — (3.5)— 19.5 
Corporate debt securities16.2 0.1 (13.4)— 2.9 
U.S. government and government agency 3.0 — — — 3.0 
Total debt securities, trading$80.6 $0.1 $(25.4)$— $55.3 
December 31, 2025
Cost or
amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Net foreign
currency
gains (losses)
Fair value
Debt securities, available for sale
Asset-backed securities$917.1 $7.3 $(3.3)$— $921.1 
Residential mortgage-backed securities950.1 17.7 (4.7)— 963.1 
Commercial mortgage-backed securities231.3 3.1 (2.5)— 231.9 
Corporate debt securities2,170.8 32.3 (2.4)(2.5)2,198.2 
U.S. government and government agency 830.5 5.6 (0.4)— 835.7 
Non-U.S. government and government agency18.5 0.2 — (0.1)18.6 
Total debt securities, available for sale (1)
$5,118.3 $66.2 $(13.3)$(2.6)$5,168.6 
Debt securities, trading
Asset-backed securities$8.3 $— $(2.4)$— $5.9 
Residential mortgage-backed securities50.7 0.1 (5.8)— 45.0 
Commercial mortgage-backed securities34.6 0.4 (3.1)— 31.9 
Corporate debt securities17.1 — (13.4)— 3.7 
U.S. government and government agency 3.9 — (0.1)— 3.8 
Total debt securities, trading$114.6 $0.5 $(24.8)$— $90.3 
(1)As of September 30, 2026 and December 31, 2025, the Company did not record an allowance for credit losses on the AFS portfolio.
As of September 30, 2026, 422 unique debt securities classified as AFS were in a gross unrealized loss position for greater than 12 months (December 31, 2025 - 379 unique debt securities). AFS debt securities in an unrealized loss position at September 30, 2026 and December 31, 2025 comprised primarily investment grade securities for which fair value declined below amortized cost, principally due to rising interest rates since the date of purchase. Refer to the tables below for the

21


Company’s breakdown of AFS debt securities in a gross unrealized loss position as of September 30, 2026 and December 31, 2025.
September 30, 2026
12 Months or LessGreater than 12 MonthsTotal
Fair valueGross unrealized lossesFair valueGross unrealized lossesFair valueGross unrealized losses
Debt securities, available for sale
Asset-backed securities$368.2 $(8.1)$39.5 $(5.4)$407.7 $(13.5)
Residential mortgage-backed securities848.2 (29.3)172.8 (15.3)1,021.0 (44.6)
Commercial mortgage-backed securities200.9 (5.8)2.6 (0.3)203.5 (6.1)
Corporate debt securities2,052.4 (67.5)159.5 (9.0)2,211.9 (76.5)
U.S. government and government agency782.9 (20.2)60.4 (3.1)843.3 (23.3)
Non-U.S. government and government agency11.0 (0.3)— — 11.0 (0.3)
Total debt securities, available for sale
$4,263.6 $(131.2)$434.8 $(33.1)$4,698.4 $(164.3)
December 31, 2025
12 Months or LessGreater than 12 MonthsTotal
Fair valueGross unrealized lossesFair valueGross unrealized lossesFair valueGross unrealized losses
Debt securities, available for sale
Asset-backed securities$184.5 $(1.5)$20.6 $(1.8)$205.1 $(3.3)
Residential mortgage-backed securities84.5 (0.5)190.5 (4.2)275.0 (4.7)
Commercial mortgage-backed securities46.2 (1.2)9.0 (1.3)55.2 (2.5)
Corporate debt securities309.4 (1.8)54.5 (0.6)363.9 (2.4)
U.S. government and government agency107.9 (0.1)42.2 (0.2)150.1 (0.3)
Non-U.S. government and government agency7.1 — — — 7.1 — 
Total debt securities, available for sale
$739.6 $(5.1)$316.8 $(8.1)$1,056.4 $(13.2)
The weighted average duration of the Company's debt securities, net of short positions in U.S. treasuries, as of September 30, 2026 was approximately 3.4 years, including short-term investments (December 31, 2025 - approximately 3.2 years).
The following table provides the cost or amortized cost and fair value of the Company's debt securities bifurcated into debt securities held for trading and AFS as of September 30, 2026 and December 31, 2025 by contractual maturity. Actual maturities could differ from contractual maturities because borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties.
September 30, 2026December 31, 2025
Debt securities, AFSDebt securities, tradingDebt securities, AFSDebt securities, trading
Cost or
amortized cost
Fair valueCost or
amortized cost
Fair valueCost or
amortized cost
Fair valueCost or
amortized cost
Fair value
Due in one year or less$214.7 $214.5 $3.1 $3.0 $202.6 $203.9 $4.1 $3.9 
Due after one year through five years2,279.0 2,223.2 1.6 1.6 1,954.5 1,974.7 2.4 2.3 
Due after five years through ten years849.9 810.1 — — 713.7 723.6 — — 
Due after ten years33.8 32.8 14.5 1.3 149.1 150.4 14.5 1.2 
Mortgage-backed and asset-backed securities2,146.5 2,084.2 61.4 49.4 2,098.4 2,116.0 93.6 82.9 
Total debt securities$5,523.9 $5,364.8 $80.6 $55.3 $5,118.3 $5,168.6 $114.6 $90.3 

22


Other long-term investments
The cost or amortized cost, gross unrealized investment gains and losses, net foreign currency gains, and fair values of the Company’s other long-term investments as of September 30, 2026 and December 31, 2025 were as follows:
Cost or
amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Net foreign
currency
gains
Fair value
September 30, 2026
Other long-term investments$398.1 $30.1 $(154.0)$2.3 $276.5 
December 31, 2025
Other long-term investments$421.9 $35.1 $(143.3)$1.4 $315.1 
The Company’s other long-term investments may be accounted for under either the equity method (“equity method investments”) or the fair value option (“equity method eligible unconsolidated entities”). The following table presents the components of other long-term investments as of September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
Equity method eligible unconsolidated entities, using the fair value option$66.0 $66.3 
Equity method investments46.0 33.1 
Other unconsolidated investments, at fair value (1)
150.1 179.5 
Other unconsolidated investments, at cost (2)
14.4 36.2 
Total other long-term investments (3)
$276.5 $315.1 
(1)Includes other long-term investments that are not equity method eligible and are measured at fair value.
(2)The Company has elected to apply the cost adjusted for market observable events impairment measurement alternative to investments that do not meet the criteria to be accounted for under the equity method, in which the investment is measured at cost and remeasured to fair value when impaired or upon observable transaction prices.
(3)As of September 30, 2026, the Company had $30.0 million of unfunded commitments relating to these investments (December 31, 2025 - $58.5 million).
Net investment income
Net investment income for the three and nine months ended September 30, 2026 and 2025 consisted of the following:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Debt securities, available for sale$65.1 $63.2 $190.0 $186.1 
Debt securities, trading0.8 2.0 3.0 6.3 
Short-term investments0.1 0.4 0.6 1.4 
Other long-term investments0.2 0.4 4.0 4.8 
Cash, cash equivalents and other3.8 5.4 15.1 21.2 
Gross investment income70.0 71.4 212.7 219.8 
Investment expenses(4.1)(4.9)(14.9)(13.9)
Net investment income$65.9 $66.5 $197.8 $205.9 

23


Net investment gains (losses)
Net investment gains (losses) for the three and nine months ended September 30, 2026 and 2025 consisted of the following:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Debt securities, available for sale
Gross realized gains$2.2 $10.3 $17.4 $20.4 
Gross realized losses(12.1)(1.2)(18.5)(15.7)
Net realized gains (losses) on Debt securities, available for sale(9.9)9.1 (1.1)4.7 
Debt securities, trading
Net realized gains (losses)(0.1)0.1 (1.4)(1.7)
Net unrealized gains (losses) (2.0)1.4 (2.2)5.2 
Other long-term investments
Net realized gains (losses)23.8 (4.9)82.7 (7.2)
Net unrealized gains (losses)(8.7)0.4 (56.5)4.1 
Other (1)
0.2 0.1 1.1 1.5 
Total net investment gains (losses)$3.3 $6.2 $22.6 $6.6 
(1)Includes short-term investments, cash and cash equivalents, and derivatives.
8. Derivatives
The Company holds derivatives for both risk management and investment purposes.
Foreign currency exchange rate derivatives
The Company executes foreign currency forwards, swaps, and futures to manage foreign currency exposure. The foreign currency exchange rate derivatives are not designated or accounted for under hedge accounting. The fair value of the swaps and forwards are estimated using a single broker quote, and accordingly, are classified as a Level 3 measurement. The fair value of the futures is widely available and have quoted prices in active markets, and accordingly, were classified as a Level 1 measurement. As of September 30, 2026, the Company pledged no securities collateral associated with the foreign currency derivatives (December 31, 2025 - none). Securities pledged as collateral are included in debt securities, available for sale, in the Company’s consolidated balance sheets.
Weather derivatives
The Company holds assets and assumes liabilities related to weather and weather contingent risk management products. Weather and weather contingent derivative contracts are entered into with the objective of generating profits in normal climatic conditions. Accordingly, the Company’s weather and weather contingent derivatives are not designed to meet the criteria for hedge accounting under U.S. GAAP. The Company receives payment of premium at the contract inception in exchange for bearing the risk of variations in a quantifiable weather index. Management uses available market data and internal pricing models based upon consistent statistical methodologies to estimate the fair value. Because of the significance of the unobservable inputs used to estimate the fair value of the Company's weather risk contracts, the fair value measurements of the contracts are deemed to be Level 3 measurements in the fair value hierarchy. The Company does not provide or hold any collateral associated with the weather derivatives.
Credit default swap
Credit default swaps protect the buyer against the loss of principal on one or more underlying bonds, loans, or mortgages in the event the issuer suffers a credit event. The Company uses its credit default swap to provide a client with protection against financial non-performance of a subsidiary. The fair value of the swap is estimated using a single broker quote, and accordingly, is classified as a Level 3 measurement. As of September 30, 2026, the Company has $15.4 million pledged in securities collateral associated with the credit default swap (December 31, 2025 - $15.0 million). Securities pledged as collateral are included in debt securities, available for sale, in the Company’s consolidated balance sheets.

24


The following table summarizes information on the classification and amount of the fair value of derivatives not designated as hedging instruments within the Company's consolidated balance sheets as of September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
Derivatives not designated as hedging instruments
Derivative assets
at fair value(1)
Derivative liabilities
at fair value(2)
Notional
Value
Derivative assets
at fair value(1)
Derivative liabilities
at fair value(2)
Notional
Value
Foreign currency forwards$2.1 $21.0 $758.5 $13.8 $3.6 $853.7 
Interest rate swaps— — — — — 29.8 
Credit default swap 0.5 — 73.1 0.6 — 73.1 
Reinsurance contracts accounted for as derivatives$— $3.6 $91.6 $— $5.4 $77.7 
(1)Derivative assets are classified within Other assets in the Company’s consolidated balance sheets.
(2)Derivative liabilities are classified within Other liabilities in the Company’s consolidated balance sheets.
The following table summarizes information on the classification and net impact on earnings, recognized in the Company’s consolidated statements of income relating to derivatives during the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
Derivatives not designated as hedging instrumentsClassification of gains (losses) recognized in earningsSeptember 30,
2026
September 30,
2025
September 30,
2026
September 30,
2025
Foreign currency forwardsForeign exchange losses$5.6 $(5.4)$(29.9)$74.3 
Weather derivativesOther revenues(0.1)0.2 0.1 0.7 
Interest rate swapsNet investment gains (losses)(0.3)(0.2)(0.3)(0.7)
Reinsurance contracts accounted for as derivativesOther revenues$— $(0.3)$(0.2)$(0.4)
9. Variable and voting interest entities
The Company consolidates the results of operations and financial position of every voting interest entity ("VOE") in which it has a controlling financial interest and variable interest entities (“VIE”) in which it is considered to be the primary beneficiary in accordance with guidance in ASC 810, Consolidation. The consolidation assessment, including the determination as to whether an entity qualifies as a VOE or VIE, depends on the facts and circumstances surrounding each entity.
Consolidated variable interest entities
Alstead Re
Alstead Reinsurance Ltd. (“Alstead Re”) is considered a VIE and the Company has concluded that it is the primary beneficiary of Alstead Re because the Company can exercise control over the activities that most significantly impact the economic performance of Alstead Re. As a result, the Company has consolidated the results of Alstead Re in its consolidated financial statements. As of September 30, 2026, Alstead Re’s assets and liabilities included in the Company’s consolidated balance sheets were $9.0 million and $3.2 million, respectively (December 31, 2025 - $6.8 million and $0.9 million, respectively).
Consolidated voting interest entities
Alta Signa
Alta Signa Holdings (“Alta Signa”) is considered a VOE and the Company holds a majority of the voting interests through its seats on Alta Signa’s board of directors. As a result, the Company has consolidated the results of Alta Signa in its consolidated financial statements. The Company’s ownership in Alta Signa as of September 30, 2026 was 75.1%. As of September 30, 2026, Alta Signa’s assets and liabilities, before intercompany eliminations, included in the Company’s consolidated balance sheets were $2.1 million and $1.2 million, respectively (December 31, 2025 - $1.8 million and $1.3 million, respectively).

25


Non-consolidated variable interest entities
The Company is a passive investor in certain third-party-managed hedge and private equity funds, some of which are VIEs. The Company is not involved in the design or establishment of these VIEs, nor does it actively participate in the management of the VIEs.
The Company calculates maximum exposure to loss to be (i) the amount invested in the debt or equity of the VIE, (ii) the notional amount of VIE assets or liabilities where the Company has also provided credit protection to the VIE with the VIE as the referenced obligation, and (iii) other commitments and guarantees to the VIE. The Company does not have any VIEs that it sponsors, nor any VIEs where it has recourse to it or has provided a guarantee to the VIE interest holders.
The following table presents the carrying amount of unconsolidated VIEs in which the Company holds a variable interest, as well as the maximum exposure to loss associated with these VIEs as of September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
Carrying Amount
Maximum Exposure to Loss (1)
Carrying Amount
Maximum Exposure to Loss (1)
Debt securities, available for sale$78.1 $101.6 $54.1 $78.8 
Other long-term investments (2)
207.6 261.0 210.1 293.9 
$285.7 $362.6 $264.2 $372.7 
(1)Maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments.
(2)Includes investments in related parties, which are also VIEs and are discussed below.
Third Point Enhanced LP (“TP Enhanced Fund”)
As of September 30, 2026, the Company and Third Point Advisors LLC (“TP GP”) hold interests of approximately 89.0% and 11.0%, respectively, of the net asset value of TP Enhanced Fund. As a result, both entities hold significant financial interests in TP Enhanced Fund. However, TP GP controls all of the investment decision-making authority and the Company does not have the power to direct the activities which most significantly impact the economic performance of TP Enhanced Fund. As a result, the Company is not considered the primary beneficiary and does not consolidate TP Enhanced Fund. The Company has no unfunded commitments on this investment, and its maximum exposure to loss on this investment corresponds to the carrying amount, which is included in Other long-term investments in the table above.
On February 28, 2025, the Company provided notice to Third Point LLC of its intent to redeem all of its capital accounts for TP Enhanced Fund. The redemptions will continue to occur over time and may be in cash or underlying investments. Refer to Note 16 for the fair value of remaining unredeemed portion.
Investment in Third Point Venture Offshore Fund I LP (“TP Venture Fund”)
Third Point Venture GP LLC controls all of the investment decision-making authority of the TP Venture Fund. The Company does not have the power to direct the activities which most significantly impact the economic performance of the TP Venture Fund. As of September 30, 2026, the Company’s maximum exposure to loss on this investment corresponds to the carrying amount plus unfunded commitments of $5.9 million (December 31, 2025 - $7.1 million), which is included in Other long-term investments in the table above.
Investment in Third Point Venture Offshore Fund II LP (“TP Venture Fund II”)
Third Point Venture GP II LLC controls all of the investment decision-making authority of the TP Venture Fund II. The Company does not have the power to direct the activities which most significantly impact the economic performance of the TP Venture Fund II. As of September 30, 2026, the Company’s maximum exposure to loss on this investment corresponds to the carrying amount plus unfunded commitments of $16.0 million (December 31, 2025 - $18.2 million), which is included in Other long-term investments in the table above.
Investment in Third Point Insurance Solutions Fund I LLC (“TP ISF”)
TP GP ultimately controls all of the investment decision making authority of TP ISF. The Company does not have the power to direct the activities which most significantly impact the economic performance of TP ISF. As of September 30, 2026, the Company’s maximum exposure to loss on this investment corresponds to the carrying amount plus unfunded commitments of $10.4 million (December 31, 2025 - $25.0 million), which is included in Other long-term investments in the table above.

26


Investment in Third Point Structured Credit Opportunities Offshore Fund LP (“TP SCOF”)
During the nine months ended September 30, 2026, the Company transferred a portion of its investment in TP Enhanced Fund into an investment in TP SCOF. TP GP controls all of the investment decision making authority of TP SCOF. The Company does not have the power to direct the activities which most significantly impact the economic performance of TP SCOF. During the third quarter of 2026, the Company provided notice to TP GP to redeem all of its capital accounts for TP SCOF. The redemptions will occur over the next four quarters beginning in the fourth quarter of 2026.
10. Loss and loss adjustment expense reserves
The following table represents the activity in the loss and loss adjustment expense reserves for the nine months ended September 30, 2026 and 2025:
September 30,
2026
September 30,
2025
Gross reserves for loss and loss adjustment expenses, beginning of period$5,782.5 $5,653.9 
Less: loss and loss adjustment expenses recoverable, beginning of period(2,102.3)(2,315.3)
Less: deferred gains (charges) on retroactive reinsurance contracts (1)
— 8.5 
Net reserves for loss and loss adjustment expenses, beginning of period3,680.2 3,347.1 
Increase (decrease) in net loss and loss adjustment expenses incurred in respect of losses occurring in:
     Current year1,189.7 1,199.1 
     Prior years (52.7)(51.8)
Total incurred loss and loss adjustment expenses1,137.0 1,147.3 
Net loss and loss adjustment expenses paid in respect of losses occurring in:
     Current year(332.6)(445.2)
     Prior years(622.8)(451.8)
Total net paid losses(955.4)(897.0)
Foreign currency translation(11.5)51.4 
Net reserves for loss and loss adjustment expenses, end of period3,850.3 3,648.8 
Plus: loss and loss adjustment expenses recoverable, end of period1,966.4 2,162.9 
Gross reserves for loss and loss adjustment expenses, end of period$5,816.7 $5,811.7 
(1)Deferred gains on retroactive reinsurance were previously presented as a separate line item on the Company’s consolidated balance sheets. As of September 30, 2026 and December 31, 2025, the deferred gain is fully amortized.
The Company's prior year reserve development arises from changes to estimates of losses and loss adjustment expenses related to loss events that occurred in previous calendar years.
For the nine months ended September 30, 2026, the Company recorded $52.7 million of net favorable prior year loss reserve development primarily driven by favorable development in A&H and Property, mainly from better than expected loss experience.
For the nine months ended September 30, 2025, the Company recorded $51.8 million of net favorable prior year loss reserve development primarily resulting from favorable development in Property, mainly from reserve releases relating to prior year’s catastrophe events, as well as favorable development in A&H.
Loss Portfolio Transfers
Workers’ Compensation Loss Portfolio Transfer
On October 1, 2024, SiriusPoint America Insurance Company, a subsidiary of the Company, and Clarendon National Insurance Company (“Clarendon National”), an insurer domiciled in Texas and an affiliate of Enstar Group Limited, a Bermuda exempted company (“Enstar”) entered into a Loss Portfolio Transfer Reinsurance Agreement (the “2024 LPT”).
The agreement between SiriusPoint America and Clarendon National is on a funds withheld basis, and the funds held liability (including reinsurance premium) of $164.6 million as of September 30, 2026 is included within Reinsurance balances payable in the Company’s consolidated balance sheets.

27


SiriusPoint International Loss Portfolio Transfer
On March 2, 2023, the Company agreed, subject to applicable regulatory approvals and other closing conditions, to enter into a loss portfolio transfer transaction (the “2023 LPT”), on a funds withheld basis, with Pallas Reinsurance Company Ltd., a subsidiary of the Compre Group. As of September 30, 2026, the Company recorded funds held payable of $271.2 million in Reinsurance balances payable in the consolidated balance sheets.
11. Allowance for expected credit losses
The Company is exposed to credit losses primarily through sales of its insurance and reinsurance products and services. The financial assets in scope of the current expected credit losses impairment model primarily include the Company’s insurance and reinsurance balances receivable and loss and loss adjustment expenses recoverable. The Company pools these amounts by counterparty credit rating and applies a credit default rate that is determined based on the studies published by the rating agencies (e.g., AM Best, Standard & Poor's, Fitch Ratings, Demotech). In circumstances where ratings are unavailable, the Company applies an internally developed default rate based on historical experience, reference data including research publications, and other relevant inputs.
The Company's assets in scope of the current expected credit loss assessment as of September 30, 2026 and December 31, 2025 are as follows:
September 30,
2026
December 31,
2025
Insurance and reinsurance balances receivable, net
$2,558.9 $2,260.3 
Loss and loss adjustment expenses recoverable, net1,966.4 2,102.3 
Other assets (1)
83.4 75.2 
Total assets in scope$4,608.7 $4,437.8 
(1)Relates to MGA trade receivables (included in Other assets in the Company’s consolidated balance sheets), loans receivables (included in Other long-term investments in the Company’s consolidated balance sheets) and interest and dividend receivables.
The Company’s allowance for expected credit losses was $27.7 million as of September 30, 2026 (December 31, 2025 - $27.6 million). For the three and nine months ended September 30, 2026, the Company recorded current expected credit losses (gains) of $(0.9) million and $0.1 million, respectively (2025 - $(3.4) million and $(3.4) million, respectively). Changes to the current expected credit losses are included in net corporate and other expenses in the consolidated statements of income.
The Company monitors counterparty credit ratings and macroeconomic conditions, and considers the most current ratings from credit rating agencies to determine the allowance each quarter. As of September 30, 2026, approximately 65% of the total gross assets in scope were balances with counterparties rated by major credit rating agencies and, of the total rated, 97% were rated A- or better.
12. Debt and letter of credit facilities
Debt obligations
The following table represents a summary of the Company’s debt obligations on its consolidated balance sheets as of September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
Amount
Effective rate (1)
Amount
Effective rate (1)
2024 Senior Notes, at face value$400.0 7.4 %$400.0 7.4 %
Unamortized discount and issuance costs(3.1)(4.0)
2024 Senior Notes, carrying value396.9 396.0 
2017 SEK Subordinated Notes, at face value275.6 6.2 %298.2 7.1 %
Unamortized discount(5.0)(5.6)
2017 SEK Subordinated Notes, carrying value270.6 292.6 
Total debt$667.5 $688.6 
(1)Effective rate considers the effect of the debt issuance costs, discount, and premium.

28


The Company was in compliance with all debt covenants as of and for the periods ended September 30, 2026 and December 31, 2025.
Interest expense
For the three and nine months ended September 30, 2026, total interest expense includes $11.7 million and $35.1 million, respectively, associated with debt obligations (2025 - $12.1 million and $35.9 million, respectively) and $5.1 million and $15.9 million, respectively, of funds withheld interest from loss portfolio transfers (2025 - $7.2 million and $23.7 million, respectively). See Note 10 - “Loss and loss adjustment expense reserves” for further discussion on the 2024 LPT and 2023 LPT.
Standby letter of credit facilities
As of September 30, 2026, the Company had entered into the following letter of credit facilities:
Letters of CreditCollateral
Committed CapacityIssuedCash and Cash EquivalentsDebt securities
Committed - Secured letters of credit facilities$255.0 $216.3 $5.2 $128.1 
Uncommitted - Secured letters of credit facilitiesn/a545.0 17.8 691.2 
$255.0 $761.3 $23.0 $819.3 
The Company’s secured letter of credit facilities are bilateral agreements that generally renew on an annual basis. The letters of credit issued under the secured letter of credit facilities are fully collateralized. The above referenced facilities are subject to various affirmative, negative and financial covenants that the Company considers to be customary for such borrowings, including certain minimum net worth and maximum debt to capitalization standards. See Note 5 for additional information.
Revolving credit facility
In addition to the letter of credit facilities above, the Company entered into a four-year, $400.0 million senior unsecured revolving credit facility (the “Facility”) with JPMorgan Chase Bank, N.A. as administrative agent, effective December 19, 2024. The Facility includes an option for the Company to request a 12-month extension, subject to satisfaction of certain conditions including, but not limited to, the consent of lenders representing a majority-in-interest of commitments, of the Facility maturity date. Subject to customary conditions precedent upon any Company borrowing request, the Facility provides access to loans for working capital and general corporate purposes, and letters of credit to support obligations under insurance and reinsurance agreements, retrocessional agreements and for general corporate purposes. As of September 30, 2026, there were no outstanding borrowings under the Facility. In addition, as of and for the periods ended September 30, 2026 and December 31, 2025, the Company was in compliance with all of the covenants under the Facility.
Federal Home Loan Bank
On September 25, 2025, SiriusPoint America, a subsidiary of the Company, was approved as a new member to the Federal Home Loan Bank of New York (“FHLBNY”). As a member of the FHLBNY, the Company will have access to FHLBNY borrowings to support general corporate purposes. The Company has the ability to obtain this funding from the FHLBNY based on a percentage of the value of its admitted assets in the State of New York, and its ability to borrow is subject to availability of eligible collateral. The borrowing limit for this program is 5% of the admitted assets of SiriusPoint America. As of June 30, 2026, the date of the latest filed statutory statement, SiriusPoint America’s admitted assets were $3.5 billion. The Company did not receive advances or make repayments of FHLBNY borrowings during the three and nine months ended September 30, 2026. There were no advances from the FHLBNY outstanding at September 30, 2026.
13. Income taxes
The Company has subsidiaries and branches that operate in various other jurisdictions around the world that are subject to tax in the jurisdictions in which they operate. The material jurisdictions in which the Company's subsidiaries and branches are subject to tax are Belgium, Bermuda, Canada, Luxembourg, Sweden, Switzerland, the United Kingdom, and the United States. The Company recognizes income tax expense or benefit based upon pre-tax income or loss reported in the consolidated statements of income and the provisions of currently enacted tax laws. Effective January 1, 2025, a 15% corporate income tax is applied to the Company’s Bermuda operations as a result of the enactment of the Corporate Income Tax Act 2023 (the “Bermuda CIT”) on December 27, 2023.

29


For the three and nine months ended September 30, 2026, the Company recorded income tax expense of $16.7 million and $51.7 million, respectively (2025 - $20.2 million and $45.1 million, respectively) on pre-tax income of $103.7 million and $309.5 million, respectively (2025 - $110.9 million and $261.1 million, respectively). The effective tax rates for the three and nine months ended September 30, 2026 were 16.1% and 16.7%, respectively. The difference between the effective tax rate on income from continuing operations and the Bermuda statutory tax rate of 15% is primarily due to income recognized in higher-tax jurisdictions, non-taxable investment gains, and adjustments pursuant to applicable U.S. GAAP guidance on interim period financial reporting of taxes, which are based on the annual estimated effective tax rate.
In arriving at the estimated annual effective tax rate for the three and nine months ended September 30, 2026 and 2025, the Company took into consideration all year-to-date income and expense items including the change in unrealized investment gains (losses) and realized investment gains (losses) and such items on a forecasted basis for the remainder of each year.
The Organisation for Economic Co-Operation and Development (“OECD”) has published global anti-base erosion model rules under Pillar Two (the “GloBE Rules”), which implemented a 15% global minimum tax applicable for in-scope multinational groups (“GMT”). Since January 1, 2024, the GloBE Rules have been in effect in the EU and other jurisdictions, including a minimum top-up tax rate of 15% for multinational companies, with many E.U. member states enacting corollary legislation as part of their respective domestic tax laws. Consistent with accounting guidance, the Company will treat the GMT as an in-period tax charge when incurred for which no deferred taxes need to be provided. The Company has recorded top-up tax of $0.8 million for the period ended September 30, 2026, based on its current estimation of 2026 GMT applied to the Company’s facts and financial data. The Company will continue to reassess and re-estimate 2026 GMT.
Uncertain tax positions
Recognition of the benefit of a given tax position is based upon whether a company determines that it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. In evaluating the more likely than not recognition threshold, the Company must presume that the tax position will be subject to examination by a taxing authority with full knowledge of all relevant information. If the recognition threshold is met, then the tax position is measured at the largest amount of benefit that is more than 50% likely of being realized upon ultimate settlement.
The total reserve for unrecognized tax benefits is $0.2 million as of September 30, 2026, which did not materially change compared to December 31, 2025. If the Company determines in the future that its reserves for unrecognized tax benefits on permanent differences and interest and penalties are not needed, the reversal of $0.1 million of such reserves as of September 30, 2026 would be recorded as an income tax benefit and would impact the effective tax rate. The remaining balance is accrued interest and penalties.
14. Shareholders' equity
Common shares
The following table presents a summary of the common shares issued and outstanding and shares repurchased as of and for the nine months ended September 30, 2026 and 2025:
20262025
Common shares issued and outstanding, beginning of period116,989,799 116,429,057 
Issuance of common shares, net of forfeitures and shares withheld2,434,993 767,427 
Issuance of common shares upon exercise of options— 100,000 
Shares repurchased(4,392,732)(500,000)
Issuance of common shares upon exercise of warrants— 11,013 
Common shares issued and outstanding, end of period115,032,060 116,807,497 
The Company’s authorized share capital consists of 300,000,000 common shares with a par value of $0.10 each. During the nine months ended September 30, 2026 and 2025, the Company did not pay any dividends to its common shareholders.
Preference shares
The Company’s authorized share capital also consists of 30,000,000 preference shares with a par value of $0.10 each.

30


Series B preference shares
On January 29, 2026, the Company announced a notice of redemption to the holders of its Series B preference shares. The Series B preference shares were previously listed on the New York Stock Exchange under the symbol “SPNT PB” and the Company had 8,000,000 of Series B preference shares outstanding, par value $0.10. Dividends on the Series B preference shares were cumulative and payable quarterly in arrears at an initial rate of 8.0% per annum. On February 26, 2026, the Company fully redeemed its 8,000,000 Series B preference shares at a redemption price of $25.00 per share plus $0.49 per share, which represented any accrued and unpaid cumulative dividends but excluding the date of redemption, for an aggregated redemption price of $203.9 million in cash, including dividends of $2.6 million for the nine months ended September 30, 2026 (2025 - $4.0 million and $12.0 million, respectively).
Following the redemption, no Series B preference shares are outstanding and all rights with respect to such Series B preference shares have ceased and terminated, except for the right to receive the redemption price. The Series B preference shares were deregistered under the Securities Exchange Act of 1934 and delisted from the New York Stock Exchange on February 26, 2026.
Share repurchase program
Under the Board authorized share repurchase program, the Company may repurchase its common stock from time to time, in amounts, at prices and at times the Company deems appropriate in its sole discretion, subject to market conditions and a variety of factors, including, but not limited to, legal requirements, price and economic conditions. Shares of common stock may be repurchased in open market purchases, privately negotiated transactions or otherwise. The Company expects that the program will be in effect until the maximum approved dollar amount has been used. The program does not require the Company to repurchase any specific number of shares of common stock, and the program may be suspended, modified or discontinued at any time. As of September 30, 2026, the Company was authorized to repurchase a maximum value of approximately $73.9 million of outstanding common shares under its repurchase program. The share repurchase program does not have an expiration date.
During the three months ended September 30, 2026, the Company repurchased 1,102,434 of its common shares in the open market for a total cost of $27.2 million, at an average cost of $24.65 per share, including commissions of $0.03 per share. During the nine months ended September 30, 2026, the Company repurchased 4,392,732 of its common shares in the open market for a total cost of $100.6 million, at an average cost of $22.88 per share, including commissions of $0.03 per share. Common shares repurchased by the Company during the period were cancelled and retired.
During the nine months ended September 30, 2025, the Company completed a previously announced transaction with CM Bermuda Limited (“CM Bermuda”) and repurchased 45,720,732 of its common shares from CM Bermuda at $14.25 per common share on February 27, 2025. This share repurchase was accounted for during the year ended December 31, 2024 in accordance with U.S. GAAP. For further detail on this transaction, please refer to Note 3 “Significant Transactions” of Part II, Item 8. “Financial Statements and Supplementary Data” included in our 2025 Form 10-K. Also on February 27, 2025, the Company repurchased 500,000 of its common shares from Daniel S. Loeb at the public offering price of $14.00 per share.

31


15. Earnings per share available to SiriusPoint common shareholders
The following sets forth the computation of basic and diluted earnings per share available to SiriusPoint common shareholders for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Weighted-average number of common shares outstanding:
Basic number of common shares outstanding115,135,159 116,726,540 116,191,819 116,412,996 
Dilutive effect of restricted share awards and units646,941 866,941 1,619,742 1,046,481 
Dilutive effect of options1,384,571 1,224,422 1,339,229 1,196,129 
Diluted number of common shares outstanding117,166,671 118,817,903 119,150,790 118,655,606 
Basic earnings per common share:
Net income available to SiriusPoint common shareholders$86.8 $86.8 $255.0 $203.6 
Net income allocated to SiriusPoint participating shareholders(0.1)(0.1)(0.1)(0.2)
Net income allocated to SiriusPoint common shareholders$86.7 $86.7 $254.9 $203.4 
Basic earnings per share available to SiriusPoint common shareholders$0.75 $0.74 $2.19 $1.75 
Diluted earnings per common share:
Net income available to SiriusPoint common shareholders$86.8 $86.8 $255.0 $203.6 
Net income allocated to SiriusPoint participating shareholders(0.1)(0.1)(0.1)(0.2)
Net income allocated to SiriusPoint common shareholders$86.7 $86.7 $254.9 $203.4 
Diluted earnings per share available to SiriusPoint common shareholders$0.74 $0.73 $2.14 $1.71 
For the three and nine months ended September 30, 2026, anti-dilutive restricted share units of 4,339 and 15,099, respectively, were excluded from the computation of diluted earnings per share attributable to SiriusPoint common shareholders. For the three and nine months ended September 30, 2025, anti-dilutive restricted share units of 38 and 14,271, respectively, were excluded from the computation of diluted earnings per share attributable to SiriusPoint common shareholders.
16. Related party transactions
In addition to the transactions disclosed in Notes 3, 9, and 14 to these consolidated financial statements, the following transactions are classified as related party transactions, as the counterparties have either a direct or indirect shareholding in the Company or the Company has an investment in such counterparty.
(Re)insurance contracts
During the three and nine months ended September 30, 2026, insurance and reinsurance contracts with certain of the Company’s insurance and MGA-related parties resulted in gross written premium of $25.1 million and $81.5 million, respectively (2025 - $42.2 million and $53.9 million, respectively). As of September 30, 2026, the Company had total receivables of $83.8 million and no payables, respectively, from these related parties (December 31, 2025 - receivables of $86.4 million and no payables).


32


Investments managed by related parties
The following table provides the fair value of the Company's investments managed by related parties as of September 30, 2026 and December 31, 2025:
September 30,
2026
December 31,
2025
Third Point Enhanced LP (1)
$41.8 $82.2 
Third Point Insurance Solutions Fund I LLC (1)
3.7 1.6 
Third Point Structured Credit Opportunities Fund (1)
36.1 — 
Third Point Venture Offshore Fund I LP (1)
33.4 27.7 
Third Point Venture Offshore Fund II LP (1)
8.8 6.3 
Third Point Optimized Credit Portfolio (2)
98.8 652.8 
Total investments managed by related parties$222.6 $770.6 
(1)The Third Point Enhanced LP, Third Point Insurance Solutions Fund I LLC, Third Point Structured Credit Opportunities Fund, Third Point Venture Offshore Fund I LP, and Third Point Venture Offshore Fund II LP are reported in Other long-term investments in the consolidated balance sheets.
(2)The Third Point Optimized Credit Portfolio is primarily reported in Debt securities, available for sale and trading, in the consolidated balance sheets.
On September 23, 2025, the Company notified Third Point LLC of its intent to withdraw investments from the Third Point Optimized Credit Portfolio. The liquidation and withdrawal of the investments is proceeding in an orderly manner, pursuant to the existing investment management agreement and consistent with the parties' discussions. The fair value of our investments will continue to change over time, and the remaining carrying value in the portfolio is shown in the table above.
Management, advisory and performance fees to related parties
The total management, advisory and performance fees to related parties for the three and nine months ended September 30, 2026 and 2025 were as follows:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Management and advisory fees$(0.1)$1.4 $1.5 $3.8 
Performance fees— — — (0.4)
Total management, advisory and performance fees to related parties (1)
$(0.1)$1.4 $1.5 $3.4 
(1)Management, advisory and performance fees to related parties, where applicable, are presented within Net investment gains (losses) in the consolidated statements of income.
17. Commitments and contingencies
Litigation
From time to time in the normal course of business, the Company may be involved in formal and informal dispute resolution processes, which may include arbitration or litigation, the outcomes of which determine the rights and obligations under the Company’s insurance and reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or to collect funds owed to it. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. The Company may also be involved, from time to time in the normal course of business, in formal and informal dispute resolution processes that do not arise from, or are not directly related to, claims activity. The Company believes that no individual litigation or arbitration to which it is presently a party is likely to have a material adverse effect on its results of operations, financial condition, business or operations.
Leases
The Company operates globally and leases office space under various non-cancelable operating lease agreements.    
During the three and nine months ended September 30, 2026, the Company recognized operating lease expense of $2.4 million and $7.1 million, respectively (2025 - $2.5 million and $7.0 million, respectively), including property taxes and routine maintenance expense, as well as rental expenses related to short-term leases.

33


The following table presents the lease balances within the consolidated balance sheets as of September 30, 2026 and December 31, 2025:
September 30,
2026
December 31,
2025
Operating lease right-of-use assets (1)
$21.0 $20.7 
Operating lease liabilities (2)
$23.6 $24.6 
Weighted average lease term (years)4.14.6
Weighted average discount rate2.9 %3.2 %
(1) Operating lease right-of-use assets are included in Other assets on the Company’s consolidated balance sheets.
(2) Operating lease liabilities are included in Other liabilities on the Company’s consolidated balance sheets.
Future minimum rental commitments as of September 30, 2026 under these leases are expected to be as follows:
Future Payments
Remainder of 2026
$1.7 
20276.3 
20286.5 
20295.4 
2030 and thereafter4.7 
Total future annual minimum rental payments24.6 
Less: present value discount(1.0)
Total lease liability as of September 30, 2026$23.6 
18. Subsequent events
Acquisition of National Motor Club and Specialized Association Services
On October 2, 2026, SiriusPoint, through its wholly owned subsidiaries, acquired National Motor Club and Specialized Association Services for $15.4 million.
Legacy Reinsurance Loss Portfolio Transfer
On October 30, 2026, SiriusPoint America Insurance Company ("SiriusPoint America") and SiriusPoint Bermuda Insurance Company Ltd. ("SiriusPoint Bermuda" and, together with SiriusPoint America, the "Cedents"), each a subsidiary of SiriusPoint Ltd., entered into a Master Agreement (the "Master Agreement"). The Master Agreement is made by and between the Cedents and RiverStone International Bermuda Limited ("RiverStone Bermuda"), an insurer domiciled in Bermuda, and Riverstone International Limited.
Pursuant to the Master Agreement, at the closing of the transactions contemplated therein: (a) the Cedents and RiverStone Bermuda will enter into a Loss Portfolio Transfer Reinsurance and Retrocession Agreement (the "LPT Agreement"), under which the Cedents will cede and RiverStone Bermuda will assume up to 100% of the net reserves with respect to certain legacy reinsurance and retrocession exposures of the Cedents (the "Subject Business"), subject to the terms and conditions of the LPT Agreement, including an aggregate limit; (b) RiverStone International Insurance, Inc., an affiliate of RiverStone Bermuda (the "Administrator"), will assume authority and responsibility for certain administrative services related to the Subject Business, pursuant to the terms of the LPT Agreement; and (c) each of the Cedents, RiverStone Bermuda, and a trustee will enter into trust agreements under which RiverStone Bermuda will provide collateral securing its reinsurance obligations with respect to the Subject Business. The Subject Business includes substantially all of the Company’s remaining run-off reserves.
This transaction covers approximately $400.0 million of SiriusPoint net loss and loss adjustment expense reserves, valued as of June 30, 2026. The aggregate limit under the LPT Agreement is $700.0 million.
The Master Agreement and the LPT Agreement include customary representations and warranties, indemnification obligations, covenants and termination rights of the parties. The transaction is subject to regulatory approvals and customary closing conditions.

34


ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our unaudited consolidated financial statements and the related notes contained elsewhere in this Quarterly Report on Form 10-Q (“Form 10-Q”) and the information under "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”). The terms “we,” “our,” “us” and the “Company,” as used in this report, refer to SiriusPoint Ltd. (“SiriusPoint”) and its directly and indirectly owned subsidiaries as a combined entity, except where otherwise stated or where it is clear that the terms mean only SiriusPoint exclusive of its subsidiaries.
The statements in this discussion regarding business outlook, our expectations regarding our future performance, liquidity and capital resources and other non-historical statements in this discussion are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in “Risk Factors” of our 2025 Form 10-K and in “Cautionary Note Regarding Forward-Looking Statements” below. Our actual results may differ materially from those contained in or implied by any forward-looking statements.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained or incorporated in this Form 10-Q may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include, without limitation, statements regarding prospects for our industry, our business strategy, plans, goals, and expectations concerning our market position, international expansion, investment portfolio expectations, future operations, margins, profitability, efficiencies, capital expenditures, liquidity and capital resources and other non-historical financial and operating information. When used in this discussion, the words “believes,” “intends,” “seeks,” “anticipates,” “aims,” “plans,” “targets,” “estimates,” “expects,” “assumes,” “continues,” “should,” “could,” “will,” “may” and the negative of these or similar terms and phrases are intended to identify forward-looking statements.
Forward-looking statements reflect our current expectations regarding future events, results, or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to have been correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results, and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties, and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, the following:
•the frequency, severity, and development of insured losses, including natural catastrophes, extreme weather events, epidemics, pandemics, man-made events, and other large loss occurrences across many classes of insurance business, along with the amount of insurance losses that may ultimately be ceded to the reinsurance market, supply chain issues, labor shortages and related increased costs;
•the adequacy, accuracy and development of pricing or loss and loss adjustment expense reserves, the lack of available capital, and periods characterized by excess underwriting capacity and unfavorable premium rates;
•our ability to maintain or improve underwriting discipline, risk selection, and portfolio diversification across lines and geographies;
•the cyclicality of the insurance and reinsurance markets, including changes in pricing, terms, conditions, and capacity;
•risks relating to our use of reinsurance, retrocessions, alternative capital and third party capital arrangements, including the availability and cost of such protections and the creditworthiness of counterparties;
•our ability to compete successfully in the insurance and reinsurance market and the effect of consolidation in the insurance and reinsurance industry;
•operational, cybersecurity, and technology-related risks, including system failures, data breaches, ransomware attacks, supply chain compromises of third party service providers, or other business interruption events, including those resulting from a malicious cyber-attack on us or our business partners or service providers;
•the effects of global climate change, including increased severity and frequency of weather-related natural disasters and catastrophes, including wildfires, heat waves, and increased coastal flooding in many geographic areas;
•geopolitical uncertainty, including the ongoing conflicts in Europe, South America, and the Middle East;
•risks related to inflation, social information, and shifts in judicial, legislative, or regulatory environments;

35


•our ability to attract, develop, and retain key personnel, distribution partners, and underwriting talent;
•a downgrade or withdrawal of our financial ratings;
•fluctuations in our results of operations;
•the performance of strategic partnerships, joint ventures, delegated underwriting authorities, and other third party relationships, including risks associated with delegating authority to third party managing general agents (“MGAs”);
•legal restrictions on certain of SiriusPoint’s insurance and reinsurance subsidiaries’ ability to pay dividends and other distributions to SiriusPoint;
•the outcome of legal and regulatory proceedings;
•regulatory, legal, and compliance developments affecting our insurance, reinsurance, MGAs, Lloyd’s or international operations, including capital, solvency, reporting, conduct risk, and data protection requirements;
•reduced returns or losses in SiriusPoint’s investment portfolio, including the impact of market volatility, credit events, interest rate movements, inflation, foreign exchange fluctuations, and changes in asset valuations;
•our exposure or potential exposure to corporate income tax in Bermuda and the EU, U.S. federal income and withholding taxes and our significant deferred tax assets, which could become devalued if we do not generate future taxable income or applicable corporate tax rates are reduced;
•future strategic transactions such as acquisitions, dispositions, investments, mergers, or joint ventures;
•SiriusPoint’s response to any acquisition proposal that may be received from any party, including any actions that may be considered by the Company’s Board of Directors or any committee thereof; and
•other risks and factors listed under “Risk Factors” in our 2025 Form 10-K and other subsequent periodic reports filed with the Securities and Exchange Commission.
Any one of these factors or a combination of these factors could materially affect our financial condition or future results of operations and could influence whether any forward-looking statements contained in this report ultimately prove to be accurate. Our forward-looking statements are not guarantees of future performance, and you should not place undue reliance on them. All forward-looking statements speak only as of the date made and we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Overview
We are a global underwriter of insurance and reinsurance, domiciled in Bermuda. We have licenses to write property, casualty and accident & health insurance and reinsurance globally, including admitted & non-admitted licensed companies in the United States, a Bermuda Class 4 company, a Lloyd’s of London (“Lloyd’s”) syndicate and managing agency, and an internationally licensed company domiciled in Sweden. Our operating companies have a financial strength rating of A (Positive) from AM Best, Fitch Ratings (“Fitch”), and Standard & Poor's (“S&P”) and A3 (Stable) from Moody’s Ratings (“Moody’s”).
We aim to drive excellence as a best-in-class underwriter, with a diverse and low-volatility portfolio of specialty lines. We seek to apply our underwriting talent, capabilities, and management expertise to underwrite a profitable book of business and identify new opportunities to create value. Our approach is to be nimble and attuned to market opportunities within our segments of Insurance & Services and Reinsurance, allocating capital where we see profitable opportunity, while remaining disciplined and focused on our specified risk tolerances and areas of expertise.
Distribution relationships are particularly important to us. A majority of our premium is produced via MGAs, including both our consolidated MGAs and non-consolidated MGAs. We seek to create capacity partnerships with MGAs that have high integrity and transparent leaders, and teams with deep underwriting expertise and track records of success, and no longer take capital positions in those business partners. Our partnerships are focused on underwriting in concentrated, niche businesses that often offer new exposure to our portfolio, while we provide guidance and oversight. As of September 30, 2026, we had equity stakes in 15 entities (MGAs, Insurtech and Other) which underwrite or distribute a wide range of lines of business, including general liability, professional liability, directors & officers, credit and bond, cyber, commercial automobile, workers’ compensation, accident & health, and other specialty insurance classes.

36


Products & Services
Insurance & Services Segment
In our Insurance & Services segment, we predominantly provide insurance coverage in addition to receiving fees for services provided within Insurance & Services and to third parties. Insurance & Services revenue allows us to diversify our traditional reinsurance portfolio and generally has lower capital requirements. In addition, service fees from MGAs and their insurance provided are generally not as prone to the volatile underwriting cycle that is common in reinsurance marketplace. The Insurance & Services segment provides coverage in Accident & Health (“A&H”), Property & Casualty, and Other Specialties.
Reinsurance Segment
In our Reinsurance segment, we provide reinsurance products to insurance and reinsurance companies, government entities, and other risk bearing vehicles. We participate in the reinsurance market with a global focus through the broker market distribution channel. We primarily write treaty reinsurance, on both a proportional and excess of loss basis, and provide facultative reinsurance in some of our business lines. In the United States and Bermuda, our core focus is on distribution, risk and clients located in North America while our international operation is focused primarily on distribution, risks and clients located in Europe. The Reinsurance segment predominantly underwrites Casualty, Property and Other Specialties lines of business.
Investment Management
We manage our investment portfolio to balance quality, liquidity, and diversification with asset/liability matching and investment return. Our investment objective is to optimize risk-adjusted net investment income after tax while (1) maintaining a high quality, diversified investment portfolio, (2) maintaining adequate liquidity, and (3) complying with the regulatory, rating agency, and internal risk and capital management requirements, all in support of the company goal of meeting policyholder obligations.
Recent Developments
Acquisition of Assist America
On December 31, 2025, we, through our wholly owned subsidiaries, entered into an agreement to acquire Assist America Inc. and its affiliates (“Assist America”) for $44.0 million in cash and other contingent considerations. Pursuant to the agreement, we consolidated Assist America as of January 1, 2026 and recognized goodwill of $18.6 million in our Insurance & Services segment.
Assist America provides reliable global emergency assistance to over 40 million members across Asia, the Middle East, and North America. The acquisition bolsters our third-party medical and travel assistance revenue, increases our scale in the U.S., and expands our coverage to Asia and the Middle East.
Acquisition of World Nomads
On September 30, 2026, the Company, through its wholly owned subsidiaries, completed the acquisition of equity interests and assets comprising the World Nomads travel insurance business operated by nib Travel Pty Ltd. (collectively, “World Nomads”) for $48.0 million in cash. World Nomads became a consolidated subsidiary of the Company as of acquisition date. The Company recognized goodwill of $27.5 million within the Insurance & Services segment, primarily attributable to the Company's travel insurance distribution capabilities and expected synergies resulting from the acquisition of World Nomads.
Ratings
On February 25, 2026, Fitch upgraded the financial strength rating of our operating subsidiaries to ‘A’ (Strong) from ‘A-’, followed by AM Best’s upgrade to ‘A’ (Excellent) from ‘A-’ on April 16, 2026 and S&P’s upgrade to ‘A’ (Strong) from ‘A-’ on April 21, 2026.
Redemption of Series B Preference Shares
On February 26, 2026, we redeemed all 8,000,000 of our issued and outstanding 8.0% Series B preference shares for a redemption price of $25.00 per share, plus $0.49, which reflects unpaid, accrued cumulative dividends, to, but excluding, February 26, 2026, for an aggregate redemption price of $203.9 million. We delisted the Series B preference shares from the

37


New York Stock Exchange and deregistered the Series B preference shares under the Securities Exchange Act of 1934. The redemption helps simplify and optimize our capital structure and financial leverage, while also eliminating the cost of capital and related cash servicing associated with the Series B preference shares.
Key Performance Indicators
We believe that the following key performance indicators are important in evaluating our performance for the three and nine months ended September 30, 2026 and 2025, and as of September 30, 2026 and December 31, 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
($ in millions, except for ratios)
Combined ratio86.5 %85.9 %87.6 %87.8 %
Core combined ratio ⁽¹⁾
90.1 %89.1 %90.1 %91.4 %
Core underwriting income ⁽¹⁾$75.9 $69.6 $201.8 $165.7 
Core net services income ⁽¹⁾$11.9 $10.1 $30.2 $37.7 
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders15.4 %17.7 %15.1 %14.5 %
September 30,
2026
December 31,
2025
Book value per common share$19.37 $19.40 
Book value per diluted common share$19.05 $18.61 
Tangible book value per diluted common share ⁽¹⁾$17.30 $17.62 
(1)Core underwriting income, Core net services income, and Core combined ratio are non-GAAP financial measures. See definitions in “Non-GAAP Financial Measures” and reconciliations in “Segment Results” below and Note 4 “Segment reporting” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q. Tangible book value per diluted common share is a non-GAAP financial measure. See definition and reconciliation in “Non-GAAP Financial Measures.”
Core Results
See “Segment Results” below for additional information.
Annualized Return on Average Common Shareholders’ Equity Attributable to SiriusPoint Common Shareholders
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders is calculated by dividing annualized net income available to SiriusPoint common shareholders for the period by the average common shareholders’ equity determined using the common shareholders’ equity balances at the beginning and end of the period.
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders for the three and nine months ended September 30, 2026 and 2025 was calculated as follows:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
($ in millions)
Net income available to SiriusPoint common shareholders$86.8 $86.8 $255.0 $203.6 
Common shareholders’ equity attributable to SiriusPoint common shareholders - beginning of period2,275.9 1,905.7 2,269.8 1,737.4 
Common shareholders’ equity attributable to SiriusPoint common shareholders - end of period2,228.3 2,009.9 2,228.3 2,009.9 
Average common shareholders’ equity attributable to SiriusPoint common shareholders$2,252.1 $1,957.8 $2,249.1 $1,873.7 
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders15.4 %17.7 %15.1 %14.5 %
The decrease in annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders for the three months ended September 30, 2026 was primarily driven by increased common shareholders’ equity compared to the prior period reflecting continuous positive underwriting and investment results.

38


The increase in annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders for the nine months ended September 30, 2026 was driven by higher net income, primarily resulting from the gain on the sale of Arcadian Risk Capital Ltd. (“Arcadian”) in the first quarter of 2026, as well as a reduced impact from foreign exchange compared to the prior period, partially offset by increased common shareholders’ equity compared to the prior period, reflecting continuous positive underwriting and investment results.
Book Value Per Share
Book value per common share is calculated by dividing common shareholders’ equity attributable to SiriusPoint common shareholders by the number of common shares outstanding. Book value per diluted common share is calculated by dividing common shareholders’ equity attributable to SiriusPoint common shareholders by the number of diluted common shares outstanding, calculated similar to the treasury stock method.
Tangible book value per diluted common share is a non-GAAP financial measure and the most comparable U.S. GAAP measure is book value per common share. See “Non-GAAP Financial Measures” for an explanation and reconciliation.
As of September 30, 2026, book value per common share was $19.37, representing a decrease of $0.24 per share, or 1.2%, from $19.61 per share as of June 30, 2026. As of September 30, 2026, book value per diluted common share was $19.05, representing a decrease of $0.25 per share, or 1.3%, from $19.30 per share as of June 30, 2026. As of September 30, 2026, tangible book value per diluted common share was $17.30, representing a decrease of $0.68 per share, or 3.8%, from $17.98 per share as of June 30, 2026.
As of September 30, 2026, book value per common share was $19.37, representing a decrease of $0.03 per share, or 0.2%, from $19.40 per share as of December 31, 2025. As of September 30, 2026, book value per diluted common share was $19.05, representing an increase of $0.44 per share, or 2.4%, from $18.61 per share as of December 31, 2025. As of September 30, 2026, tangible book value per diluted common share was $17.30, representing a decrease of $0.32 per share, or 1.8%, from $17.62 per share as of December 31, 2025.
The decreases were primarily due to the accumulated other comprehensive loss from unrealized losses from AFS debt securities during the three and nine months ended September 30, 2026.
Consolidated Results of Operations—Three and nine months ended September 30, 2026 and 2025
The following table sets forth the key items discussed in the consolidated results of operations section, and the period over period change, for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025ChangeSeptember 30, 2026September 30, 2025Change
($ in millions)
Total underwriting income$103.5 $91.4 $12.1 $254.7 $235.7 $19.0 
Net investment income65.9 66.5 (0.6)197.8 205.9 (8.1)
Net investment gains (losses)3.3 6.2 (2.9)22.6 6.6 16.0 
Other revenues30.8 35.5 (4.7)119.1 92.5 26.6 
Net corporate and other expenses(75.7)(62.5)(13.2)(220.6)(194.0)(26.6)
Intangible asset amortization(2.5)(2.8)0.3 (7.5)(8.5)1.0 
Interest expense(18.4)(21.0)2.6 (53.9)(60.2)6.3 
Foreign exchange gains (losses)(3.2)(2.4)(0.8)(2.7)(16.9)14.2 
Income tax expense(16.7)(20.2)3.5 (51.7)(45.1)(6.6)
Net income$87.0 $90.7 $(3.7)$257.8 $216.0 $41.8 

39


The key changes in our consolidated results for the three and nine months ended September 30, 2026 compared to the prior year periods are discussed below.
Underwriting results
The improvement in net underwriting results for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 was primarily a result of lower attritional loss ratios and increased favorable prior year loss reserve development, partially offset by higher acquisition cost and other underwriting expense ratios.
The improvement in net underwriting results for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by lower attritional loss ratios as well as a decrease in catastrophe losses as the prior period included losses from the California wildfires. This improvement was partially offset by higher expenses. Increased acquisition costs primarily resulted from profit commission accruals related to favorable loss experience and increased other underwriting expense is largely driven by expenses related to incentive compensation award outperformance.
Investments
Investment Portfolio
The following table presents the carrying value of our total investments, cash and cash equivalents and restricted cash and cash equivalents as of September 30, 2026 and December 31, 2025:
September 30,
2026
December 31, 2025
($ in millions)
Debt securities, available for sale$5,364.8 $5,168.6 
Debt securities, trading55.3 90.3 
Total debt securities (1)
5,420.1 5,258.9 
Short-term investments17.1 28.3 
Other long-term investments (2)
276.5 315.1 
Total investments5,713.7 5,602.3 
Cash and cash equivalents434.3 731.2 
Restricted cash and cash equivalents (3)
127.4 171.2 
Total invested assets and cash$6,275.4 $6,504.7 
(1)Includes $98.8 million of investments in the Third Point Optimized Credit portfolio (“TPOC Portfolio”) as of September 30, 2026 (December 31, 2025 - $652.8 million).
(2)Includes $60.4 million of strategic investments as of September 30, 2026 (December 31, 2025 - $102.2 million).
(3)Primarily consists of cash and fixed income securities such as U.S. Treasuries, money markets funds, and sovereign debt, securing our contractual obligations under certain (re)insurance contracts that we will not be released from until the underlying risks have expired or have been settled.
The decrease in total invested assets and cash was primarily driven by the use of cash and investments to fund the redemption of the Series B preference shares of $203.9 million and the common share repurchases of $100.6 million.
The average duration of our fixed income portfolio, excluding cash and cash equivalents, is 3.4 years (December 31, 2025 - 3.2 years). The duration remained consistent from the comparative period due to our efforts to match our asset duration with economic liabilities in the current interest rate environment. The average credit rating of our investment portfolio is “AA-” as of September 30, 2026 (December 31, 2025 - “AA-”) with no defaults in the investment portfolio.
The following table provides a breakdown of structured products between investment and non-investment grade securities as of September 30, 2026 and December 31, 2025. These are fixed income investments which are included in debt securities in

40


the table above. Refer to Note 7 “Investments” to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for further discussion of these securities.
September 30, 2026December 31, 2025
Investment Grade (1)
Non-investment Grade (2)
Investment Grade (1)
Non-investment Grade (2)
($ in millions)
Asset-backed securities$397.1 $29.8 $583.5 $18.9 
Collateralized loan obligations345.6 2.5 324.6 — 
Total asset-backed securities742.7 32.3 908.1 18.9 
Agency residential mortgage-backed securities844.7 — 799.2 — 
Non-agency residential mortgage-backed securities222.4 24.4 186.7 22.2 
Total residential mortgage-backed securities1,067.1 24.4 985.9 22.2 
Agency commercial mortgage-backed securities26.1 — 48.1 — 
Non-agency commercial mortgage-backed securities240.9 — 215.2 0.5 
Total commercial mortgage-backed securities267.0 — 263.3 0.5 
Total mortgage-backed securities1,334.1 24.4 1,249.2 22.7 
Total asset and mortgage-backed securities$2,076.8 $56.7 $2,157.3 $41.6 
(1)Investment grade securities are considered rated BBB or higher.
(2)Non-investment grade securities are considered rated below BBB.
Investment Results
Net investment income for the three and nine months ended September 30, 2026 and 2025 consisted of the following:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
($ in millions)
Debt securities, available for sale$65.1 $63.2 $190.0 $186.1 
Debt securities, trading0.8 2.0 3.0 6.3 
Short-term investments0.1 0.4 0.6 1.4 
Other long-term investments 0.2 0.4 4.0 4.8 
Cash, cash equivalents and other3.8 5.4 15.1 21.2 
Gross investment income70.0 71.4 212.7 219.8 
Investment expenses(4.1)(4.9)(14.9)(13.9)
Net investment income$65.9 $66.5 $197.8 $205.9 
The decrease in net investment income for the three and nine months ended September 30, 2026 compared to the three and nine months ended September 30, 2025 is primarily driven by lower yields on cash and short-term investments, as well as portfolio repositioning.

41


Net investment gains (losses) for the three and nine months ended September 30, 2026 and 2025 consisted of the following:
Three months endedNine months ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
($ in millions)
Debt securities, available for sale
Gross realized gains$2.2 $10.3 $17.4 $20.4 
Gross realized losses(12.1)(1.2)(18.5)(15.7)
Net realized gains (losses) on Debt securities, available for sale(9.9)9.1 (1.1)4.7 
Debt securities, trading
Net realized gains (losses)(0.1)0.1 (1.4)(1.7)
Net unrealized gains (losses)(2.0)1.4 (2.2)5.2 
Other long-term investments
Net realized gains (losses)23.8 (4.9)82.7 (7.2)
Net unrealized gains (losses)(8.7)0.4 (56.5)4.1 
Other (1)
0.2 0.1 1.1 1.5 
Net investment gains (losses)$3.3 $6.2 $22.6 $6.6 
(1)Includes short-term investments, cash and cash equivalents, and derivatives.
The decrease in net investment gains (losses) for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 was primarily related to realized losses on sales of TPOC and other AFS debt securities, slightly offset by higher gains on sales of other long-term investments.
The increase in net investment gains (losses) for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily due to gains from fair value changes in the Company's investments managed by related parties, which are included in Other long-term investments, partially offset by the reversal of inception to date unrealized gains. The nine months ended September 30, 2026 also includes realized gains, and related reversals of inception to date unrealized gains, on private equity funds, also classified in Other long-term investments, when compared to the nine months ended September 30, 2025.
Refer to Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risks” of this Form 10-Q for a discussion of certain risks and factors that could adversely impact our investments results.
Other Revenues
For the three months ended September 30, 2026, other revenues primarily consisted of $30.3 million of service fee revenue from MGAs, compared to $25.8 million of service fee revenue from MGAs in addition to a non-recurring $11.0 million insurance recovery related to a legacy litigation for the three months ended September 30, 2025. The increase in service fee revenue is primarily driven by increases in International Medical Group, Inc. (“IMG”) from continued growth of its travel business and the acquisition of Assist America, partially offset by the deconsolidation of ArmadaCorp Capital, LLC (“Armada”).
For the nine months ended September 30, 2026, other revenues primarily consisted of $25.2 million from the gain on the sale of Arcadian and $90.8 million of service fee revenue from MGAs, compared to $84.1 million of service fee revenue from MGAs in addition to a non-recurring $11.0 million insurance recovery related to a legacy litigation for the nine months ended September 30, 2025. The increase in service fee revenue is primarily driven by increases in IMG from continued growth of its travel business and the acquisition of Assist America, partially offset by the deconsolidation of Armada.
Net Corporate and Other Expenses
Net corporate and other expenses include costs associated with operating as a publicly-traded company and non-underwriting activities, including services expenses from our MGA subsidiaries, and current expected credit losses from our insurance and reinsurance balances receivable and loss and loss adjustment expenses recoverable.
The increase in net corporate and other expenses for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 was primarily driven by increases in expenses related to incentive compensation award outperformance and expenses associated with non-recurring projects. For the three months ended September 30, 2026,

42


services expenses increased to $49.4 million compared to $48.5 million for the three months ended September 30, 2025, primarily driven by increases in expenses from IMG from continued growth of its travel business and the acquisition of Assist America, partially offset by the deconsolidation of Armada.
The increase in net corporate and other expenses for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by increases in expenses related to incentive compensation award outperformance attributable to the recent gains on sales of Armada and Arcadian and expenses associated with non-recurring projects, as well as increases in services expenses. For the nine months ended September 30, 2026, services expenses increased to $145.1 million compared to $141.2 million for the nine months ended September 30, 2025, primarily driven by increases in expenses from IMG from continued growth of its travel business and the acquisition of Assist America, partially offset by the deconsolidation of Armada.
Amortization of Intangible Assets
Amortization of intangible assets for the three and nine months ended September 30, 2026 was $2.5 million and $7.5 million (2025 - $2.8 million and $8.5 million, respectively). The decrease in amortization is primarily driven by changes to the Company’s intangible asset balance as a result of recent acquisitions and dispositions.
Interest Expense
Interest expense and finance costs are related to interest due on our senior and subordinated notes, as well as interest associated with certain reinsurance contracts.
Interest expense for the three and nine months ended September 30, 2026 was $18.4 million and $53.9 million, respectively, compared to $21.0 million and $60.2 million for the three and nine months ended September 30, 2025. The decrease is primarily driven by decreases in funds withheld interest on loss portfolio transfers.
Foreign Currency Translation
Except for the Canadian reinsurance operations of SiriusPoint America and certain subsidiaries of IMG, the U.S. dollar is the functional currency for our business. Assets and liabilities are remeasured into the functional currency using current exchange rates; revenues and expenses are remeasured into the functional currency using the average exchange rate for the period. The remeasurement process results in foreign exchange (gains) losses in the consolidated results of operations. Foreign exchange (gains) losses exclude investment generated net realized and unrealized investment gains as addressed in Investment Results above.
Foreign exchange losses were $3.2 million and $2.7 million for the three months and nine months ended September 30, 2026, respectively, compared to $2.4 million and $16.9 million for the three months and nine months ended September 30, 2025, respectively. The foreign exchange losses for the current and prior periods were primarily driven by the impact of certain foreign exchange exposures related to our underwriting activities, partially offset by the impact of our currency hedges.
On an aggregate basis, the effects of foreign exchange resulted in charges to net income of $4.5 million and $5.7 million, as well as charges to comprehensive income of $0.7 million and $6.0 million for the three and nine months ended September 30, 2026, respectively. The effects of foreign exchange are consistent with the recent market fluctuations in rates and our economic currency hedging strategy.
Income Tax Expense
Income tax expense for the three months ended September 30, 2026 decreased compared to the three months ended September 30, 2025 primarily due to decreases in pre-tax income. The increases in income tax expense for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 is consistent with the increases in pre-tax income.
Segment Results — Three and nine months ended September 30, 2026 and 2025
The determination of our reportable segments is based on the manner in which management monitors the performance of our operations. We classify our business into two reportable segments - Insurance & Services and Reinsurance. Collectively, the sum of these two segments constitute “Core” results. Core underwriting income, Core net services income, Core income, and Core combined ratio are non-GAAP financial measures. We believe it is useful to review Core results as they reflect how

43


management views the business and reflects our decision to exit the run-off business. The sum of Core results and Corporate results are equal to the consolidated results of operations.
Corporate results include all run-off business, which represents certain classes of business that we ceased underwriting as part of fundamental changes to our business strategy, including the effect of the restructuring of the underwriting platform announced in 2022 and certain reinsurance contracts that have interest crediting features. Corporate results also include asbestos and environmental and other latent liability exposures on a gross basis, which have mostly been ceded, as well as specific workers’ compensation and cyber programs which we no longer write.
The following tables set forth the operating segment results and ratios for the three months ended September 30, 2026 and 2025:
Three months ended September 30, 2026
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$673.0 $317.6 $990.6 $— $4.3 $— $994.9 
Net written premium403.5 275.2 678.7 — 1.7 — 680.4 
Net earned premium460.8 304.0 764.8 — 2.8 — 767.6 
Loss and loss adjustment expenses incurred, net263.6 154.0 417.6 (2.1)0.4 — 415.9 
Acquisition costs, net136.9 86.2 223.1 (28.7)0.8 — 195.2 
Other underwriting expenses27.3 20.9 48.2 — 4.8 — 53.0 
Underwriting income (loss)33.0 42.9 75.9 30.8 (3.2)— 103.5 
Services revenues61.5 — 61.5 (31.2)— (30.3)— 
Services expenses49.4 — 49.4 — — (49.4)— 
Net services fee income12.1 — 12.1 (31.2)— 19.1 — 
Services noncontrolling income(0.2)— (0.2)— — 0.2 — 
Net services income11.9 — 11.9 (31.2)— 19.3 — 
Segment income (loss)$44.9 $42.9 $87.8 $(0.4)$(3.2)$19.3 $103.5 
Attritional losses$272.7 $163.2 $435.9 $(2.1)$1.9 $— $435.7 
Catastrophe losses— — — — — — — 
Prior year loss reserve development(9.1)(9.2)(18.3)— (1.5)— (19.8)
Loss and loss adjustment expenses incurred, net$263.6 $154.0 $417.6 $(2.1)$0.4 $— $415.9 
Underwriting Ratios: (1)
Attritional loss ratio59.2 %53.7 %57.0 %56.8 %
Catastrophe loss ratio— %— %— %— %
Prior year loss development ratio(2.0)%(3.0)%(2.4)%(2.6)%
Loss ratio57.2 %50.7 %54.6 %54.2 %
Acquisition cost ratio29.7 %28.4 %29.2 %25.4 %
Other underwriting expenses ratio5.9 %6.9 %6.3 %6.9 %
Combined ratio
92.8 %86.0 %90.1 %86.5 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.

44


Three months ended September 30, 2025
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$562.0 $309.6 $871.6 $— $2.8 $— $874.4 
Net written premium396.8 268.1 664.9 — 5.4 — 670.3 
Net earned premium381.2 262.3 643.5 — 4.2 — 647.7 
Loss and loss adjustment expenses incurred, net225.3 145.5 370.8 (1.5)3.6 — 372.9 
Acquisition costs, net98.3 64.7 163.0 (26.9)3.7 — 139.8 
Other underwriting expenses19.9 20.2 40.1 — 3.5 — 43.6 
Underwriting income (loss)37.7 31.9 69.6 28.4 (6.6)— 91.4 
Services revenues58.5 — 58.5 (32.7)— (25.8)— 
Services expenses48.5 — 48.5 — — (48.5)— 
Net services fee income10.0 — 10.0 (32.7)— 22.7 — 
Services noncontrolling loss0.1 — 0.1 — — (0.1)— 
Net services income10.1 — 10.1 (32.7)— 22.6 — 
Segment income (loss)$47.8 $31.9 $79.7 $(4.3)$(6.6)$22.6 $91.4 
Attritional losses$234.8 $145.1 $379.9 $(1.5)$3.4 $— $381.8 
Catastrophe losses— — — — — — — 
Prior year loss reserve development(9.5)0.4 (9.1)— 0.2 — (8.9)
Loss and loss adjustment expenses incurred, net$225.3 $145.5 $370.8 $(1.5)$3.6 $— $372.9 
Underwriting Ratios: (1)
Attritional loss ratio61.6 %55.3 %59.0 %59.0 %
Catastrophe loss ratio— %— %— %— %
Prior year loss development ratio(2.5)%0.2 %(1.4)%(1.4)%
Loss ratio59.1 %55.5 %57.6 %57.6 %
Acquisition cost ratio25.8 %24.7 %25.3 %21.6 %
Other underwriting expenses ratio5.2 %7.7 %6.2 %6.7 %
Combined ratio 90.1 %87.9 %89.1 %85.9 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
Core Premium Volume
Gross written premium increased by $119.0 million, or 13.7%, for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. Net written premium increased by $13.8 million, or 2.1%, for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. Net earned premium increased by $121.3 million, or 18.9%, for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The increases in written premium were driven by our Insurance & Services segment, including growth in Surety business as well as an increase in our estimated premium for Professional Liability business, slightly offset by the exit of an International A&H program. The increase in net earned premium was primarily related to increases in our estimate of the earned premium in Professional Liability and A&H businesses. The Professional Liability and A&H premium estimate changes were largely offset by corresponding loss and acquisition costs, with no significant impact on underwriting income.

45


Core Underwriting Results
The improvement in underwriting income of $6.3 million was primarily driven by lower attritional loss ratios and increased favorable prior year loss reserve development, slightly offset by higher expense ratios. For the three months ended September 30, 2026, favorable prior year loss reserve development was $18.3 million primarily driven by favorable prior year loss reserve development on Property and A&H business, compared to $9.1 million for the three months ended September 30, 2025, which was primarily driven by favorable development in A&H business.
Core Services Results
Services revenues increased to $61.5 million for the three months ended September 30, 2026 compared to $58.5 million for the three months ended September 30, 2025 primarily driven by growth in the IMG travel business and the acquisition of Assist America, partially offset by the deconsolidation of Armada in the fourth quarter of 2025.
Net services income increased to $11.9 million for the three months ended September 30, 2026 compared to $10.1 million during the three months ended September 30, 2025, also driven by growth in IMG and the acquisition of Assist America, partially offset by the deconsolidation of Armada. Service margin, which is calculated as Net service fee income as a percentage of services revenues, increased to 19.7% for the three months ended September 30, 2026 from 16.3% for the three months ended September 30, 2025, when adjusted to exclude Armada, driven by the acquisition of Assist America.
Nine months ended September 30, 2026
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$2,002.2 $973.7 $2,975.9 $— $0.1 $— $2,976.0 
Net written premium1,287.0 798.0 2,085.0 — 0.9 — 2,085.9 
Net earned premium1,222.6 819.3 2,041.9 — 4.9 — 2,046.8 
Loss and loss adjustment expenses incurred, net 695.8 428.1 1,123.9 (5.7)18.8 — 1,137.0 
Acquisition costs, net349.1 225.7 574.8 (73.2)(1.8)— 499.8 
Other underwriting expenses 79.2 62.2 141.4 — 13.9 — 155.3 
Underwriting income (loss)98.5 103.3 201.8 78.9 (26.0)— 254.7 
Services revenues174.9 — 174.9 (84.1)— (90.8)— 
Services expenses145.1 — 145.1 — — (145.1)— 
Net services fee income29.8 — 29.8 (84.1)— 54.3 — 
Services noncontrolling loss0.4 — 0.4 — — (0.4)— 
Net services income30.2 — 30.2 (84.1)— 53.9 — 
Segment income (loss)$128.7 $103.3 $232.0 $(5.2)$(26.0)$53.9 $254.7 
Attritional losses$734.8 $449.6 $1,184.4 $(5.7)$4.3 $— $1,183.0 
Catastrophe losses1.3 5.4 6.7 — — — 6.7 
Prior year loss reserve development(40.3)(26.9)(67.2)— 14.5 — (52.7)
Loss and loss adjustment expenses incurred, net$695.8 $428.1 $1,123.9 $(5.7)$18.8 $— $1,137.0 
Underwriting Ratios: (1)
Attritional loss ratio60.1 %54.9 %58.0 %57.9 %
Catastrophe loss ratio0.1 %0.7 %0.3 %0.3 %
Prior year loss development ratio(3.3)%(3.3)%(3.3)%(2.6)%
Loss ratio56.9 %52.3 %55.0 %55.6 %
Acquisition cost ratio28.6 %27.5 %28.2 %24.4 %
Other underwriting expenses ratio6.5 %7.6 %6.9 %7.6 %
Combined ratio
92.0 %87.4 %90.1 %87.6 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.

46


Nine months ended September 30, 2025
Insurance & ServicesReinsuranceCore
Eliminations (2)
CorporateSegment Measure ReclassTotal
Gross written premium$1,757.5 $1,034.1 $2,791.6 $— $15.7 $— $2,807.3 
Net written premium1,273.1 843.6 2,116.7 — 1.0 — 2,117.7 
Net earned premium1,086.6 828.3 1,914.9 — 11.5 — 1,926.4 
Loss and loss adjustment expenses incurred, net644.4 497.2 1,141.6 (5.0)10.7 — 1,147.3 
Acquisition costs, net283.5 202.3 485.8 (83.1)7.7 — 410.4 
Other underwriting expenses61.4 60.4 121.8 — 11.2 — 133.0 
Underwriting income (loss)97.3 68.4 165.7 88.1 (18.1)— 235.7 
Services revenues178.7 — 178.7 (94.6)— (84.1)— 
Services expenses141.2 — 141.2 — — (141.2)— 
Net services fee income37.5 — 37.5 (94.6)— 57.1 — 
Services noncontrolling loss0.2 — 0.2 — — (0.2)— 
Net services income37.7 — 37.7 (94.6)— 56.9 — 
Segment income (loss)$135.0 $68.4 $203.4 $(6.5)$(18.1)$56.9 $235.7 
Attritional losses$661.3 $470.1 $1,131.4 $(5.0)$5.3 $— $1,131.7 
Catastrophe losses4.8 62.6 67.4 — — — 67.4 
Prior year loss reserve development(21.7)(35.5)(57.2)— 5.4 — (51.8)
Loss and loss adjustment expenses incurred, net$644.4 $497.2 $1,141.6 $(5.0)$10.7 $— $1,147.3 
Underwriting Ratios: (1)
Attritional loss ratio60.9 %56.7 %59.1 %58.8 %
Catastrophe loss ratio0.4 %7.6 %3.5 %3.5 %
Prior year loss development ratio(2.0)%(4.3)%(3.0)%(2.7)%
Loss ratio59.3 %60.0 %59.6 %59.6 %
Acquisition cost ratio26.1 %24.4 %25.4 %21.3 %
Other underwriting expenses ratio5.7 %7.3 %6.4 %6.9 %
Combined ratio91.1 %91.7 %91.4 %87.8 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
(2)Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
Core Premium Volume
Gross written premium increased by $184.3 million, or 6.6%, for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. Net written premium decreased by $31.7 million, or 1.5%, for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. Net earned premium increased by $127.0 million, or 6.6%, for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. The increases in gross written premium and net earned premium were driven by our Insurance & Services segment, primarily driven by an increase in premium estimates on Professional Liability and A&H businesses, new program growth, mainly in General Liability, as well as continued organic growth in existing programs and growth in A&H. The Professional Liability and A&H premium estimate changes were largely offset by corresponding loss and acquisition costs, with no significant impact on underwriting income. The premium increases in Insurance & Services were partially offset by decreases in our Reinsurance segment, mainly in Casualty, Property Catastrophe, and Other Specialties. The decrease in net written premium was primarily driven by the decreases in our Reinsurance segment and the ceded premium related to the inception of an aggregate reinsurance program in 2026.

47


Core Underwriting Results
The improvement in underwriting income of $36.1 million for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by increased favorable prior year reserve development and decreased catastrophe losses, partially offset by higher acquisition costs and other underwriting expense. Catastrophe losses were $6.7 million, or 0.3 percentage points on the combined ratio, for the nine months ended September 30, 2026 compared to $67.4 million, or 3.5 percentage points on the combined ratio, for the nine months ended September 30, 2025, primarily driven by the California wildfires in the prior period. Increased acquisition costs primarily resulted from profit commission accruals related to favorable loss experience and increased other underwriting expense is largely driven by expenses related to incentive compensation award outperformance.
Core Services Results
Services revenues decreased to $174.9 million for the nine months ended September 30, 2026 compared to $178.7 million for the nine months ended September 30, 2025 primarily due to the deconsolidation of Armada in the fourth quarter of 2025, partially offset by growth in the IMG travel business and the acquisition of Assist America.
Net services income decreased to $30.2 million for the nine months ended September 30, 2026 from $37.7 million for the nine months ended September 30, 2025. The decrease in net service income from the prior period is also driven by the deconsolidation of Armada, partially offset by growth in IMG and the acquisition of Assist America. Service margin, which is calculated as Net service fee income as a percentage of services revenues, increased to 17.0% for the nine months ended September 30, 2026 compared to 14.6% for the nine months ended September 30, 2025, when adjusted to exclude Armada, which is driven by the acquisition of Assist America.
Insurance & Services Segment
In our Insurance & Services segment, we underwrite primary insurance in several sectors globally. We offer innovative insurance solutions to meet the changing risk circumstances of our clients. The Insurance & Services segment includes A&H, Property & Casualty, and Other Specialties.
As of September 30, 2026, we have equity stakes in 15 entities (MGAs, Insurtech and Other), which underwrite or distribute a wide range of lines of business, including general liability, professional liability, directors & officers, credit and bond, cyber, commercial automobile, workers’ compensation, accident & health, and other specialty insurance classes. As of September 30, 2026, we consolidated two MGAs in our financial statements: Alta Signa Holdings (“Alta Signa”) and IMG. Effective November 1, 2025, we deconsolidated Armada upon the sale to Octave Specialty Group, Inc (formerly known as Ambac Financial Group, Inc.) . We will continue our underwriting capacity partnership with Armada until the end of 2030. We provide underwriting capacity in the form of insurance or reinsurance to 6 non-consolidated entities in addition to the two consolidated MGAs. We also have investment stakes in 7 other entities where we have no underwriting relationships. The investment interests in the non-consolidated entities are included in strategic investments within Other long-term investments on the consolidated balance sheet.

48


The following table sets forth underwriting results, net MGA results, and ratios for the segment results, and the period over period changes, for the Insurance & Services segment for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025ChangeSeptember 30, 2026September 30, 2025Change
($ in millions)
Gross written premium$673.0 $562.0 $111.0 $2,002.2 $1,757.5 $244.7 
Net written premium403.5 396.8 6.7 1,287.0 1,273.1 13.9 
Net earned premium460.8 381.2 79.6 1,222.6 1,086.6 136.0 
Loss and loss adjustment expenses incurred, net263.6 225.3 38.3 695.8 644.4 51.4 
Acquisition costs, net136.9 98.3 38.6 349.1 283.5 65.6 
Other underwriting expenses27.3 19.9 7.4 79.2 61.4 17.8 
Underwriting income33.0 37.7 (4.7)98.5 97.3 1.2 
Services revenues61.5 58.5 3.0 174.9 178.7 (3.8)
Services expenses49.4 48.5 0.9 145.1 141.2 3.9 
Net services fee income12.1 10.0 2.1 29.8 37.5 (7.7)
Services noncontrolling (income) loss(0.2)0.1 (0.3)0.4 0.2 0.2 
Net services income11.9 10.1 1.8 30.2 37.7 (7.5)
Segment income$44.9 $47.8 $(2.9)$128.7 $135.0 $(6.3)
Underwriting ratios: (1)
Loss ratio57.2 %59.1 %(1.9)%56.9 %59.3 %(2.4)%
Acquisition cost ratio29.7 %25.8 %3.9 %28.6 %26.1 %2.5 %
Other underwriting expense ratio5.9 %5.2 %0.7 %6.5 %5.7 %0.8 %
Combined ratio92.8 %90.1 %2.7 %92.0 %91.1 %0.9 %
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.
Premium Volume
Gross written premium increased by $111.0 million, or 19.8%, for the three months ended September 30, 2026 compared to the three months ended September 30, 2025, primarily driven by growth in Surety business as well as an increase in premium estimate in Professional Liability business, slightly offset by the exit of an International A&H program. The Professional Liability premium estimate change was largely offset by corresponding loss and acquisition costs, with no significant impact on underwriting income.
Gross written premium increased by $244.7 million, or 13.9%, for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025, primarily driven by an increase in premium estimate in Professional Liability business and Surety, new program growth mainly in General Liability, as well as continued organic growth in existing programs and growth in North America A&H. The Professional Liability premium estimate change was largely offset by corresponding loss and acquisition costs, with no significant impact on underwriting income.
Consolidated MGAs
Gross written premium generated by the consolidated MGAs in the aggregate decreased by $12.8 million, or 17.1%, to $62.2 million for the three months ended September 30, 2026 compared to $75.0 million for the three months ended September 30, 2025.
Gross written premium generated by the consolidated MGAs in the aggregate decreased by $60.5 million, or 24.9%, to $182.5 million for the nine months ended September 30, 2026 compared to $243.0 million for the nine months ended September 30, 2025.
The decreases for the three and nine months ended September 30, 2026 primarily resulted from the deconsolidation of Armada in the fourth quarter of 2025.

49


Book value for the consolidated MGAs was $160.8 million as of September 30, 2026, compared to $80.3 million as of December 31, 2025. The increase in book value from December 31, 2025 was a result of the acquisition of Assist America, which was effective as of January 1, 2026 and the acquisition of World Nomads, which was effective as of September 30, 2026.
Underwriting Results
The decrease in underwriting income of $4.7 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 was primarily a result of higher acquisition and other underwriting expense ratios, slightly offset by lower attritional loss ratios.
The improvement in underwriting income of $1.2 million for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by increased favorable prior year loss reserve development, partially offset by higher acquisition and other underwriting expense ratios. For the nine months ended September 30, 2026, favorable prior year loss reserve development was $40.3 million compared to $21.7 million for the nine months ended September 30, 2025, primarily driven by favorable development in A&H. Increased acquisition costs primarily resulted from profit commission accruals related to favorable loss experience and increased other underwriting expense is largely driven by expenses related to incentive compensation award outperformance.
Services Results
The increase in services revenues of $3.0 million and net services income of $1.8 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 were primarily driven by growth in the IMG travel business and the acquisition of Assist America, partially offset by the deconsolidation of Armada in the fourth quarter of 2025.
The decrease in services revenues of $3.8 million and net services income of $7.5 million for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 were primarily due to the deconsolidation of Armada in the fourth quarter of 2025, partially offset by growth in the IMG travel business and the acquisition of Assist America.
Reinsurance Segment
The Reinsurance segment predominantly underwrites Casualty, Property and Other Specialties lines of business on a worldwide basis. The following table sets forth underwriting results and ratios and the period over period changes for the Reinsurance segment for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025ChangeSeptember 30, 2026September 30, 2025Change
($ in millions)
Gross written premium$317.6 $309.6 $8.0 $973.7 $1,034.1 $(60.4)
Net written premium275.2 268.1 7.1 798.0 843.6 (45.6)
Net earned premium304.0 262.3 41.7 819.3 828.3 (9.0)
Loss and loss adjustment expenses incurred, net154.0 145.5 8.5 428.1 497.2 (69.1)
Acquisition costs, net86.2 64.7 21.5 225.7 202.3 23.4 
Other underwriting expenses20.9 20.2 0.7 62.2 60.4 1.8 
Underwriting income$42.9 $31.9 $11.0 $103.3 $68.4 $34.9 
Underwriting ratios: (1)
Loss ratio50.7 %55.5 %(4.8)%52.3 %60.0 %(7.7)%
Acquisition cost ratio28.4 %24.7 %3.7 %27.5 %24.4 %3.1 %
Other underwriting expense ratio6.9 %7.7 %(0.8)%7.6 %7.3 %0.3 %
Combined ratio86.0 %87.9 %(1.9)%87.4 %91.7 %(4.3)%
(1)Underwriting ratios are calculated by dividing the related expense by net earned premium.

50


Premium Volume
Gross written premium in the Reinsurance segment increased by $8.0 million, or 2.6%, for the three months ended September 30, 2026 compared to the three months ended September 30, 2025, primarily driven by increases in certain Other Specialties lines, specifically Property and Marine & Energy.
Gross written premium in the Reinsurance segment decreased by $60.4 million, or 5.8%, for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025, primarily driven by deliberate reductions in Casualty, rate and exposure reductions in Property Catastrophe, and reductions in Other Specialties.
Underwriting Results
The increase in net underwriting income for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 was primarily driven by increased favorable prior year reserve development in Property and Energy.
The increase in net underwriting results for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025, was primarily driven by decreased catastrophe losses, as the nine months ended September 30, 2025 included losses of $62.6 million, or 7.6 percentage points on the combined ratio, primarily from the California wildfires. This was partially offset by lower favorable prior year loss reserve development of $26.9 million for the nine months ended September 30, 2026, compared to $35.5 million for the nine months ended September 30, 2025, mainly from reserve releases in Property relating to prior year’s catastrophe events.
Corporate
Corporate results include all run-off business, which represents certain classes of business that we ceased underwriting as part of fundamental changes to our business strategy, including the effect of the restructuring of the underwriting platform announced in 2022 and certain reinsurance contracts that have interest crediting features. Corporate results also include asbestos and environmental and other latent liability exposures on a gross basis, which have mostly been ceded, as well as specific workers’ compensation and cyber programs which we no longer write. The following table sets forth underwriting results and the period over period changes for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30, 2026September 30, 2025ChangeSeptember 30, 2026September 30, 2025Change
($ in millions)
Gross written premium$4.3 $2.8 $1.5 $0.1 $15.7 $(15.6)
Net written premium1.7 5.4 (3.7)0.9 1.0 (0.1)
Net earned premium2.8 4.2 (1.4)4.9 11.5 (6.6)
Loss and loss adjustment expenses incurred, net0.4 3.6 (3.2)18.8 10.7 8.1 
Acquisition costs, net0.8 3.7 (2.9)(1.8)7.7 (9.5)
Other underwriting expenses4.8 3.5 1.3 13.9 11.2 2.7 
Underwriting loss$(3.2)$(6.6)$3.4 $(26.0)$(18.1)$(7.9)
Minimal premium volume for the three and nine months ended September 30, 2026 reflect the expiration and non-renewal of the classes of business that we no longer actively underwrite. The increase in the underwriting loss for the nine months ended September 30, 2026 compared the nine months ended September 30, 2025 was primarily driven by adverse prior year loss reserve development of $14.5 million, mainly from one large claim settlement during the first quarter of 2026.
Non-GAAP Financial Measures
We have included certain financial measures that are not calculated under standards or rules that comprise U.S. GAAP. Such measures, including Core underwriting income, Core net services income, Core income, Core combined ratio, attritional loss ratio and tangible book value per diluted common share, are referred to as non-GAAP financial measures. These non-GAAP financial measures may be defined or calculated differently by other companies. We believe these measures allow for a more complete understanding of our underlying business. These measures are used by management to monitor our results and should not be viewed as a substitute for those determined in accordance with U.S. GAAP. Reconciliations of non-GAAP measures to the most comparable U.S. GAAP measures are included below.

51


Core Results
Collectively, the sum of the Company's two segments, Insurance & Services and Reinsurance, constitute "Core" results. Core underwriting income, Core net services income, and Core combined ratio are non-GAAP financial measures. We believe it is useful to review Core results as they reflect how management views the business and reflects our decision to exit the run-off business. The sum of Core results and Corporate results are equal to the consolidated results of operations.
Core underwriting income - calculated by subtracting Core loss and loss adjustment expenses incurred, net, Core acquisition costs, net, and Core other underwriting expenses from Core net premiums earned.
Core net services income - consists of services revenues which include commissions, brokerage and fee income related to consolidated MGAs, and other revenues, as well as services expenses which include direct expenses related to consolidated MGAs and services noncontrolling income which represent minority ownership interests in consolidated MGAs. Net services income is a key indicator of the profitability of the Company's services provided.
Core combined ratio - calculated by dividing the sum of Core loss and loss adjustment expenses incurred, net, Core acquisition costs, net and Core other underwriting expenses by Core net premiums earned. Attritional loss ratio excludes catastrophe losses from the accident year loss ratio as they are not predictable as to timing and amount. These ratios are useful indicators of our underwriting profitability.
See Note 4 “Segment reporting” to our unaudited consolidated financial statements included elsewhere in this Form 10-Q and the discussion of Segment Results above for additional information and a calculation of Core results and reconciliations to the most comparable U.S. GAAP measures.
Tangible Book Value Per Diluted Common Share
Tangible book value per diluted common share, as presented, is a non-GAAP financial measure and the most directly comparable U.S. GAAP measure is book value per common share. Tangible book value per diluted common share excludes goodwill and intangible assets. Management believes that effects of goodwill and intangible assets make book value comparisons to less acquisitive peer companies less meaningful.
The following table sets forth the computation of book value per common share, book value per diluted common share and tangible book value per diluted common share as of September 30, 2026 and December 31, 2025:
September 30,
2026
December 31,
2025
($ in millions, except share and per share amounts)
Common shareholders’ equity attributable to SiriusPoint common shareholders$2,228.3 $2,269.8 
Intangible assets158.8 121.2 
Goodwill46.0 — 
Tangible common shareholders' equity attributable to SiriusPoint common shareholders$2,023.5 $2,148.6 
Common shares outstanding115,032,060 116,989,799 
Effect of dilutive stock options and restricted share units1,949,637 4,983,345 
Book value per diluted common share denominator116,981,697121,973,144
Book value per common share$19.37 $19.40 
Book value per diluted common share$19.05 $18.61 
Tangible book value per diluted common share
$17.30 $17.62 
Liquidity and Capital Resources
Liquidity Requirements
Liquidity is a measure of a company’s ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. SiriusPoint’s insurance and reinsurance operations are subject to regulation and supervision in each of the jurisdictions where they are domiciled and licensed to conduct business. Generally, regulatory
52


authorities have broad supervisory and administrative powers over such matters as licenses, standards of solvency, premium rates, policy forms, investments, security deposits, methods of accounting, form and content of financial statements, reserves for unpaid loss and loss adjustment expenses, reinsurance, minimum capital and surplus requirements, dividends and other distributions to shareholders, periodic examinations, and annual and other report filings. In general, such regulation is for the protection of policyholders rather than shareholders. SiriusPoint manages its liquidity needs primarily through the maintenance of a short duration and high quality fixed income portfolio.
SiriusPoint is a holding company and has no substantial operations of its own and its assets consist primarily of its investments in subsidiaries. Its cash needs primarily consist of the payment of corporate expenses, interest and principal payments on debt obligations and investment opportunities. SiriusPoint may also require cash to repurchase shares of our common stock pursuant to the share repurchase program or redeem other securities issued by us. For further details, see Note 14 “Shareholders' equity” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q. Cash at the subsidiaries is used primarily to pay loss and loss adjustment expenses, reinsurance premiums, acquisition costs, interest expense, taxes, general and administrative expenses and to purchase investments. The insurance and reinsurance business of our operating subsidiaries inherently provide liquidity, as premiums are received in advance of the time losses are paid. However, the amount of cash required to fund loss payments can fluctuate significantly from period to period, due to the low frequency/high severity nature of certain types of business we write.
For additional commitments and contingencies that may affect our liquidity requirements see Note 17 “Commitments and contingencies” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Dividend Capacity and Capital
We are subject to regulations and other constraints that affect our ability to pay dividends. During the nine months ended September 30, 2026, SiriusPoint paid dividends of $2.6 million to the Series B preference shareholders as the Series B preference shares were fully redeemed on February 26, 2026 (2025 - $4.0 million and $12.0 million, respectively). See Note 14 “Shareholders' equity” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q for further discussion on the redemption. During the three and nine months ended September 30, 2026, SiriusPoint did not pay any dividends to its common shareholders.
For the three and nine months ended September 30, 2026, SiriusPoint received distributions of $45.0 million and $90.0 million, respectively, from SiriusPoint Bermuda Insurance Company Ltd. (“SiriusPoint Bermuda”), its immediate wholly-owned subsidiary (2025 - $17.0 million and $452.0 million, respectively). We believe the dividend/distribution capacity of SiriusPoint’s subsidiaries, which was approximately $694.7 million as of December 31, 2025, provides SiriusPoint with sufficient liquidity. For a further discussion of the various restrictions on SiriusPoint Bermuda’s ability to pay dividends, see Part I, Item 1 “Business - Regulation” in our 2025 Form 10-K.
In addition to the regulatory and other contractual constraints to paying dividends, we manage the capital of the group and each of our operating subsidiaries to support our current ratings from AM Best, Fitch, S&P and Moody’s. This could further reduce the ability and amount of dividends that could be paid from subsidiaries to SiriusPoint. In addition, the Company annually files the prescribed form of capital and solvency return, which comprises the insurer’s Bermuda Solvency Capital Requirement (“BSCR”) model. The BSCR model is a risk-based capital model which provides a method for determining a Class 3A and Class 4 insurer’s capital requirements (statutory economic capital and surplus) by taking into account the risk characteristics of different aspects of the Class 3A and Class 4 insurer’s business. Our filed 2025 BSCR ratio is 256%. The Company is also currently completing its third quarter 2026 Bermuda Quarterly Financial Return, with an estimated ratio of 232%.
Sources of Liquidity
Our operating subsidiaries sources of liquidity have primarily consisted of net written premium, reinsurance recoveries, investment income and proceeds from sales of or dividends or distributions attributable to investments. Other potential sources of liquidity include borrowings under our credit facilities, the Federal Home Loan Bank of New York (“FHLBNY”) advance program and issuances of securities.
Effective December 19, 2024, we entered into a four-year, $400.0 million senior unsecured revolving credit facility (the “Facility”) with JPMorgan Chase Bank, N.A. as administrative agent. The Facility includes an option for the Company to request a 12-month extension, subject to satisfaction of certain conditions including, but not limited to, the consent of lenders representing a majority-in-interest of commitments, of the Facility maturity date. Subject to customary conditions precedent upon any borrowing request, the Facility provides access to loans for working capital and general corporate purposes, as well
53


as letters of credit to support obligations under insurance and reinsurance agreements, retrocessional agreements and for general corporate purposes. As of September 30, 2026, the Company was in compliance with all of the covenants under the Facility and there were no outstanding borrowings under the Facility.
Effective September 2025, we became a member of the FHLBNY. As a member, we may borrow through the advance program of the FHLBNY. The FHLBNY advance program provides short- and long-term, fully collateralized loans, called advances, to their members. We have the ability to obtain this funding based on a percentage of the value of our admitted assets in the State of New York, subject to availability of eligible collateral. As of September 30, 2026, there were no outstanding FHLBNY borrowings.
Financing
We expect that our cash and cash equivalents on the balance sheet and cash flow from operations will provide us with the financial flexibility to execute our strategic objectives. Our ability to generate cash, however, is subject to our performance, general economic conditions, industry trends, and other factors. To the extent cash and cash equivalents on the balance sheet, investment returns and cash flow from operations are insufficient to fund our future activities and requirements, we may need to raise additional funds through public or private equity or debt financing. If we issue equity securities in order to raise additional funds, substantial dilution to existing shareholders may occur. If we raise cash through the issuance of additional indebtedness, we may be subject to additional contractual restrictions on our business. There is no assurance that we would be able to raise the additional funds on favorable terms or at all.
The following table represents a summary of our debt obligations as of September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
Amount
Effective rate (1)
Amount
Effective rate (1)
2024 Senior Notes, at face value$400.0 7.4 %$400.0 7.4 %
Unamortized discount and issuance costs(3.1)(4.0)
2024 Senior Notes, carrying value396.9 396.0 
2017 SEK Subordinated Notes, at face value275.6 6.2 %298.2 7.1 %
Unamortized discount(5.0)(5.6)
2017 SEK Subordinated Notes, carrying value270.6 292.6 
Total debt$667.5 $688.6 
(1)Effective rate considers the effect of the debt issuance costs, discount, and premium.
For further details and discussion with respect to the 2024 Senior Notes and 2017 SEK Subordinated Notes, please refer to Note 12 “Debt and letter of credit facilities” of Part II, Item 8. “Financial Statements and Supplementary Data” included in our 2025 Form 10-K.
Debt Covenants
As of September 30, 2026, we were in compliance with all of the covenants under the 2024 Senior Notes and the 2017 SEK Subordinated Notes.
Letter of Credit Facilities
As of September 30, 2026, letters of credit in the amount of $761.3 million had been issued by the Company to various insurance and reinsurance counterparties. Each of the facilities contain customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and a minimum rating from rating agencies. Each restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists under any of the letter of credit facilities, our subsidiaries could be prohibited from paying dividends. We were in compliance with all of the covenants under the aforementioned letter of credit facilities as of September 30, 2026.
For further details and discussion with respect to letter of credit facilities, see Note 12 “Debt and letter of credit facilities” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
54


Cash Secured Letter of Credit Agreements
Under the cash secured letter of credit facilities, we provide collateral that consists of cash and cash equivalents and debt securities. As of September 30, 2026, total cash and cash equivalents and debt securities with a fair value of $842.3 million were pledged as collateral against the letters of credit issued.
We believe that we have adequate capacity between our existing cash secured letter of credit agreements as well as available investments to post in reinsurance trusts to meet our collateral obligations under our existing and future reinsurance business.
For further details and discussion with respect to cash secured letter of credit agreements, see Note 12 “Debt and letter of credit facilities” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Cash, Restricted Cash and Cash Equivalents and Restricted Investments
Cash and cash equivalents consist of cash held in banks and other short-term, highly liquid investments with original maturity dates of 90 days or less. We invest a portion of the collateral securing certain reinsurance contracts in U.S. treasury securities and sovereign debt. This portion of the collateral is included in debt securities in the consolidated balance sheets and is disclosed as part of restricted investments. In addition, restricted investments also pertain to limited partnership interests in Third Point funds securing the Company’s contractual obligations under certain reinsurance contracts that the Company will not be released from until the underlying risks have expired or have been settled.
Restricted cash and cash equivalents and restricted investments decreased to $1.9 billion as of September 30, 2026 from $2.2 billion as of December 31, 2025. The decrease was primarily due to the release of collateral pledged against prior underwriting years’ (re)insurance contracts.
For additional information on restricted cash, cash equivalents and investments, see Note 5 “Cash, cash equivalents, restricted cash and restricted investments” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Cash Flows
Our cash flows from operations generally represent the difference between: (1) premiums collected and investment income and (2) loss and loss expenses paid, reinsurance purchased, underwriting and other expenses paid. Cash flows from operations may differ substantially from net income and may be volatile from period to period depending on the underwriting opportunities available to us and other factors. Due to the nature of our underwriting portfolio, claim payments can be unpredictable and may need to be made within relatively short periods of time. Claim payments can also be required several months or years after premiums are collected. In addition, as discussed above, SiriusPoint has access to the $400.0 million Facility that provides access to loans for working capital and general corporate purposes, and letters of credit to support obligations under insurance and reinsurance agreements and retrocessional agreements.
Operating, investing, and financing cash flows for the nine months ended September 30, 2026 and 2025 were as follows:
20262025
($ in millions)
Net cash provided by operating activities$306.7 $128.8 
Net cash provided by (used in) investing activities(333.0)234.9 
Net cash used in financing activities(314.4)(517.0)
Net decrease in cash, cash equivalents and restricted cash(340.7)(153.3)
Cash, cash equivalents and restricted cash at beginning of period902.4 894.6 
Change in cash, cash equivalents and restricted cash classified as assets held for sale— (23.6)
Cash, cash equivalents and restricted cash at end of period$561.7 $717.7 
Operating Activities
Cash flows provided by operating activities can fluctuate due to timing differences between the collection of premiums and reinsurance recoverable, the payment of losses and loss expenses, and the payment of premiums to reinsurers. The increase in cash flows provided by operating activities for the nine months ended September 30, 2026 was primarily driven by an increase in the collection of premiums consistent with the underlying growth of the business, compared to lower cash flows provided by operating activities for the nine months ended September 30, 2025 primarily impacted by payments for California wildfire claims.
55


Investing Activities
Cash flows used in investing activities for the nine months ended September 30, 2026 were driven by lower proceeds from sales and maturities of debt securities compared to purchases during the period and cash used to complete the acquisitions of Assist America and World Nomads. Cash flows provided by investing activities for the nine months ended September 30, 2025 were driven by higher proceeds from sales and maturities of debt securities compared to purchases during the period.
Financing Activities
Cash flows used in financing activities for the nine months ended September 30, 2026 primarily consisted of a $203.9 million payment for the redemption of the Series B Preference share and $100.6 million in payments for share repurchases. Cash flows used in financing activities for the nine months ended September 30, 2025 primarily consisted of $490.8 million in payments for share repurchases.
Financial Condition
As of September 30, 2026, total shareholders’ equity was $2.2 billion, compared to $2.5 billion as of December 31, 2025. The decrease was primarily driven by the redemption of the Series B preference shares of $203.9 million, common share repurchases of $100.6 million and the accumulated other comprehensive loss from unrealized losses from AFS debt securities of $190.0 million, partially offset by net income of $255.0 million for the nine months ended September 30, 2026.
Contractual Obligations
There have been no material changes to our contractual obligations from our 2025 Form 10-K.
Critical Accounting Policies and Estimates
For a summary of our significant accounting and reporting policies, please refer to Note 2 “Significant accounting policies” of Part II, Item 8. “Financial Statements and Supplementary Data” included in our 2025 Form 10-K.
Our consolidated financial statements are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect the reported and disclosed amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and such differences could be material to the financial statements. As of December 31, 2025, the accounting policies that required the most significant judgments and estimations by management include, but are not limited to: (1) premium revenue recognition, (2) loss and loss adjustment expense reserves, (3) fair value measurements related to our investments and (4) income taxes. If actual events differ significantly from the underlying judgments or estimates used by management in the application of these accounting policies, there could be a material adverse effect on our results of operations and financial condition. Refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our 2025 Form 10-K.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
Our consolidated balance sheets include a substantial amount of assets and liabilities whose fair values are subject to market risk. The term market risk refers to the risk of loss arising from adverse changes in interest rates, credit spreads, equity markets prices, and other relevant market rates and prices. Due to our sizable investment portfolio, market risk can have a significant effect on our consolidated financial position.
We believe we are principally exposed to the following types of market risk:
▪interest rate risk; and
▪foreign currency exchange risk.
Interest Rate Risk
Interest rate risk is the price sensitivity of a security to changes in interest rates. Our investment portfolio includes fixed income investments, whose fair values will fluctuate with changes in interest rates. Increases and decreases in prevailing interest rates generally translate into decreases and increases in fair values of fixed income investments, respectively. Additionally, fair values of interest rate sensitive instruments may be affected by the creditworthiness of the issuer, prepayment options, relative values of alternative investments, the liquidity of the instrument, and other market factors.
56


We manage the interest rate risk associated with our portfolio of fixed income investments by matching assets backing reserves with that of our economic liabilities, in addition to monitoring the average yield of investment-grade corporate securities; U.S. government and agency securities; foreign government, agency and provincial obligations; preferred stocks; asset-backed and mortgage-backed securities; and municipal obligations.
The following table summarizes the estimated effects of hypothetical increases and decreases in market interest rates on our debt securities as of September 30, 2026:
Fair valueAssumed change in interest rateEstimated fair value after change in interest ratePre-tax increase (decrease) in carrying value
($ in millions)
Debt securities$5,420.1 300 bp decrease$5,932.5 $512.4 
200 bp decrease5,761.6 341.5 
100 bp decrease5,590.8 170.7 
50 bp decrease5,505.3 85.2 
50 bp increase5,330.4 (89.7)
100 bp increase5,239.6 (180.5)
200 bp increase5,057.8 (362.3)
300 bp increase$4,875.4 $(544.7)
The magnitude of the fair value decrease in rising rates scenarios may be more significant than the fair value increase in comparable falling rates scenarios. This can occur because (i) the analysis floors interest rates at a de minimis level in falling rate scenarios, muting price increases, (ii) portions of the fixed income investment portfolio may be callable, muting price increases in falling interest rate scenarios and/or (iii) portions of the fixed income investment portfolio may experience cash flow extension in higher interest rate environments, which generally results in lower fixed income asset prices.
Interest payments on our 2017 SEK Subordinated Notes are required to be serviced in Swedish kronor by reference to Stockholm Interbank Offered Rate, a floating interest rate benchmark. This benchmark rate has increased year to date and it is possible that it will continue to do so, which could result in increasing our interest expense in U.S. dollars.
Foreign Currency Exchange Risk
In the ordinary course of business, we hold non-U.S. dollar denominated assets and liabilities, which are valued using period-end exchange rates. Non-U.S. dollar denominated foreign revenues and expenses are valued using average exchange rates over the period. Foreign currency exchange-rate risk is the risk that we will incur losses on a U.S. dollar basis due to adverse changes in foreign currency exchange rates. We aim to mitigate foreign currency exchange risk through the use of foreign currency forwards. Refer to Note 8 “Derivatives” to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information on foreign currency hedging.
The following table, presented net of currency hedges, summarizes the estimated effects of a hypothetical 10% increase and decrease in the value of the U.S. dollar against select foreign currencies would have had on the carrying value of our net assets as of September 30, 2026:
10% increase10% decrease
($ in millions)
Swedish Krona to U.S. Dollar$(1.1)$1.1 
British Pound to U.S. Dollar(2.4)2.4 
Swiss Franc to U.S. dollar(1.0)1.0 
Euro to U.S. Dollar(2.0)2.0 
Canadian Dollar to U.S. Dollar$(0.1)$0.1 
57


ITEM 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) as of September 30, 2026. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2026.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that occurred during the three months ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - Other Information
ITEM 1. Legal Proceedings
The Company and its subsidiaries are subject to lawsuits and regulatory actions in the normal course of business that do not arise from or directly relate to claims on reinsurance treaties or contracts or direct surplus lines insurance policies. In the Company’s industry, business litigation may involve allegations of underwriting or claims-handling errors or misconduct, disputes relating to the scope of, or compliance with, the terms of delegated underwriting agreements, employment claims, regulatory actions, or disputes arising from the Company’s business ventures. The Company’s operating subsidiaries are subject to claims litigation involving, among other things, disputed interpretations of policy coverages. Generally, the Company’s direct insurance operations are subject to greater frequency and diversity of claims and claims-related litigation than its reinsurance operations and, in some jurisdictions, may be subject to direct actions by allegedly injured persons or entities seeking damages from policyholders. These lawsuits, which involve or arise out of claims on policies issued by the Company’s subsidiaries, are typical to the insurance industry in general and in the normal course of our business. These claims are considered in the Company’s loss and loss expense reserves. In addition, the Company may from time to time engage in litigation or arbitration related to its claims for payment in respect of ceded reinsurance, including disputes that challenge the Company’s ability to enforce its underwriting intent. Such matters could result, directly or indirectly, in providers of protection not meeting their obligations to the Company or not doing so on a timely basis. The Company may also be subject to other disputes from time to time relating to operational or other matters distinct from insurance or reinsurance claims. Any litigation or arbitration, or regulatory process, contains an element of uncertainty, and the value of an exposure or a gain contingency related to a dispute is difficult to estimate. The Company believes that no individual litigation or arbitration to which it is presently a party is likely to have a material adverse effect on its results of operations, financial condition, business, or operations.
ITEM 1A. Risk Factors     
Our business is subject to a number of risks, including those described in the Company’s risk factors disclosed in Part I, Item 1A of our 2025 Form 10-K, that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, cash flows and results of operations. There have been no material changes to the risk factors disclosed in our 2025 Form 10-K.
58


ITEM 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
Under the share repurchase program, the Company may repurchase its common stock from time to time, in amounts, at prices and at times the Company deems appropriate in its sole discretion, subject to market conditions and a variety of factors, including legal requirements, price and economic conditions. Shares of common stock may be repurchased in open market purchases, privately negotiated transactions or otherwise. The Company expects that the program will be in effect until the maximum approved dollar amount has been used. The program does not require the Company to repurchase any specific number of shares of common stock, and the program may be suspended, modified or discontinued at any time.
The following table summarizes our repurchase of common shares during the three months ended September 30, 2026:
(a) Total number of shares purchased
(b) Average price paid per share (1)
(c) Total number of shares purchased as part of publicly announced plans or programs
(d) Maximum $ value of shares that may yet be purchased under the plans or programs (2)
July 1, 2026 - July 31, 2026977,890 $24.76 977,890 $76,883,630 
August 1, 2026 - August 31, 2026124,544 23.83 124,544 73,919,333 
September 1, 2026 - September 30, 2026— — — 73,919,333 
Total1,102,434 $24.65 1,102,434 $73,919,333 
(1)Including commissions.
(2)Maximum value of common shares that may yet be purchased under the share repurchase programs previously authorized on May 4, 2016, February 28, 2018, and July 31, 2024.
ITEM 3. Defaults Upon Senior Securities
None.
ITEM 4. Mine Safety Disclosures
Not applicable.
ITEM 5. Other Information
Legacy Reinsurance Loss Portfolio Transfer
On October 30, 2026, SiriusPoint America Insurance Company ("SiriusPoint America") and SiriusPoint Bermuda Insurance Company Ltd. ("SiriusPoint Bermuda" and, together with SiriusPoint America, the "Cedents"), each a subsidiary of SiriusPoint Ltd., entered into a Master Agreement (the "Master Agreement"). The Master Agreement is made by and between the Cedents and RiverStone International Bermuda Limited ("RiverStone Bermuda"), an insurer domiciled in Bermuda, and Riverstone International Limited.

Pursuant to the Master Agreement, at the closing of the transactions contemplated therein: (a) the Cedents and RiverStone Bermuda will enter into a Loss Portfolio Transfer Reinsurance and Retrocession Agreement (the "LPT Agreement"), under which the Cedents will cede and RiverStone Bermuda will assume up to 100% of the net reserves with respect to certain legacy reinsurance and retrocession exposures of the Cedents (the "Subject Business"), subject to the terms and conditions of the LPT Agreement, including an aggregate limit; (b) RiverStone International Insurance, Inc., an affiliate of RiverStone Bermuda (the "Administrator"), will assume authority and responsibility for certain administrative services related to the Subject Business, pursuant to the terms of the LPT Agreement; and (c) each of the Cedents, RiverStone Bermuda, and a trustee will enter into trust agreements under which RiverStone Bermuda will provide collateral securing its reinsurance obligations with respect to the Subject Business. The Subject Business includes substantially all of the Company’s remaining run-off reserves.

This transaction covers approximately $400.0 million of SiriusPoint net loss and loss adjustment expense reserves, valued as of June 30, 2026. The aggregate limit under the LPT Agreement is $700.0 million.

The Master Agreement and the LPT Agreement include customary representations and warranties, indemnification obligations, covenants and termination rights of the parties. The transaction is subject to regulatory approvals and customary closing conditions.
59


Trading Arrangements
During the three months ended September 30, 2026, none of the Company’s directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).
60


ITEM 6. Exhibits
10.1†
31.1
31.2
32.1**
32.2**
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.LABInline XBRL Taxonomy Extension Labels Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
†     The Registrant has omitted portions of the referenced exhibit pursuant to Regulation S-K Item 601(b)(10)(iv).

**    This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

61

SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SiriusPoint Ltd.
Date: November 5, 2026
/s/ Scott Egan
Scott Egan
Chief Executive Officer
(Principal Executive Officer)
/s/ Jim McKinney
Jim McKinney
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)


EXECUTION VERSION
CONFIDENTIAL

CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN OMITTED.









image_0a.jpg

MASTER AGREEMENT BY AND AMONG
SIRIUSPOINT AMERICA INSURANCE COMPANY, SIRIUSPOINT BERMUDA INSURANCE COMPANY LTD., RIVERSTONE INTERNATIONAL BERMUDA LIMITED AND
(SOLELY FOR THE LIMITED PURPOSES SET FORTH HEREIN) RIVERSTONE INTERNATIONAL LIMITED
DATED AS OF OCTOBER 30, 2026

image_1a.jpg



TABLE OF CONTENTS
Page
Article I
DEFINITIONS
Section 1.1.    Definitions    2
Article II
CLOSING; REINSURANCE PREMIUM
Section 2.1.    Closing    10
Section 2.2.    Closing Deliveries    10
Section 2.3.    Payment at Closing    11
Section 2.4.    Post-Closing Adjustments    12
Article III
REPRESENTATIONS AND WARRANTIES OF THE CEDENTS
Section 3.1.    Organization, Standing and Corporate Power    14
Section 3.2.    Authority    14
Section 3.3.    No Conflict or Violation    15
Section 3.4.    Governmental Consents    15
Section 3.5.    Compliance    15
Section 3.6.    Broker    16
Section 3.7.    Information Disclosed    16
Section 3.8.    Financial    16
Section 3.9.    Absence of Changes    17
Section 3.10. SP Contracts    17
Section 3.11. Specified Data    17
Section 3.12. Solvency    18
Section 3.13. Inuring Reinsurance    18
Section 3.14. Third-Party Administrators    19
Article IV
REPRESENTATIONS AND WARRANTIES OF REINSURER
Section 4.1.    Organization, Standing and Corporate Power    19
Section 4.2.    Authority    19
Section 4.3.    No Conflict or Violation    20
Section 4.4.    Governmental Consents    20
Section 4.5.    Compliance    20



Section 4.6.    Broker    21
Section 4.7.    Financial Statements    21
Section 4.8.    Administrator    21
Article V
COVENANTS
Section 5.1.    Conduct of the Subject Business    21
Section 5.2.    Access to Information    22
Section 5.3.    Consents, Approvals and Filings    23
Section 5.4.    Public Announcements    24
Section 5.5.    Further Assurances    25
Section 5.6.    Confidentiality    25
Section 5.7.    Reinsurer Financial Statements    25
Section 5.8.    Trust Account Funding    25
Section 5.9.    Ancillary Agreements    26
Section 5.10. Sanctions and AML Compliance    26
Section 5.11. SP Contract and Underlying SP Contract Covenants    26
Section 5.12. Parental Guarantee    26
Article VI
CONDITIONS PRECEDENT
Section 6.1.    Conditions to Each Party’s Obligations    28
Section 6.2.    Conditions to Obligations of the Reinsurer    28
Section 6.3.    Conditions to Obligations of the Cedents    29
Article VII
INDEMNIFICATION
Section 7.1.    Survival of Representations, Warranties and Covenants    30
Section 7.2.    Indemnification    30
Section 7.3.    Certain Limitations    31
Section 7.4.    Procedures for Third Party Claims    33
Section 7.5.    Direct Claims    34
Section 7.6.    Certain Other Matters    34





Article VIII
TERMINATION
Section 8.1.    Termination of Agreement    35
Section 8.2.    Effect of Termination    35
Article IX
GENERAL PROVISIONS
Section 9.1.    Fees and Expenses    36
Section 9.2.    Notices    36
Section 9.3.    Entire Agreement    37
Section 9.4.    Waiver and Amendment    37
Section 9.5.    Successors and Assigns    38
Section 9.6.    Headings    38
Section 9.7.    Dispute Resolution    38
Section 9.8.    Governing Law    40
Section 9.9.    Service of Suit    40
Section 9.10. Third Party Beneficiaries    40
Section 9.11. Counterparts    40
Section 9.12. Severability    41
Section 9.13. Specific Performance    41
Section 9.14. Incontestability    41
Section 9.15. Currency    41
Section 9.16. Construction    42
Section 9.17. Certain Limitations    44



Exhibits and Attachments
SCHEDULE I        –    Subject Business
SCHEDULE II        –    Specified Data

EXHIBIT A        –    Form of the LPT Agreement
EXHIBIT B        –    Form of Common Interest and Confidentiality Agreement
EXHIBIT C        –    Form of Closing Statement
Cedents Disclosure Schedule
Reinsurer Disclosure Schedule



MASTER AGREEMENT
This MASTER AGREEMENT, dated as of October 30, 2026 (this “Agreement”), is made by and among SiriusPoint America Insurance Company, a New York domiciled property and casualty insurance company (“SP America”), SiriusPoint Bermuda Insurance Company Ltd., a Bermuda exempted company limited by shares and licensed as a Class 4 insurer pursuant to the Insurance Act 1978 of Bermuda (“SP Bermuda” and together with SP America, the “Cedents” and each, a “Cedent”), RiverStone International Bermuda Limited, a Bermuda exempted company limited by shares and licensed as a Class 3B insurer pursuant to the Insurance Act 1978 of Bermuda (the “Reinsurer”) and solely for purposes of Section 5.12, Section 9.2, Section 9.7 through Section 9.9, and Section 9.17, RiverStone International Limited, a Bermuda exempted company limited by shares (“Guarantor”). In this Agreement, each of the Cedents and the Reinsurer are referred to individually as a “Party” and together as the “Parties”.
WHEREAS, the Cedents issued the SP Contracts that constitute the Subject Business;
WHEREAS, the Parties hereto desire to enter into this Agreement pursuant to which, on the terms and subject to the conditions set forth herein, at the Closing (as defined below), among other things:
(A)the Cedents will enter into that certain Loss Portfolio Transfer Reinsurance and Retrocession Agreement with the Reinsurer and the Administrator, substantially in the form of Exhibit A (the “LPT Agreement”), pursuant to which (i) the Cedents will cede, and the Reinsurer will accept and reinsure the Covered Losses (as defined in the LPT Agreement), and (ii) the Administrator will provide certain administrative services with respect to the Subject Business, on the terms and subject to the conditions specified in the LPT Agreement;
(B)the Cedents, the Reinsurer and the Administrator will enter into a common interest and confidentiality agreement substantially in the form of Exhibit B (the “Common Interest and Confidentiality Agreement”);
(C)SP America, the Reinsurer and the Trustee shall enter into a trust agreement (the “SP America Trust Agreement”) pursuant to which a reinsurance trust account established in New York in compliance with New York Insurance Regulation 114 shall hold assets as security for the satisfaction of the reinsurance obligations of the Reinsurer to SP America under the LPT Agreement; and
(D)SP Bermuda, the Reinsurer and the Trustee shall enter into a trust agreement (the “SP Bermuda Trust Agreement” and together with the SP America Trust Agreement, the “Trust Agreements”) pursuant to which a reinsurance trust account established in New York shall hold assets as security for the satisfaction of the reinsurance obligations of the Reinsurer to SP Bermuda under the LPT Agreement, in each case of (A) through (D), upon the terms and subject to the conditions set forth herein, the LPT Agreement and the Trust Agreements (as applicable).
1


NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and upon the terms and subject to the conditions set forth herein, the Parties, intending to be legally bound, hereby agree as follows:
ARTICLE I
DEFINITIONS

Section 1.1. Definitions. Capitalized terms used but not defined elsewhere in this Agreement shall have the meanings ascribed to them below:
“Action” means any action, arbitration, suit, claim, counterclaim, complaint, demand, investigation, litigation, examination, hearing, mediation charge or proceeding, in each case by or before a Governmental Authority, or an arbitrator or arbitration panel or similar Person or body, whether civil, criminal, regulatory or administrative.
“Administrator” means RiverStone International U.S., LLC, a Massachusetts limited liability company.
“Affiliate” means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under direct or indirect common control with, such specified Person; provided, however, notwithstanding anything to the contrary set forth herein, as applicable to the Reinsurer, the term “Affiliate” shall include only (x) the Administrator and (y) the Reinsurer’s subsidiaries, and shall exclude (1) any direct or indirect investor in the Reinsurer or any direct or indirect beneficial owner of the Reinsurer’s securities, and (2) any portfolio company, limited partner or similar Person that is an Affiliate of such direct or indirect investor in, or beneficial owner of securities of, the Reinsurer, in each case, other than the Reinsurer and its subsidiaries. For purposes of this Agreement, “control” (including the terms “controlling”, “controlled by” and “under common control”) with respect to the relationship between or among two (2) or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person whether through the ownership of voting securities, by contract or otherwise.
“Aggregate Limit” means an amount equal to (a) USD $[***] minus (b) the Interim Paid UNL; provided, however, that, without limitation of the foregoing, the Section B Subject Business shall also be subject to the Sub-Limit.
“AML Laws” means all applicable anti-money laundering and combatting the financing of terrorism rules, including the U.S. Bank Secrecy Act, as amended by the
2


USA PATRIOT Act of 2001, and the U.S. Money Laundering Control Act of 1986, as amended.
“Ancillary Agreements” means the LPT Agreement, the Common Interest and Confidentiality Agreement and the Trust Agreements.

“Applicable Law” means any domestic or foreign, federal, state or local statute, law, ordinance or code, or any written rules or regulations or administrative interpretations issued by any Governmental Authority pursuant to any of the foregoing, in each case applicable to any Party,

and any Order, writ, injunction, directive, judgment or decree of a court or arbitral panel of competent jurisdiction applicable to the Parties.
“Applicable Reserves” has the meaning set forth in the LPT Agreement.
“Base Reinsurance Premium” means an amount equal to USD $[***].
“Books and Records” means originals or copies of all records and all other data and information (in whatever form maintained) to the extent in the possession or control of the Cedents or their Affiliates and relating to the Subject Business, the Covered Losses or the SP Contracts including: (i) administrative records, (ii) claim records, (iii) policy and reinsurance contract files, (iv) sales records, (v) underwriting records and (vi) accounting records, but, excluding: (a) Tax Returns (other than Tax Returns relating to Federal Excise Taxes), (b) files, records, data and information with respect to employees of the Cedents, or any employee benefit plan, (c) books and records that are subject to the attorney-client, work product, or other similar privilege or doctrine, or such materials or other information the disclosure or transfer of which would violate confidentiality obligations owed to a third party, in each case, it being understood that the Cedents shall use commercially reasonable efforts to obtain waivers or make other arrangements (including redacting information) that would enable any such item to be provided to the Reinsurer without destroying such privilege or breaching such confidentiality obligations, (d) any materials or other information the disclosure or transfer of which would violate Applicable Law, and (e) any internal drafts, opinions, valuations, correspondence or other materials prepared by, or provided between or among, the Cedents and their Affiliates, Representatives or other advisors in connection with the negotiation, valuation and consummation of the transactions contemplated by this Agreement.
“Burdensome Condition” means any restriction, condition, limitation, requirement or qualification that, individually or in the aggregate with all such restrictions, conditions, limitations, requirements or qualifications, would or would reasonably be expected to (a) in the case of the Cedents, materially and adversely affect the economics of the transactions reasonably expected to be obtained by the Cedents or their Affiliates in connection with the transactions contemplated by this Agreement, or (b) in the case of the Reinsurer, (i) materially and adversely affect the economics of the transactions reasonably expected to be obtained by the Reinsurer or its Affiliates (without regard to the proviso set forth in the definition of “Affiliates”)
3


in connection with the transactions contemplated by this Agreement, (ii) have a material adverse effect on the financial condition or results of operations of the Reinsurer and its Affiliates (without regard to the proviso set forth in the definition of “Affiliates”), taken as a whole, but measured as if the Reinsurer and such Affiliates were the size of the Subject Business (taking into account the Aggregate Limit), or (iii) impose any condition, restriction, requirement (including, for the avoidance of doubt, and without limitation, any obligation to furnish any information about any such Person, such Person’s controlling Persons or its or their respective employees, officers, directors or direct or indirect investors) or other obligation on (x) any direct or indirect investor in the Reinsurer or any direct or indirect beneficial owner of the Reinsurer’s securities, or (y) any portfolio company, limited partner, or similar Person that is an Affiliate of such direct or indirect investor in, or beneficial owner of securities of, the Reinsurer, in each case, other than the Reinsurer and its subsidiaries.

“Business Day” means any day other than a Saturday, Sunday or a day on which commercial banks in New York, New York or Hamilton, Bermuda are required or authorized by law to be closed.
“Carried Reserves” has the meaning set forth in the LPT Agreement.
“Cedents Disclosure Schedule” means the disclosure schedule (including any attachments thereto) delivered by the Cedents to the Reinsurer on the date hereof in connection with, and constituting a part of, this Agreement.
“Cedent Fundamental Representations” means the representations and warranties set forth in Section 3.1 (Organization, Standing and Corporate Power), Section 3.2 (Authority), Section 3.3(a) (No Conflict or Violation) and Section 3.6 (Broker).
“Confidentiality Agreement” means the mutual confidentiality agreement, dated December 5, 2023 between the Cedents or an Affiliate of the Cedents and the Reinsurer or an Affiliate of the Reinsurer, as amended by amendment number 1 to the confidentiality agreement, dated June 30, 2026.
“Contract” means, with respect to any Person, any agreement, contract, lease, instrument or other legally binding obligation to which such Person is a party or is otherwise subject or bound.
“Data Room” means the virtual data room coordinated by Marsh Re LLC (“Marsh Re”) on behalf of the Cedents in respect of the transactions contemplated by this Agreement located at https://us-mmc-datatransfer.mmc.com/web/folder/0.
“Domicile” means the jurisdiction in which a particular entity is domiciled.
“Domicile Accounting Rules” means, as of any date of determination, as to any Person, the statutory accounting principles and practices prescribed or permitted by the Governmental Authorities responsible for the regulation of insurance companies in such Person’s Domicile.
4


“Estimated Aggregate Limit” means an amount equal to (a) USD $[***] minus (b) the Estimated Interim Paid UNL; provided, however, that, without limitation of the foregoing, the Section B Subject Business shall also be subject to the Estimated Sub-Limit.
“Estimated Interim Paid UNL” means the Section A Estimated Interim Paid UNL plus the Section B Estimated Interim Paid UNL.
“Estimated Reinsurance Premium” means an amount equal to (a) the Base Reinsurance Premium minus (b) the Estimated Interim Paid UNL.
“Estimated Sub-Limit” means an amount equal to (a) USD $[***] minus (b) the Section B Estimated Interim Paid UNL.

“Federal Excise Tax” has the meaning set forth in the LPT Agreement.

“Governmental Authority” means any government, political subdivision, court, arbitrator, arbitration panel, mediator, mediation panel, board, commission, regulatory or administrative agency or other instrumentality thereof, whether federal, state, local or foreign and including any regulatory authority which may be partly or wholly autonomous.
“Guarantor” has the meaning set forth in the Preamble.
“Indemnifiable Losses” means any and all damages, judgments, awards, liabilities, Taxes, losses, obligations, claims of any kind or nature, fines, fees, costs and documented expenses (including reasonable fees and expenses of attorneys, auditors, consultants or other agents); provided that any Indemnifiable Losses (a) shall in no event include any amounts constituting (i) special, punitive or exemplary damages (except to the extent such types of damages are actually paid to a third party in connection with a Third Party Claim) or (ii) consequential damages except to the extent reasonably foreseeable and (b) shall be net of any amounts actually recovered (after deducting reasonable costs and expenses of recovery and actual or reasonably anticipated resulting premium increases) by the Indemnitee for the Indemnifiable Losses for which such indemnity payment is made under any insurance policy, warranty or indemnity or otherwise from any Person other than a Party hereto or an Affiliate of the Indemnitee.
“Indemnitee” means any Person entitled to indemnification under this Agreement.
“Indemnitor” means any Person required to provide indemnification under this Agreement.
“Indemnity Payment” means any amount of Indemnifiable Losses required to be paid pursuant to this Agreement.
“Interim Paid UNL” means the Section A Interim Paid UNL plus the Section B Interim Paid UNL.
5


“Inuring Reinsurance” has the meaning set forth in the LPT Agreement.
“IRS” means the U.S. Internal Revenue Service.
“Knowledge of the Cedents” means, as it relates to any fact or other matter concerning a particular Cedent, the actual knowledge of the chief executive officer, chief financial officer, deputy chief financial officer, chief claims officer, the global head of ceded reinsurance and chief actuary of such Cedent, in each case after reasonable due inquiry, including reasonable due inquiry of direct reports, relating to such fact or other matter.
“Material Adverse Effect” means any fact, occurrence, event, change, development, circumstance, condition or occurrence or effect that has had or would reasonably be expected to (a) have a material adverse effect on the condition (financial or otherwise), operations or results of operations of the Subject Business, taken as a whole, but excluding any such effect solely to the extent resulting from, arising out of, or relating to: (i) changes to United States or global capital, financial or securities markets or conditions, including prevailing interest rates, currency exchange rates or equity prices in the United States or foreign security markets and corresponding changes in the value of the Subject Business; (ii) any occurrence or condition generally affecting participants in any jurisdiction or geographic area in any segment of the industries or markets in which the Subject Business operates; (iii) any change or proposed change in Applicable Law, a Cedent’s Domicile Accounting Rules, or the interpretation or enforcement of any of the foregoing; (iv) local or national political conditions, natural disasters, catastrophic events, communicable disease, hostilities, acts of war or terrorism, or any escalation or worsening thereof; (v) the negotiation, execution and delivery of, or compliance with the terms of, or the taking of any action required by, this Agreement or the other Transaction Agreements, provided that if any of the foregoing result in a breach of Section 3.2 or Section 3.3, the event, circumstances, developments, changes, effects or occurrences that result from, arise out of or relate to such breach shall not be disregarded in determining whether a “Material Adverse Effect” has occurred; (vi) any matter disclosed to the Reinsurer at least two (2) Business Days prior to the date hereof; (vii) the identity of or facts related to the Reinsurer or any action taken by the Reinsurer or its Affiliates, or taken by the Cedents or any of their Affiliates at the request of the Reinsurer or with the Reinsurer’s prior written consent; (viii) any downgrade (or potential downgrade) in the credit, financial strength or other rating or outlook assigned to a Cedent or any of its Affiliates (it being understood that the facts and circumstances contributing to such change or potential change may be taken into account in determining whether a Material Adverse Effect has occurred or would be likely to occur); (ix) any change in loss development, case or incurred but not reported (“IBNR”) reserve estimates or actuarial assumptions or methodologies with respect to the Subject Business (it being understood that the facts and circumstances contributing to such change may be taken into account in determining whether a Material Adverse Effect has occurred or would be likely to occur), provided that if any of the foregoing directly result in, or from, a breach or inaccuracy of a representation or warranty under Article III or a breach of covenant under Article V, the event, circumstances, developments, changes, effects or occurrences that caused or result from such breach or inaccuracy shall not be disregarded in determining
6


whether a “Material Adverse Effect” has occurred; or (x) any failure of the Cedents to achieve any financial projections or forecasts (it being understood that the facts and circumstances contributing to such failure may be taken into account in determining whether a Material Adverse Effect has occurred or would be likely to occur, unless otherwise independently excluded by this definition); provided that notwithstanding the foregoing, with respect to clauses (i), (ii) and (iii) above, such fact, circumstance, change or effect shall be taken into account in determining whether a Material Adverse Effect has occurred or would be reasonably likely to occur if such fact, circumstance, change or effect is disproportionately adverse with respect to the Cedents or the Subject Business as compared to the business of other participants in the United States or Bermuda, as applicable, engaged in reinsurance of lines or risks comprising the Subject Business; or (b) cause impairment or delay of the ability of the Cedents or any of their Affiliates to perform any of their material obligations under this Agreement or the other Transaction Agreements, taken as a whole, including consummation of the transactions contemplated hereby or thereby.
“Order” means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.
“Person” means an individual, corporation, partnership, joint venture, limited liability company, association, trust, unincorporated organization, Governmental Authority, or other entity.

“Reinsurance Premium” means an amount equal to (a) the Base Reinsurance Premium
minus (b) the Interim Paid UNL.

“Reinsurer Disclosure Schedule” means the disclosure schedule (including any attachments thereto) delivered by the Reinsurer to the Cedents on the date hereof in connection with, and constituting a part of, this Agreement.
“Reinsurer Fundamental Representations” means the representations and warranties set forth in Section 4.1 (Organization, Standing and Corporate Power), Section 4.2 (Authority), Section 4.3(a) (No Conflict or Violation) and Section 4.6 (Broker).
“Representative” means, with respect to any Person, such Person’s officers, directors, employees, managing directors, agents, advisors, successors, permitted assigns, attorneys or consultants of such Person or an Affiliate of such Person.
“Required Regulatory Approvals” means those consents, approvals, non-disapprovals, licenses, permits, orders, qualifications, authorizations of, or registrations, waivers or other actions by, or any filings with or notifications to, any Governmental Authority set forth in Section 5.3(a) of the Cedents Disclosure Schedule and Section 5.3(a) of the Reinsurer Disclosure Schedule.
“Retained Share” has the meaning set forth in the LPT Agreement.
“Sanctioned Jurisdiction” means a country or territory that is itself the subject or target of any comprehensive sanctions (at the time of this Agreement, Iran, Cuba,
7


North Korea, the Crimea region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic regions of Ukraine, and the areas of Zaporizhzhia and Kherson not controlled by the Ukrainian government).
“Sanctioned Person” means any Person or vehicle that is the target of any sanctions or party-specific export controls, including: (a) any Person on any list of sanctioned or restricted parties maintained by the United States (including U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”), the U.S. Department of Commerce, or the U.S. Department of State), the United Nations Security Council, the European Union, any European Union member state, the United Kingdom, or Bermuda or other jurisdiction where either Party conducts business; (b) any Person located, organized, or ordinarily resident in a Sanctioned Jurisdiction; (c) the Government of Venezuela; or (d) any Person directly or indirectly, individually or in the aggregate, fifty percent (50%) or more owned or controlled by any such Person or Persons described in (a), (b) and/or (c).
“Sanctions” means economic, financial and trade sanctions, trade embargoes, and similar rules relating to anti-terrorism, the importation of restricted items, and export controls.
“Section A Estimated Interim Paid UNL” means the Cedents’ reasonable estimate of all amounts paid in respect of Ultimate Net Loss corresponding to Section A Subject Business by or on behalf of the Cedents during the Roll Forward Period (as defined in the LPT Agreement).
“Section A Interim Paid UNL” means all amounts paid in respect of Ultimate Net Loss corresponding to Section A Subject Business by or on behalf of the Cedents during the Roll Forward Period (as defined in the LPT Agreement).

“Section A Subject Business” has the meaning set forth on Schedule I.

“Section B Estimated Interim Paid UNL” means the Cedents’ reasonable estimate of all amounts paid in respect of Ultimate Net Loss corresponding to Section B Subject Business by or on behalf of the Cedents during the Roll Forward Period (as defined in the LPT Agreement).
“Section B Interim Paid UNL” means all amounts paid in respect of Ultimate Net Loss corresponding to Section B Subject Business by or on behalf of the Cedents during the Roll Forward Period (as defined in the LPT Agreement).
“Section B Subject Business” has the meaning set forth on Schedule I.
“SP Contracts” means those reinsurance and retrocession agreements, including binders, slips, covers, supplements, riders, amendments, addendums and endorsements thereto, entered into by a Cedent with respect to the Subject Business prior to the Valuation Date.
“Specified Data” means the data, information and files listed or set forth on, or described or referenced in, Schedule II.
8


“Sub-Limit” means an amount equal to (a) USD $[***] minus (b) the Section B Interim Paid UNL.
“Subject Business” has the meaning set forth on Schedule I.
“Tax” means any and all U.S. federal, state, local or non-U.S. income, gross receipts, premium, capital stock, franchise, retaliatory, profits, withholding, social security, unemployment, disability, real property, ad valorem/personal property, stamp, excise, occupation, sales, use, transfer, value added, alternative minimum, estimated or other tax, fee, duty, levy, custom, tariff, impost, assessment, obligation or charge of the same or of a similar nature to any of the foregoing, including any interest, penalty or addition thereto.
“Tax Return” means any report, estimate, extension request, information statement, claim for refund, or return relating to, or required to be filed in connection with, any Tax, including any schedule or attachment thereto, and any amendment thereof.
“Third Party Claim” means any Action made or brought by any Person that is not a Party to this Agreement or an Affiliate thereof.
“Transaction Agreements” means this Agreement and the Ancillary Agreements.
“Transaction Expenses” means, without duplication, all liabilities incurred by any Party for fees, expenses, costs, or charges as a result of the contemplation, negotiation, efforts to consummate, or consummation of the transactions contemplated by this Agreement, including any fees and expenses of investment bankers, attorneys, accountants, or other advisors, and any fees payable by such parties to Governmental Authorities or other third parties, in each case, in connection with the consummation of the transactions contemplated by this Agreement.

“Trust Accounts” means, collectively, (a) the reinsurance trust account established in New York in compliance with New York Insurance Regulation 114 for the benefit of SP America pursuant to the SP America Trust Agreement and (b) the reinsurance trust account established in New York for the benefit of SP Bermuda pursuant to the SP Bermuda Trust Agreement.
“Trustee” means Brown Brothers Harriman Institutional Trust Company of New York, LLC or another mutually acceptable successor of such Trustee.
“Ultimate Net Loss” shall have the meaning set forth in the LPT Agreement, without giving effect to the last sentence of such definition.
“Underlying Cedent” means the ceding company under an SP Contract.
“Underlying SP Contract” means that certain Reserve Reinsurance Contract, by and between SP Bermuda and SiriusPoint International, dated as of July 1, 2024.
“Valuation Date” means June 30, 2026.
9


In addition, the following terms shall have the respective meanings set forth in the following sections of this Agreement:
Accounting Firm    2.4(c)
Agreement    Preamble
ARIAS·US    9.7(b)
Cap    7.3(a)
Cedent    Preamble
Cedent Indemnified Persons    7.2(b)
Cedents    Preamble
Cedents Statutory Financial Statements    3.8(a)
Closing    2.1
Closing Date    2.1
Closing Securities    2.3(b)
Common Interest and Confidentiality Agreement    Recitals
Condition Satisfaction    2.1
Deadline Date    8.1(b)
Deductible    7.3(a)
Disclosure Schedules    9.16(g)
Disputed Item    2.4(b)
Enforceability Exceptions    3.2
Final Aggregate Limit    2.4(d)
Final Closing Statement    2.4(a)
Final Interim Paid UNL    2.4(d)
Final Reinsurance Premium    2.4(d)
Final Section A Interim Paid UNL    2.4(d)
Final Section B Interim Paid UNL    2.4(d)
Final Sub-Limit    2.4(d)
Initial Closing Statement    2.3(a)
LPT Agreement    Recitals
New York Courts                         9.9(b)

10


Notice of Disagreement    2.4(b)
Parties    Preamble
Party    Preamble
Reinsurer    Preamble
Reinsurer Indemnified Persons    7.2(a)
Reinsurer Statutory Financial Statements    4.7
Resolution Period    2.4(c)
Solvent    3.12
SP America    Preamble
SP America Trust Agreement    Recitals
SP Bermuda    Preamble
SP Bermuda Trust Agreement    Recitals
Springing Date    5.8
Threshold Amount    7.3(a)
Trust Agreements    Recitals
Unresolved Items    2.4(c)

ARTICLE II

CLOSING; REINSURANCE PREMIUM
Section 2.1. Closing. The closing of the transactions contemplated hereby (the “Closing”) shall take place remotely via the exchange of documents and signature pages, (i) at 11:59:59 p.m., Eastern Time, on December 31, 2026, subject to all the conditions set forth in Article VI having been satisfied or waived in accordance with this Agreement at least three (3) Business Days prior to such date and time (other than those conditions that by their terms are to be satisfied at the Closing but subject to the satisfaction or waiver of such conditions) (“Condition Satisfaction”) or (ii) if Condition Satisfaction has not occurred at least three (3) Business Days prior to 11:59:59 p.m., Eastern Time, on December 31, 2026, at 11:59:59 p.m., Eastern Time, on the third (3rd) Business Day following the date as of which Condition Satisfaction occurs or such other date, place, and time as the Parties may mutually agree in writing (the date on which the Closing occurs being the “Closing Date”).
11


Section 2.2.    Closing Deliveries.
(a)Cedents’ Closing Deliveries. At the Closing, the Cedents shall pay the Estimated Reinsurance Premium in accordance with Section 2.3(b) and also deliver to the Reinsurer:
(i)a certificate of each Cedent duly executed by its respective authorized officers, dated as of the Closing Date, certifying as to such Cedent ’s compliance with the conditions set forth in Section 6.2(a) and Section 6.2(b); counterparts of each Transaction Agreement to be entered into by the Cedents or one of their Affiliates, duly executed by such Cedent or its Affiliate;

(ii)counterparts of each Trust Agreement to be entered into by the Trustee, duly executed by the Trustee; and
(iii)a properly completed and duly executed IRS Form W-9 from each of SP Bermuda and SP America.
(b)Reinsurer’s Closing Deliveries. At the Closing, the Reinsurer shall deliver to the Cedents:
(i)a certificate of the Reinsurer duly executed by an authorized officer of the Reinsurer, dated as of the Closing Date, certifying as to the Reinsurer’s compliance with the conditions set forth in Section 6.3(a) and Section 6.3(b);
(ii)counterparts of each Transaction Agreement, duly executed by the Reinsurer or its applicable Affiliate; and
(iii)Reinsurer’s properly completed and duly executed IRS Form W-8BEN-E.
Section 2.3.    Payment at Closing.
(a)No later than ten (10) Business Days prior to the anticipated Closing Date, the Cedents shall deliver to the Reinsurer a statement in the form of Exhibit C hereto (the “Initial Closing Statement”) setting forth the Cedents’ good faith calculation in accordance with (i) Applicable Law, (ii) applicable Domicile Accounting Rules, consistently applied, (iii) the Cedents’ historical financial and accounting practices (to the extent consistent with Domicile Accounting Rules evidenced to Reinsurer in materials made available in the Data Room), (iv) generally accepted actuarial principles and practices, and (v) Cedents’ historical actuarial principles and practices (to the extent consistent with actuarial principles and practices evidenced to Reinsurer in materials made available in the Data Room) ((i) through (v), the “Closing Statement Methodologies”) of Estimated Reinsurance Premium, the Estimated Aggregate Limit, the Estimated Sub-Limit, the Section A Estimated Interim Paid UNL and the Section B Estimated Interim Paid UNL, in each case as of the Closing Date. The Initial Closing Statement will be accompanied by
12


reasonable information and detail to support the calculation of the amounts set forth therein. During the period following the delivery of the Initial Closing Statement and before the Closing, the Cedents shall consider in good faith any comments reasonably proposed by the Reinsurer. Any revised version of the Initial Closing Statement that results from changes agreed between the Parties as contemplated by the immediately preceding sentence shall thereafter be deemed the Initial Closing Statement for all purposes hereunder; provided, however, the foregoing shall in no way limit or restrict, or constitute a waiver of, the Reinsurer’s ability to challenge any aspect of the Final Closing Statement pursuant to Section 2.4.
(b)    As consideration for the reinsurance by the Reinsurer provided under the LPT Agreement, on the Closing Date (and to be adjusted in accordance with Section 2.4) the Cedents shall pay to the Reinsurer an amount equal to the Estimated Reinsurance Premium. This payment shall consist of a deposit by the Cedents, on behalf of the Reinsurer, to the Trust Accounts of cash and certain duration matched investment grade government or corporate debt securities (the “Closing Securities”) in an amount equal to the Estimated Reinsurance Premium (allocated to each Trust Account pursuant to the Initial Closing Statement); provided that the Cedents and the Reinsurer shall mutually agree prior to the Closing on any Closing Securities to be deposited into the Trust Accounts on the Closing Date; provided, further, that if the Parties have not so agreed on any Closing Securities by the third (3rd) Business Day
prior to the Closing Date, the Cedents shall pay the applicable portion of the Estimated Reinsurance Premium in cash, and the absence of such agreement shall not delay the Closing.
Section 2.4.    Post-Closing Adjustments.
(a)No later than ninety (90) calendar days following the Closing Date, the Cedents shall deliver to the Reinsurer a detailed statement in the form of Exhibit C hereto (the “Final Closing Statement”) setting forth the Cedents’ good faith calculation in accordance with the Closing Statement Methodologies of the Reinsurance Premium, the Aggregate Limit, Sub-Limit, the Section A Interim Paid UNL and the Section B Interim Paid UNL, in each case as of the Closing Date.
(b)In connection with the Reinsurer’s review of the Final Closing Statement, the Cedents shall provide, and shall use commercially reasonable efforts to cause their Affiliates and Representatives to provide, the Reinsurer and its Representatives, upon the reasonable request of the Reinsurer, reasonable access to the non-privileged books and records and, subject to the execution of customary access letters, any independent accountants’, valuation experts’, or actuaries’ work papers or internal accounting record s or reserving papers, files and models, in each case to the extent relevant to the preparation of the applicable Final Closing Statement, and make reasonably available to the Reinsurer and its Representatives personnel of the Cedents and their Affiliates who are responsible for and knowledgeable about the information set forth in the Final Closing Statement, in each case, during normal business hours upon reasonable advance notice; provided that such access does not unreasonably interfere with the conduct of the business of the Cedents and any of their Affiliates. If the Reinsurer disagrees with the Final Closing Statement, the Reinsurer may, within twenty-five (25) calendar days after receipt of
13


the Final Closing Statement, deliver a notice of disagreement (a “Notice of Disagreement”) to the Cedents which specifies each item that the Reinsurer disputes (each, a “Disputed Item”) and the amount in dispute for each such Disputed Item. If the Reinsurer does not deliver a Notice of Disagreement within such twenty-five (25) calendar day period, then the Reinsurance Premium, the Aggregate Limit, the Sub-Limit, the Section A Interim Paid UNL and the Section B Interim Paid UNL shall be deemed to equal the amounts provided in the Final Closing Statement and such amounts shall be final, binding and conclusive on the Parties.
(c)    If a Notice of Disagreement is timely delivered pursuant to Section 2.4(b), the Parties shall, during the thirty (30) calendar days following the receipt of such Notice of Disagreement by the Cedents, or such other period as to which the Parties mutually agree in writing (the “Resolution Period”), cooperate in good faith to reach agreement on the Disputed Items. If, by the end of the Resolution Period, the Parties are unable to reach such agreement with respect to all of the Disputed Items, they shall promptly thereafter engage and submit the unresolved Disputed Items (the “Unresolved Items”) to Ernst & Young LLP, or in the event Ernst & Young LLP refuses or is unable to accept or resigns from appointment provided hereunder, another independent, internationally recognized accounting firm with relevant expertise mutually selected by the Parties (the “Accounting Firm”) which shall promptly review this Agreement and the Unresolved Items. The Accounting Firm shall issue its written determination with respect to each Unresolved Item within thirty (30) calendar days after the Unresolved Items are submitted for review to the Accounting Firm; provided that the failure of the Accounting Firm to make its determination in such thirty (30) calendar day period shall not be grounds to defend against or object to the enforcement of such determination; provided, further, that the Parties shall instruct the Accounting Firm not to assign a value to any Unresolved Item greater than the greatest value for such Unresolved Item claimed by either the Cedents or the Reinsurer or less than the smallest value for such Unresolved Item claimed by either the Cedents or the Reinsurer. Each Party shall use commercially reasonable efforts to furnish to the Accounting Firm such non-privileged work papers, books, records and documents and other information pertaining to the Unresolved Items as the Accounting Firm may request and make reasonably available to the Accounting Firm personnel of each Party that have been involved in the preparation of the applicable Final Closing Statement or the Notice of Disagreement, as applicable. Any such information and documentation provided by any Party to the Accounting Firm shall concurrently be provided to the other Party to the extent not already so provided. The Cedents, on the one hand, and the Reinsurer, on the other hand, shall promptly (and in any event within ten (10) Business Days) after the Accounting Firm’s engagement each submit to the Accounting Firm their respective computations of the Unresolved Items identified in the Notice of Disagreement and information, arguments and support for their respective positions, and shall concurrently deliver a copy of such materials to the other Party. Each Party shall then be given an opportunity to supplement the information, arguments and support included in its initial submission with one additional submission to respond to any arguments or positions taken by the other Party in such other Party’s initial submission, which supplemental information shall be submitted to the Accounting
14


Firm (with a copy thereof to the other Party), within fifteen (15) Business Days after the first date on which both Parties have submitted their respective initial submissions to the Accounting Firm. The Accounting Firm shall thereafter be permitted to request additional or clarifying information from the Parties, and each of the Parties shall cooperate and shall cause its Representatives to cooperate with such requests of the Accounting Firm. The Parties acknowledge and agree that (i) the review by and determination of the Accounting Firm shall be limited to, and only to, the Unresolved Items that are contained in the reports prepared and submitted to the Accounting Firm by the Cedents and the Reinsurer, and (ii) the determinations by the Accounting Firm shall be based solely on (A) such reports submitted by the Cedents and the Reinsurer and the information and documents (including work papers) provided to the Accounting Firm which form the basis for the Cedents’ and the Reinsurer’s respective positions and not on the basis of an independent review and (B) this Agreement (including the defined terms set forth herein). Neither Party shall disclose to the Accounting Firm, and the Accounting Firm shall not consider for any purpose, any settlement discussions or settlement offer made by either Party with respect to any Notice of Disagreement unless otherwise agreed in writing by both Parties. The Accounting Firm shall act as an expert and not as an arbitrator, and the determination of the Accounting Firm shall be final, binding and conclusive on the Parties, absent manifest or mathematical error. The fees, expenses and costs of the Accounting Firm incurred in rendering any determination pursuant to this Section 2.4 shall be split equally between the Parties. Each Party agrees to enter into a customary engagement letter with the Accounting Firm.(d)    Following final resolution of the Reinsurance Premium (such amount, as fully and finally determined in accordance with this Section 2.4, the “Final Reinsurance Premium”), the Aggregate Limit (such amount, as fully and finally determined in accordance with this Section 2.4, the “Final Aggregate Limit”), Sub-Limit (such amount, as fully and finally determined in accordance with this Section 2.4, the “Final Sub-Limit”), the Section A Interim Paid UNL (such amount, as fully and finally determined in accordance with this Section 2.4, the “Final Section A Interim Paid UNL”) and the Section B Interim Paid UNL (such amount, as fully and finally determined in accordance with this Section 2.4, the “Final Section B Interim Paid UNL” and, together with the Final Section A Interim Paid UNL, the “Final Interim Paid UNL”), whether by the absence of timely delivery of a Notice of Disagreement or pursuant to Section 2.4(c), if the Final Reinsurance Premium exceeds the Estimated Reinsurance Premium, the Cedents shall, within five (5) Business Days following such resolution, deposit, on behalf of the Reinsurer, to the Trust Accounts (as applicable) an amount of cash equal to such excess by wire transfer of immediately available funds. If the Estimated Reinsurance Premium exceeds the Final Reinsurance Premium, the Reinsurer shall, within five (5) Business Days following such resolution, pay to the Cedents an amount equal to such excess, which payment may be satisfied, in the Reinsurer’s sole discretion, by either (i) a direct payment to the applicable Cedent by wire of immediately available funds or (ii) authorizing withdrawal by the applicable Cedent from the applicable Trust Account of such excess amount. The amount of any adjustment to be made pursuant to this Section 2.4(d) shall bear interest from and including the Closing Date to but excluding the date of payment at a rate per annum equal to five and three tenths percent (5.3%). Such interest shall be payable by the Party obligated to make, in the
15


same manner and at the same time as, the payment to which it relates and shall be calculated daily on the basis of a 365-day year and the actual number of calendar days elapsed.
ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE CEDENTS
Subject to Section 9.16(g), except as disclosed in the Cedents Disclosure Schedule delivered by the Cedents to the Reinsurer simultaneously with the execution of this Agreement, each Cedent hereby represents and warrants to the Reinsurer, severally and solely as to itself, as of the date of this Agreement and as of the Closing Date as follows:
Section 3.1. Organization, Standing and Corporate Power. Each Cedent is an insurer duly incorporated and validly existing under the laws of its jurisdiction of Domicile. Each Cedent has all requisite corporate power and authority to carry on the operations of its business as it is now being conducted. As of the Closing Date, the Cedents will have obtained all authorizations and approvals required under Applicable Law to perform the obligations contemplated of the Cedents under the Transaction Agreements to which it will be a party.

Section 3.2. Authority. Each Cedent has the requisite corporate (or other organizational) power and authority to enter into the Transaction Agreements to which it will be a party and to consummate the transactions contemplated thereby. The execution and delivery by each Cedent of the Transaction Agreements to which it will be a party and the consummation by such Cedent of the transactions contemplated thereby have been and, with respect to the Transaction Agreements to which it will be a party to be executed and delivered at Closing, will be duly authorized by all necessary corporate or other organizational action on the part of such Cedent. Each of the Transaction Agreements to which it will be a party has been or, with respect to the Transaction Agreements to which it will be a party to be executed and delivered at the Closing, will be duly executed and delivered by such Cedent and, assuming the Transaction Agreements constitute valid and binding agreements of the other parties thereto, constitute valid and binding obligations of such Cedent, enforceable against such Cedent in accordance with their terms, except that (a) such enforcement may be subject to applicable bankruptcy, insolvency, reorganization, moratorium, or other similar laws, now or hereafter in effect, affecting creditors’ rights generally and (b) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (clauses (a) and (b) shall be referred to as, the “Enforceability Exceptions”).
Section 3.3. No Conflict or Violation. The execution, delivery and performance by each Cedent of the Transaction Agreements to which it will be a party and the consummation of the transactions contemplated thereby in accordance
16


with the respective terms and conditions hereof will not (a) violate any provision of the organizational documents of such Cedent, (b) violate any material contract, permit, Order against or imposed or binding upon, such Cedent in any material respect or (c) conflict with, result in a breach of or default under, be prohibited by, require any consent or other action under, or give rise to a right of termination, amendment or acceleration under, any material Contract or instrument to which it is a party, except, in the case of the foregoing clause (b) and clause (c), as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no material claim (other than ordinary course claims and claims litigation), action, suit, litigation, legal, administrative or arbitration proceeding, regulatory inquiry, investigation or examination relating to the Subject Business that is pending or, to the Knowledge of the Cedents, threatened against or involving any of the Cedents or any of their Affiliates, or any of their or their Affiliates’ assets, properties, rights or privileges that, individually or in the aggregate, is material to the Subject Business or that challenges or would reasonably be expected to have the effect of preventing or materially delaying or making unlawful the consummation of the transactions contemplated by this Agreement or the other Transaction Agreements.
Section 3.4. Governmental Consents. Subject to the matters referred to in the next sentence, the execution, delivery and performance by each Cedent of the Transaction Agreements to which it will be a party or otherwise bound and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions thereof will not contravene any Applicable Law. No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority is required by or with respect to any Cedent in connection with the execution and delivery of this Agreement or the Transaction Agreements to which it will be party, or the consummation by such Cedent of the transactions contemplated hereby or thereby, except for the approvals, filings, and notices set forth in Section 3.4 of the Cedents Disclosure Schedule and such other consents, approvals, authorizations, declarations, filings, or notices that, if not obtained or made, would not, individually or in the aggregate, reasonably be expected to (i) be material to the Subject Business or the administration of the SP Contracts or the transactions contemplated by the Transaction Agreements or (ii) materially impair or delay the ability of the Cedents or any of their Affiliates to perform any of their material obligations under this Agreement or the other Transaction Agreements.

Section 3.5. Compliance. Except as disclosed in Section 3.5 of the Cedents Disclosure Schedule, each Cedent is in compliance in all material respects with all Applicable Law, its organizational documents and all material permits and licenses issued to such Cedent by any Governmental Authority except for any non-compliance which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. None of the Cedents nor any of their respective directors, officers, or to the Knowledge of the Cedents, employees or agents, is a Sanctioned Person. The Subject Business does not include any policies, agreements, contracts or other dealings with or involving any Sanctioned Person or any Sanctioned
17


Jurisdiction. Each Cedent has adopted and maintains, or is subject to, written policies, procedures and internal controls reasonably designed and implemented to comply with all applicable Sanctions and AML Laws.
Section 3.6. Broker. No broker or finder other than Marsh Re has acted directly or indirectly for any Cedent which might be entitled to any fee or commission from the Reinsurer or its Affiliates in connection with the transactions contemplated by this Agreement. The Cedents shall be responsible for any fee due to Marsh Re in connection with the transactions contemplated by this Agreement.
Section 3.7. Information Disclosed. As of the date of this Agreement, to the Knowledge of the Cedents: (a) all material relevant information relating to the Subject Business has been made available in the Data Room and (b) the contents of the Data Room are accurate and complete in all material respects.
Section 3.8.    Financial.
(a)Each of the Cedents has made available to the Reinsurer in the Data Room prior to the date hereof, copies of (x) the audited annual statutory financial statements of such Cedent as of and for the years ended December 31, 2025 and December 31, 2024 and (y) the unaudited quarterly statutory financial statements of such Cedent as of and for the quarters ended March 31, 2026 and June 30, 2026 ((x) and (y) collectively, the “Cedents Statutory Financial Statements”). The statutory policy reserves with respect to the SP Contracts contained in the Cedents Statutory Financial Statements were determined in all material respects in accordance with Applicable Law, the Domicile Accounting Rules, the SP Contracts and generally accepted actuarial standards applicable to such Cedent applying consistent practices, assumptions and methodologies used as of their respective dates (except as otherwise noted in the Cedents Statutory Financial Statements); provided, however, nothing in this Section 3.8 shall be deemed a representation or warranty with respect to the adequacy of reserves for the Subject Business. Since the date of the last audited Cedents Statutory Financial Statements, there has been no change which is materially adverse to the condition (financial or otherwise), prospects, results of operations or general affairs of the Subject Business.
(b)There are no permitted practices granted to the Cedents by a Governmental Authority that have the potential to affect such Cedent’s financial reporting under Domicile Accounting Rules as of the date hereof with respect to the Subject Business.
(c)    The Cedents Statutory Financial Statements were derived from, prepared using, and are consistent in all material respects with the Books and Records of the Cedents. The Books and Records of the Cedents have been maintained in compliance in all material respects with Applicable Law and have been prepared using processes and procedures for which there are no weaknesses or deficiencies in internal controls over financial reporting that could adversely affect the reporting of the financial condition and results of operations of the Subject Business.
18


Section 3.9. Absence of Changes. Since the Valuation Date, (a) the Subject Business has been conducted in all material respects in the ordinary course consistent with past practices and (b) there has not been any adverse event, change or circumstance that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on (i) the Subject Business or (ii) the liabilities to be reinsured by the Reinsurer under the LPT Agreement . Since the Valuation Date to the date of this Agreement, the Cedents have not taken any action or failed to take any action that would have required the Reinsurer’s consent under Section 5.1. had such action or omission occurred during the period from the date hereof to Closing.
Section 3.10. SP Contracts.
(a)With respect to each SP Contract: (i) neither of the Cedents nor, to the Knowledge of the Cedents, the other party or parties thereto, is in default under such SP Contract in any material respect, and to the Knowledge of the Cedents, no event has occurred which would create a material default or breach under such SP Contract; (ii) such SP Contract is in full force and effect and is valid and enforceable in accordance with its terms subject to the Enforceability Exceptions; and (iii) to the Knowledge of the Cedents, such SP Contract complies in all material respects with Applicable Law. There are no material pending or, to the Knowledge of the Cedents, threatened disputes with respect to the parties’ performance under, or the validity of, any such SP Contract.
(b)The execution, delivery and performance of the LPT Agreement and the consummation of the transactions contemplated thereby do not and will not violate or result in a breach of (including of any net retention, net retained lines, restriction on retrocession or similar provision), or constitute an occurrence of default under, result in the acceleration or cancellation of or give rise to a right by any party to terminate or amend or increase collateralization requirements under, any SP Contracts.
(c)Except as would not, individually or in the aggregate, reasonably be expected to be material and adverse to the Subject Business, taken as a whole, since December 31, 2023, all amounts payable or credited by or on behalf of any of the Cedents, to any Person under any SP Contract have in all material respects been paid or credited in accordance with Applicable Law and the terms of the SP Contracts under which they arose, and such payments or credits were not materially delinquent and were paid or credited without fines or penalties except for such claims for which the applicable Cedent believed there was a reasonable basis to contest payment.
(d)To the Knowledge of the Cedents, there are no material unpaid claims or assessments made against any Underlying Cedents by any state insurance guaranty associations or similar organizations in connection with such association’s insurance guaranty fund for which either of the Cedents is liable under any SP Contract.
19



Section 3.11. Specified Data. The Specified Data supplied by or on behalf of the Cedents or any of their Affiliates to the Reinsurer or any of its Affiliates in connection with this Agreement, the other Transaction Agreements and the transactions contemplated hereby or thereby as of the date supplied (a) was derived from the Books and Records, (b) was generated from the same underlying sources and systems that were relied on to prepare the Cedents Statutory Financial Statements and (c) was complete and accurate in all material respects (including the factual information contained therein); provided, however, with respect to Items 8 through 16 set forth on Schedule II, the following shall apply in lieu of the preceding clauses (a) through (c): (a) was true and complete copies of such documents as received by the Cedents or any of their Affiliates from the preparer of such documents, and no preparer has (i) issued to the Cedents or any of their Affiliates any newer, subsequent or revised version of any such documents or (ii) notified the Cedents or any of their Affiliates that any such documents contains errors or is inaccurate in any material respects and (b) to the Knowledge of the Cedents does not contain any material error, omission or inaccuracy. For the avoidance of doubt, the Cedents are not making any representation with respect to the accuracy of projections or forecasts of the future performance of the SP Contracts or the Subject Business.
Section 3.12. Solvency. Each Cedent is Solvent and is not subject to any liquidation, rehabilitation, receivership, supervision, conservation or bankruptcy proceeding or any similar or analogous process. For the purposes of this Section 3.12, the term “Solvent” means, with respect to a Cedent as of any date of determination, that (a) the amount of the fair saleable value of the assets of such Cedent exceeds (i) the value of all liabilities of such Cedent, including contingent and other liabilities, and (ii) the amount that will be required to pay the probable liabilities of such Cedent on its existing debts (including contingent liabilities) as such debts become absolute and matured, (b) such Cedent does not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged following such date and (c) such Cedent will be able to pay its liabilities, including contingent and other liabilities, in the ordinary course as they come due.
Section 3.13. Inuring Reinsurance.

(a)    Except as set forth in Section 3.13(a) of the Cedents Disclosure Schedule, each Inuring Reinsurance is a legal, valid and binding obligation of the Cedents and, to the Knowledge of the Cedents, each other party to such Inuring Reinsurance, and is enforceable against the applicable Cedent, and, to the Knowledge of the Cedents, each such other party, in accordance with its terms except as such enforceability may be limited by the Enforceability Exceptions, and neither the Cedents nor, to the Knowledge of the Cedents, any other party to an Inuring Reinsurance is in material default or material breach or has failed to perform any material obligation under an Inuring Reinsurance, and, to the Knowledge of the Cedents, there does not exist any event, condition or omission that would constitute
20


such a material breach or material default (whether by lapse of time or notice or both). The Cedents have not received any written notice, or to the Knowledge of the Cedents, oral notice, in respect of a cancellation, termination or non-renewal of an Inuring Reinsurance that remains in effect, or of an intent to, terminate, or not renew any Inuring Reinsurance or any transaction contemplated thereby. No Inuring Reinsurance contains any provision providing that the party other than the Cedents may terminate, re-capture, commute, rescind, accelerate or declare any of the Cedents in breach under such agreement by reason of the transactions contemplated by this Agreement or the other Transaction Agreements.

(b)    Except pursuant to the Inuring Reinsurances, no risks or liabilities of the SP Contracts have been ceded to, or assumed from, any other Person.

(c)    To the Knowledge of the Cedents, each Cedent is entitled to take full reinsurance credit with respect to each Inuring Reinsurance in its Cedents Statutory Financial Statements pursuant to Applicable Law. Each of the Cedents has administered the Inuring Reinsurances in accordance with their terms in all material respects and all amounts owed (that are not being disputed in good faith) under any Inuring Reinsurance have been paid in accordance with their terms in all material respects.

Section 3.14. Third-Party Administrators. To the Knowledge of the Cedents, since January 1, 2024, each third-party administrator that managed or administered any material portion of the Subject Business, at the time such Person managed or administered such Subject Business, was duly licensed as required by Applicable Law (for the type of business managed or administered on behalf of such entity), and to the Knowledge of the Cedents, no such third-party administrator has been since January 1, 2024 or is in violation (or with or without notice or lapse of time or both, would be in violation) of any term or provision of any Applicable Law applicable to the administration or management of insurance business for the Cedents except for such failures to be licensed or such violations that would not, individually or in the aggregate, result in a Material Adverse Effect.
The Cedents make no representations or warranties with respect to this Agreement other than those expressly set forth in this Article III. The representations and warranties of the Cedents contained in this Article III are limited to this Agreement, and are not intended to be representations or warranties of the Cedents under any other Transaction Agreements. Nothing contained herein shall be construed to alter or add to any representations or warranties that may be separately given by any Cedent under any Transaction Agreement (which representations and warranties shall relate solely to the Transaction Agreement in which they are given).
ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF REINSURER
21


Subject to Section 9.16(g), except as disclosed in the applicable sections of the Reinsurer Disclosure Schedule delivered by the Reinsurer to the Cedents simultaneously with the execution of this Agreement, the Reinsurer hereby represents and warrants to the Cedents as of the date of this Agreement and as of the Closing Date as follows:
Section 4.1. Organization, Standing and Corporate Power. The Reinsurer is an insurance company duly organized, validly existing and in good standing under the laws of Bermuda and has all requisite corporate power and authority to carry on the operations of its business as they are now being conducted. As of the Closing Date, the Reinsurer will have obtained all authorizations and approvals required under Applicable Law to perform the obligations contemplated of the Reinsurer under the Transaction Agreements.

Section 4.2. Authority. The Reinsurer has the requisite corporate (or other organizational) power and authority to enter into the Transaction Agreements to which it will be a party and to consummate the transactions contemplated thereby. The execution and delivery by the Reinsurer of the Transaction Agreements to which it will be a party and the consummation by the Reinsurer of the transactions contemplated thereby have been and, with respect to the Transaction Agreements to which it will be a party to be executed and delivered at Closing, will be duly authorized by all necessary corporate or other organizational action on the part of the Reinsurer. Each of the Transaction Agreements to which the Reinsurer is a party has been or, with respect to the Transaction Agreements to be executed and delivered at the Closing, will be duly executed and delivered by the Reinsurer and, assuming the Transaction Agreements constitute valid and binding agreements of the other parties thereto, constitute valid and binding obligations of the Reinsurer, enforceable against the Reinsurer in accordance with their terms, subject to the Enforceability Exceptions.
Section 4.3. No Conflict or Violation. The execution, delivery and performance by the Reinsurer of the Transaction Agreements to which it will be a party and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions hereof will not (a) violate any provision of the organizational documents of the Reinsurer, or (b) violate any material contract, permit, Order, condition or agreement, against or imposed or binding upon, the Reinsurer in any material respect.
Section 4.4. Governmental Consents. Subject to the matters referred to in the next sentence, the execution, delivery and performance by the Reinsurer of the Transaction Agreements and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions hereof will not contravene any Applicable Law which would, individually or in the aggregate, impair the ability of the Reinsurer to consummate the transactions contemplated by the Transaction Agreements or perform its obligations thereunder. No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority is required by or with respect to the Reinsurer in connection with the
22


execution and delivery of the Transaction Agreements by the Reinsurer, or the consummation by the Reinsurer of the transactions contemplated hereby or thereby, except for the approvals, filings, and notices set forth in Section 4.4 of the Reinsurer Disclosure Schedule and such other consents, approvals, authorizations, declarations, filings, or notices that, if not obtained or made, would not, individually or in the aggregate, impair the ability of the Reinsurer to consummate the transactions contemplated by the Transaction Agreements or perform its obligations thereunder.
Section 4.5.    Compliance.
(a)Except as disclosed in Section 4.5(a) of the Reinsurer Disclosure Schedule, the Reinsurer is and has been in compliance in all material respects with all Applicable Laws, its articles of incorporation and bylaws or other organizational documents and all material permits and licenses issued to the Reinsurer by any Governmental Authority, except for any non-compliance which would not, individually or in the aggregate, reasonably be expected to impair the ability of the Reinsurer to consummate the transactions contemplated by the Transaction Agreements or perform its obligations thereunder.
(b)    Within the past five (5) years, no Governmental Authority has revoked any license or status held by the Reinsurer to conduct its business or operations. The Reinsurer meets all of the requirements on the part of such respective entity set forth by Applicable Law (including the Applicable Laws of its jurisdiction of formation) in order for all necessary consents, approvals, authorizations, declarations, filings or notices with
23


Governmental Authorities related to the transactions contemplated by the Transaction Agreements to be obtained, and there are no facts, events or circumstances, involving or relating to the Reinsurer that may prevent or delay the granting of any such consents, approvals, authorizations, declarations, filings or notices with Governmental Authorities.
Section 4.6. Broker. No broker or finder has acted directly or indirectly for the Reinsurer who might be entitled to any fee or commission from the Cedents or their Affiliates in connection with the transactions contemplated by this Agreement.
Section 4.7. Financial Statements. The Reinsurer has previously delivered to the Cedents copies of (i) the audited annual financial statements of the Reinsurer as of and for the years ended December 31, 2025 and December 31, 2024 and (ii) the unaudited quarterly financial statements of the Reinsurer as of and for the quarter ended June 30, 2026 (the “Reinsurer Statutory Financial Statements”). Such Reinsurer Statutory Financial Statements were prepared in accordance with Applicable Law and Domicile Accounting Rules consistently applied throughout the periods involved. The Reinsurer has also delivered to the Cedents a draft of the unaudited quarterly financial statements of the Reinsurer as of and for the quarter ended September 30, 2026 (the “Draft Q3 Financial Statements”). Since the date of the last audited Reinsurer Statutory Financial Statements, there has been no change (nor any development or event involving a prospective change of which the Reinsurer is, or might reasonably be expected to be, aware) which is materially adverse to the condition (financial or otherwise), prospects, results of operations or general affairs of the Reinsurer.
Section 4.8. Administrator. The representations and warranties set forth in Section 4.1 through Section 4.5 are true and correct with respect to the Administrator, mutatis mutandis, as if each reference therein to the Reinsurer were a reference to the Administrator and each reference to the Transaction Agreements were a reference to the Transaction Agreements to which the Administrator will be a party; provided that such representations and warranties shall be made with the understanding that the Administrator is a limited liability company organized under the laws of the Commonwealth of Massachusetts.

Each of the Reinsurer and the Administrator makes no representations or warranties with respect to this Agreement other than those expressly set forth in this Article IV. The representations and warranties of the Reinsurer and the Administrator contained in this Article IV are limited to this Agreement, and are not intended to be representations or warranties of the Reinsurer and the Administrator under any other Transaction Agreements. Nothing contained herein shall be construed to alter or add to any representations or warranties that may be separately given by either the Reinsurer or the Administrator under any Transaction Agreement (which representations and warranties shall relate solely to the Transaction Agreement in which they are given).

24


ARTICLE V
COVENANTS

Section 5.1.    Conduct of the Subject Business. During the period from the date of this Agreement through the earlier of the Closing Date or the termination of this Agreement, except (x) as otherwise expressly required to effectuate the transactions contemplated by this Agreement or the Ancillary Agreements, (y) as expressly permitted by any Transaction Agreement or as required by Applicable Law or its Domicile Accounting Rules, or (z) with the consent of the Reinsurer (which consent shall not be unreasonably withheld, conditioned, or delayed), the Cedents (a) shall, and (where applicable) shall cause their Affiliates to, conduct the Subject Business in the ordinary course consistent with past practice and (b) shall not, and (where applicable) shall cause their Affiliates not to:
(i)enter into any new reinsurance agreements with respect to the Subject Business;
(ii)make any material changes to the reserving methodologies for the Subject Business in effect as of the date hereof, outside the ordinary course of business;
(iii)make any material changes with respect to the claims management of the Subject Business;
(iv)modify, amend, terminate or waive any material right under any Inuring Reinsurance;
(v)take any actions that, if taken on or following the Closing Date, would not be permitted pursuant to or would constitute a breach under Section 2.5 or Section 13.4 of the LPT Agreement; or
(vi)enter into a binding agreement to take any of the foregoing actions.
Section 5.2.    Access to Information.
(a)From and after the date hereof until the earlier of the Closing Date and the termination of this Agreement, no more than two (2) times per calendar year, upon ten (10) Business Days’ prior notice, the Reinsurer and the Administrator, at such entity’s own expense, shall have the right to inspect all Books and Records at any reasonable time during normal business hours at the office of the Cedents; provided, however, that if any Books and Records are maintained by the Cedents’ Representatives, then the Cedents shall undertake commercially reasonable efforts to make such Books and Records available to the Reinsurer or Administrator, as applicable, in accordance with this Section 5.2 (at the Reinsurer’s or Administrator’s own expense, as applicable). No Cedent shall be obligated to provide access to any
25


such books, records or documents hereunder if such Cedent determines, in its reasonable judgment, that doing so would (a) violate Applicable Law or a contract, agreement or obligation of confidentiality owing to a third party, (b) jeopardize the protection of an attorney-client privilege or other professional, regulatory, or legal duty of confidentiality, (c) expose a Cedent or its Affiliates to liability (including for disclosure of sensitive or personal information) or (d) jeopardize the protection of any Trade Secrets of such Party (Trade Secrets shall have the meaning provided in Section 1839 of the United States Economic Espionage Act of 1996), it being understood that such Cedent shall use its commercially reasonable efforts to enable such information to be furnished or made available to the Reinsurer or Administrator, as applicable, without so jeopardizing privilege, contravening such obligation or exposing such Party to such liability. Without limiting the terms thereof, the provisions of Section 5.6 shall govern the obligations of the Reinsurer, the Administrator and their respective Representatives with respect to all information of any type furnished or made available to them pursuant to this Section 5.2.
(b)The Reinsurer shall hold, and shall cause the Administrator to hold, all Books and Records furnished to it by or on behalf of the Cedents in accordance with Section 5.6, the Confidentiality Agreement and the confidentiality obligations agreed to between the Parties pursuant to the Transaction Agreements (including but not limited to the Common Interest and Confidentiality Agreement). The Reinsurer shall cause the Administrator to comply with Section 5.6, the Confidentiality Agreement and the Common Interest and Confidentiality Agreement, and shall be responsible for any breach thereof by the Administrator or its Representatives.
Section 5.3.    Consents, Approvals and Filings.
(a)Upon the terms and subject to the conditions hereof, each of the Cedents and the Reinsurer shall, and shall cause their respective Affiliates to, use their reasonable best efforts to take, or cause to be taken, all reasonable actions, and to do, or cause to be done, and to assist and cooperate with the other Party in doing, all things reasonably necessary, proper or advisable, to fulfill all conditions applicable to such Party pursuant to the Transaction Agreements and to consummate and make effective, as promptly as reasonably practicable, the transactions contemplated by this Agreement and the other Transaction Agreements, including (i) preparing and filing with any applicable Governmental Authority as promptly as practicable (but in any case no later than fifteen (15) Business Days after the date of this Agreement) all notices, filings and requests for approval necessary, proper or advisable to consummate the transactions contemplated by this Agreement and the other Transaction Agreements, including the Required Regulatory Approvals, as set forth on, with respect to the Cedents, Section 5.3(a) of the Cedents Disclosure Schedule and, with respect to the Reinsurer, Section 5.3(a) of the Reinsurer Disclosure Schedule, (ii) obtaining any other consents, approvals, waivers, authorizations, notices and filings set forth on, with respect to the Cedents, Section 3.4 of the Cedents Disclosure Schedule and, with respect to the Reinsurer, Section 4.4 of the Reinsurer Disclosure Schedule, (iii) using reasonable best efforts to obtain all Governmental Approvals necessary, proper or advisable to consummate the transactions
26


contemplated by this Agreement and other Transaction Agreements, including by using reasonable best efforts to provide, and causing their respective Affiliates to use reasonable best efforts to provide, such information and documents to Governmental Authorities (or to the other Party, for inclusion in submissions to Governmental Authorities) as such Governmental Authorities may reasonably require or request, and (iv) using reasonable best efforts to comply as promptly as practicable with all requirements and requests of Governmental Authorities applicable to the transactions contemplated by this Agreement and the other Transaction Agreements; provided that in no event shall any Party be required to commence, continue, participate in, support or defend any Action in opposition to any Governmental Authority; provided, further, in no event shall any Party be required to consent to any Burdensome Condition imposed by any Governmental Authority on such Party or its Affiliates nor shall any Party agree to take any action that would reasonably be expected to constitute a Burdensome Condition with respect to the other Party.

(b)Each of the Parties shall consult and cooperate with one another, and shall provide to the other Party copies of all applications or other communications to Governmental Authorities in connection with this Agreement in advance of the filing or submission thereof, and each Party shall keep the other apprised at reasonable intervals of the status of such matters relating to such applications or communications. The Cedents and the Reinsurer shall have the right to review in advance and shall be provided with a reasonable opportunity to comment on, and to the extent practicable each shall consult the other on, in each case subject to Applicable Law, any material filing made with, or written materials submitted to, any Governmental Authority in connection with the transactions contemplated by this Agreement, solely to the extent relating to the Subject Business and the Ancillary Agreements, and each party agrees to consider in good faith any comments of the other Party thereon. The Cedents and the Reinsurer shall promptly advise each other upon receiving any substantive communication from any Governmental Authority whose consent, approval, waiver or authorization is required to consummate the transactions contemplated by this Agreement, including promptly furnishing each other copies of any written or electronic communication, and shall promptly advise each other when any such communication causes such Party to believe that there is a reasonable likelihood that any such consent, approval, waiver or authorization will not be obtained or that the receipt of any such consent, approval, waiver or authorization will be materially delayed or conditioned. Each Party shall give to the other Party reasonable prior written notice of the time and place when any meetings, telephone calls or other conferences may be held by it with any Governmental Authority on or after the date hereof in connection with obtaining consents, approvals, waivers or authorizations necessary to consummate the transactions contemplated by this Agreement or the Ancillary Agreements, and the other Party shall have the right to have a representative or representatives attend or otherwise participate in any such meeting, telephone call or other conference.

(c)Prior to either Party being entitled to invoke a Burdensome Condition, each of the Parties and their respective Representatives shall promptly confer in good faith in order to (x) exchange and review their respective views and positions as to
27


any Burdensome Condition or potential Burdensome Condition, (y) discuss in good faith potential approaches that may mitigate or eliminate such Burdensome Condition or potential Burdensome Condition and (z) act reasonably and in good faith in determining, in its sole discretion, whether any such potential approaches should be accepted, and not unreasonably delay in the implementation of any potential approaches so accepted by such Party in its sole discretion.

(d)In no event shall the Reinsurer, the Cedents or their respective Affiliates be required to propose, commit to, accept or effect any action requested by a Governmental Authority that is not conditioned upon the occurrence of, and to be performed at or after, the Closing.

Section 5.4. Public Announcements. Each of the Reinsurer and the Cedents, and their respective Affiliates, shall consult with each other before issuing, and provide each other the opportunity to review and comment upon, any press release or other public statement with respect to the transactions contemplated by the Transaction Agreements and shall not issue any such press release or make any such public statement with respect to such matters without the advance approval of the other Party following such consultation (such approval not to be unreasonably withheld, delayed, or conditioned), except as may be required by
28


Applicable Law or by the requirements of any securities exchange; provided that in the event that any Party is required by Applicable Law or the requirements of any securities exchange to issue any such press release or make any public statement and it is not feasible to obtain the advance approval of the other Party hereto as required by this Section 5.4, the Party that issues such press release or makes such statement shall provide the other Party with notice and a copy of such press release or statement as soon as reasonably practicable.
Section 5.5. Further Assurances. The Cedents and the Reinsurer shall (a) execute and deliver, or shall cause to be executed and delivered, such documents, certificates, agreements, and other writings and shall take, or shall cause to be taken, such further actions as may be reasonably required or requested by any party to carry out the provisions of the Transaction Agreements and consummate or implement expeditiously the transactions contemplated by the Transaction Agreements; and (b) refrain from taking any actions that could reasonably be expected to impair, delay, or impede the Closing. Upon the terms and subject to the conditions and other agreements set forth in this Agreement, each Party agrees to use its commercially reasonable efforts, except to the extent that a higher standard might be imposed elsewhere in this Agreement, to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other Party in doing, all things necessary, proper, or advisable to consummate and make effective, in the most expeditious manner practicable, the transactions contemplated by the Transaction Agreements.
Section 5.6. Confidentiality. The Parties hereto agree that the Confidentiality Agreement shall be deemed to be incorporated herein and shall remain in full force and effect in accordance with its terms, notwithstanding the termination provisions thereof, and, in addition, covenant and agree to keep confidential, in accordance with the provisions of the Confidentiality Agreement, information provided to the other pursuant to this Agreement. If this Agreement is, for any reason, terminated prior to the Closing, each of the Confidentiality Agreement and the provisions of this Section 5.6 shall nonetheless continue in full force and effect in accordance with its terms.
Section 5.7.    Reinsurer Financial Statements.
(a)The Reinsurer shall deliver to the Cedents (i) the finalized unaudited quarterly financial statements of the Reinsurer as of and for the quarter ended September 30, 2026 within five (5) Business Days following the approval thereof by the board of directors of the Reinsurer and in any event prior to the Closing, and (ii) copies of the audited annual statements of the Reinsurer as of and for the year ended December 31, 2026 and unaudited quarterly statements of the Reinsurer as of and for the quarter ended March 31, 2027, in each case, within five (5) Business Days of such financial statements becoming available.
(b)    Each of the Cedents shall deliver to the Reinsurer (i) the finalized unaudited quarterly financial statements of such Cedent as of and for the quarter ended September 30, 2026 within five (5) Business Days following the
29


approval thereof by the board of directors of such Cedent and in any event prior to the Closing, and (ii) copies of the audited annual statements of such Cedent as of and for the year ended December 31, 2026 and unaudited quarterly statements of such Cedent as of and for the quarter ended March 31, 2027, in each case, within five (5) Business Days of such financial statements becoming available.
Section 5.8. Trust Account Funding. The Parties acknowledge and agree that the Reinsurer shall not be required to deposit funds in the Trust Accounts on the Closing Date. Further, no investment income shall be withdrawn from the Trust Accounts until January 1, 2028 (the “Springing Date”).
Section 5.9. Ancillary Agreements. During the period from the date of this Agreement through the earlier of the Closing or the termination of this Agreement, the Parties agree to, and to cause their applicable Affiliates to, promptly negotiate in good faith and finalize the Ancillary Agreements, including the schedules and exhibits thereto. Except as otherwise set forth herein or in the applicable Ancillary Agreements, the finalized schedules and exhibits to each of the Ancillary Agreements shall be attached to the applicable forms of Ancillary Agreements to be executed and delivered by the Parties or their respective Affiliates at the Closing.
Section 5.10. Sanctions and AML Compliance. In no event shall any Party be required to or be deemed to be required to make any payment hereunder, or have or be deemed to have any rights or obligations under this Agreement, to the extent that such payment, right or obligation would be prohibited under Sanctions or AML Laws applicable to such Party; provided that to the extent permissible under applicable Sanctions and AML Laws, if it is reasonably practicable to provide only partial coverage under this Agreement, such permissible partial coverage shall remain in effect, and any suspended amounts shall become due and payable once such payment or performance is no longer prohibited. If either Party becomes aware that any payment or other performance under this Agreement has likely violated, or is likely to violate, any Sanctions or AML Laws, it will promptly notify the other Party and the Parties shall cooperate to take reasonable corrective actions. Each Party will comply with requirements of Sanctions and AML Laws applicable to it in all material respects and shall not cause the other Party to violate any Sanctions or AML Laws.
Section 5.11. SP Contract and Underlying SP Contract Covenants.
(a)From and after the date hereof, each Cedent will comply in all material respects with all of the terms and conditions of, and its obligations under, and enforce its rights under, the SP Contracts and the Underlying SP Contract to which it is a party.
(b)From the date hereof until the earlier of the Closing Date or the date of termination of this Agreement, except with the prior written consent of the Reinsurer (not to be unreasonably withheld, delayed or conditioned), (i) each of the Cedents shall comply in all material respects with its obligations under the SP Contracts and the Underlying SP Contract and (ii) each of the Cedents shall in the
30


ordinary course of business maintain the SP Contracts and the Underlying SP Contract.
Section 5.12. Parental Guarantee.
(a)    Guarantor hereby absolutely, unconditionally and irrevocably guarantees to the Cedents (the “Parental Guarantee”) full and prompt payment when due of the Reinsurer’s and the Administrator’s payment obligations to the Cedents pursuant to this Agreement and the Ancillary Agreements, less amounts paid by the Reinsurer or the Administrator in respect thereof or satisfied by application of any offset, setoff or recoupment provision of such Ancillary Agreement (the “Guaranteed Obligations”). The Guarantor’s aggregate liability to the Cedents under this Agreement and the Ancillary Agreements shall not exceed the Final Aggregate Limit (including the Final Sub-Limit). Notwithstanding anything to the contrary contained in this Agreement, to the extent the Reinsurer or the Administrator is relieved of all or any portion of the Guaranteed Obligations in accordance with the express terms of this Agreement or an Ancillary Agreement (other than by reason of any of the circumstances described in clauses (i) through (iv) of Section 5.12(e)), Guarantor shall be similarly relieved of its obligations under this Agreement and such Ancillary Agreement.
(b)    Guarantor shall, within fifteen (15) Business Days of receipt of a written demand from the Cedents, pay the full amount of any Guaranteed Obligation that is then due and payable and has not been paid by the Reinsurer pursuant to this Agreement or an Ancillary Agreement (following a request for payment from the Cedents to the Reinsurer and taking into account and giving effect to any applicable notice and cure or grace periods therein). All payments made by Guarantor hereunder shall be paid in U.S. dollars in immediately available funds to such accounts as may be designated by the Cedents from time to time.
(c)The Parental Guarantee is a guarantee of payment of the Guaranteed Obligations when due and not merely of collection. If the Reinsurer fails to pay when due all or any portion of the Guaranteed Obligations, following the expiration of the fifteen (15) Business Day period specified in Section 5.12(b) and Guarantor’s failure to comply with its obligations thereunder and following a request for payment from the Cedents to the Reinsurer, the Cedents may, at their option, proceed directly against Guarantor to collect and recover the full amount of the Reinsurer’s liability to pay such Guaranteed Obligation (or any portion thereof) then due and owing and otherwise enforce the rights of the Cedents to demand Guarantor to pay such Guaranteed Obligations then due and owing as it is required to pay in accordance with the terms of this Agreement, without proceeding against or joining the Reinsurer or any other Person.
(d)For the avoidance of doubt, any payment of a Guaranteed Obligation by Guarantor shall be deemed to satisfy the Reinsurer’s obligation to pay such Guaranteed Obligation under this Agreement and the applicable Ancillary Agreement to the extent of such payment by Guarantor. The Cedents shall not be entitled to obtain payment of a Guaranteed Obligation from the Reinsurer or any
31


replacement or successor thereof or substitution therefor, to satisfy such Guaranteed Obligation or apply any right of offset, setoff, recoupment or deduction, to satisfy such Guaranteed Obligation to the extent that such Guaranteed Obligation has theretofore been paid by Guarantor.
(e)    The Parental Guarantee is a continuing guaranty and the obligations of Guarantor hereunder are and shall be absolute under any and all circumstances provided for in this Agreement and to the fullest extent permitted by Applicable Law, and subject to the last sentence of this Section 5.12(e), and Guarantor hereby waives any defense it may have relating to, (i) any claim as to the validity or enforceability of this Agreement or any Ancillary Agreement, (ii) any change in time, manner or place of payment of the Guaranteed Obligations or any other amendment or waiver of or consent to departure from any of the terms or conditions of this Agreement or any Ancillary Agreement (which are made in accordance with the terms and conditions of any Ancillary Agreement or this Agreement, as applicable) or (iii) any change, restructuring or termination of the corporate structure or existence of the Reinsurer or the Administrator or (iv) any dissolution, liquidation, conservation, rehabilitation, bankruptcy, statutory reorganization, receivership, compulsory composition, or similar proceeding affecting the Reinsurer or the Administrator or any of their assets or any resulting release or discharge of any obligation of the Reinsurer or the Administrator under this Agreement or any Ancillary Agreement. Subject to the last sentence of this Section 5.12(e), Guarantor hereby expressly waives promptness, diligence, demand, notice of dishonor, and notice of protest or other default with respect to the Guaranteed Obligations, or any requirements that any right or power be exhausted or any action taken against the Reinsurer or the Administrator, except as provided in this Agreement. Notwithstanding the foregoing, Guarantor does not waive and expressly preserves (x) defenses based on fraud or willful misconduct, (y) defenses to the payment of the Guaranteed Obligations that are available to the Reinsurer or the Administrator under any Ancillary Agreement (for the avoidance of doubt, including any rights or defenses of a Cedent under an SP Contract to which the Reinsurer or Administrator is entitled), including setoff, offset, recoupment, deduction and counterclaim, to the extent such rights exist for the Reinsurer or the Administrator under any Ancillary Agreement, and (z) defenses based on breach of this Agreement.
(f)    Section 9.7 (Dispute Resolution), Section 9.8 (Governing Law) and Section 9.9 (Service of Suit) shall apply to the Guarantor and to any dispute arising under or relating to this Section 5.12, mutatis mutandis, and for such purposes the Guarantor shall be treated as a Party on the same side as the Reinsurer.
(g)    This Section 5.12 shall only become effective upon the Closing.
ARTICLE VI
CONDITIONS PRECEDENT

Section 6.1.    Conditions to Each Party’s Obligations. The obligations of the Reinsurer
32


and Cedents to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following conditions:
(a)Approvals. All Required Regulatory Approvals shall have been obtained or made, and shall be in full force and effect, each without the imposition of a Burdensome Condition on the Party seeking to invoke this condition.
(b)No Injunctions or Restraints. No Governmental Authority of competent jurisdiction shall have enacted, enforced or entered any Applicable Law or Order that prohibits, restrains or enjoins the consummation of the transactions contemplated by the Transaction Agreements.

If the Closing occurs, all conditions set forth in this Section 6.1 that have not been fully satisfied as of the Closing shall be deemed to have been fully waived by the Parties for purposes of this Article VI.

Section 6.2. Conditions to Obligations of the Reinsurer. The obligations of the Reinsurer to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following additional conditions:
(a)Representations and Warranties. (i) The Cedent Fundamental Representations shall be true and correct in all respects except for any inaccuracies that are de minimis as of the Closing Date as though made on and as of the Closing Date (except to the extent they refer to another date, in which case they shall be true and correct as though made on and as of such other date), (ii) the representations and warranties set forth in Section 3.9(b) shall be true and correct in all respects as of the Closing Date as though made on and as of the Closing Date and (iii) the representations and warranties of the Cedents set forth in Article III (other than the Cedent Fundamental Representations and the representations and warranties set forth in Section 3.9(b)) shall be true and correct (without giving effect to any limitation set forth therein as to materiality or Material Adverse Effect) on and as of the Closing Date as though made on and as of the Closing Date (except to the extent any such representation and warranty speaks only as of an earlier date, in which event such representation and warranty shall have been true and correct as of such date), except where the failure of all such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(b)Performance of Obligations of the Cedents. The Cedents shall have performed and complied in all material respects with all agreements, obligations, and covenants required to be performed or complied with by them under this Agreement on or prior to the Closing Date.
(c)Closing Deliveries. The Cedents shall have delivered or caused to be delivered to the Reinsurer each of the documents required to be delivered pursuant to Section 2.2.
33


If the Closing occurs, all conditions set forth on this Section 6.2 that have not been fully satisfied as of the Closing shall be deemed to have been fully waived by the Reinsurer for purposes of this Article VI.
Section 6.3. Conditions to Obligations of the Cedents. The obligations of the Cedents to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following additional conditions:
(a)    Representations and Warranties. (i) The Reinsurer Fundamental Representations shall be true and correct in all respects except for any inaccuracies that are de minimis as of the Closing Date as though made on and as of the Closing Date (except to the extent they refer to another date, in which case they shall be true and correct as though made on and as of such other date), and (ii) the representations and warranties of the Reinsurer set forth in Article IV (other than the Reinsurer Fundamental Representations) shall be true and correct (without giving effect to any limitation set forth therein as to materiality) on and as of the date hereof and as of the Closing Date as though made on and as of the Closing Date (except to the extent any such representation and warranty speaks only as of an earlier date, in which event such representation and warranty shall have been true and correct as of such date), except where the failure of all such representations and warranties to be so true and correct would not, individually or in the aggregate, impair the ability of the Reinsurer to consummate any of the transactions contemplated by the Transaction Agreements.
(b)    Performance of Obligations of Reinsurer. The Reinsurer shall have performed and complied in all material respects with all agreements, obligations, and covenants required to be performed or complied with by it under this Agreement on or prior to the Closing Date.
(c)    Closing Deliveries. The Reinsurer shall have delivered or caused to have delivered to the Cedents each of the documents required to be delivered pursuant to Section 2.2.
If the Closing occurs, all conditions set forth in this Section 6.3 that have not been fully satisfied as of the Closing shall be deemed to have been fully waived by the Cedents for purposes of this Article VI.
ARTICLE VII
INDEMNIFICATION

Section 7.1.    Survival of Representations, Warranties and Covenants.
(a)The representations and warranties of the Cedents and the Reinsurer contained in this Agreement shall survive the Closing solely for purposes of this Article VII and shall terminate and expire on that certain date which is fifteen
34


(15) months following the Closing Date; provided that the representations and warranties made in Section 3.1 (Organization, Standing and Corporate Power), Section 3.2 (Authority), Section 4.1 (Organization, Standing and Corporate Power) and Section 4.2 (Authority), shall survive until the expiration of the applicable statute of limitations. Any claim for indemnification in respect of any representation or warranty that is not asserted by notice given as required herein prior to the expiration of the applicable survival period specified in this Section 7.1(a) shall not be valid and any right to indemnification is hereby irrevocably waived after the expiration of such period of survival to the extent no such notice was given prior to such expiration. Any claim for an Indemnifiable Loss in respect of such a breach or inaccuracy that is asserted within such period of survival (as herein provided) shall be deemed “timely made” for all purposes hereof.
(b)To the extent that it is to be performed after the Closing, each covenant in this Agreement shall, for purposes of this Article VII, survive and remain in effect in accordance with its terms plus a period of six (6) months following such time as of which it is fully performed, after which no claim for indemnification with respect thereto may be brought hereunder. All covenants in this Agreement that by their terms are required to be fully performed prior to the Closing shall, for purposes of this Article VII, survive for a period of six (6) months after the Closing, after which time no claim for indemnification with respect thereto may be brought hereunder.
Section 7.2.    Indemnification.
(a)    Subject to Section 7.1, the Cedents shall be severally but not jointly liable with respect to, and indemnify and hold harmless the Reinsurer and its Affiliates (collectively, the “Reinsurer Indemnified Persons”) from and against, any and all Indemnifiable Losses to the extent resulting from or arising out of:
(i)any breach of any representation or warranty of such Cedent made in Article III of this Agreement (other than a Cedent Fundamental Representation);
(ii)any breach or nonfulfillment of any agreement or covenant of such Cedent under this Agreement; or
(iii)any breach of a Cedent Fundamental Representation made by such Cedent.
(b)    Subject to Section 7.1, the Reinsurer shall indemnify and hold harmless the Cedents and their Affiliates (collectively, the “Cedent Indemnified Persons”) from and against any and all Indemnifiable Losses to the extent resulting from or arising out of:
(i)any breach of any representation or warranty of the Reinsurer made in Article IV of this Agreement (other than a Reinsurer Fundamental Representation);
35


(ii)any breach or nonfulfillment of any agreement or covenant of the Reinsurer under this Agreement; or
(iii)any breach of a Reinsurer Fundamental Representation.
(c)For purposes of determining whether there has been a breach or failure to be true of any representation or warranty contained in this Agreement and for purposes of determining the amount of any Indemnifiable Losses under this Article VII, each representation and warranty contained in this Agreement (other than in respect of Section 3.9 (Absence of Changes)) shall be read without regard to any materiality or Material Adverse Effect qualifier contained therein.
Section 7.3.    Certain Limitations.
(a)    The Reinsurer will not be obligated to indemnify and hold harmless the Cedent Indemnified Persons under Section 7.2(b)(i) and the Cedents will not be obligated to indemnify and hold harmless the Reinsurer Indemnified Persons under Section 7.2(a)(i) unless and until, in each case, (i) such claim or series of related claims involves Indemnifiable Losses in excess of $[***] (the “Threshold Amount”) and (ii) the aggregate amount of all Indemnifiable Losses under Section 7.2(a)(i) or under Section 7.2(b)(i), respectively, exceeds USD $[***] (excluding any claim or series of related claims that does not exceed the Threshold Amount) (the “Deductible”), at which point the indemnifying Party shall be liable only for Indemnifiable Losses in excess of the Deductible, subject to the limitations set forth in this Article VII. The maximum aggregate liability of the Cedents to all the Reinsurer Indemnified Persons for any and all Indemnifiable Losses under Section 7.2(a)(i) and Section 7.2(a)(ii) (other than Indemnifiable Losses arising out of any intentional breach of any agreement or covenant of a Cedent) shall not exceed USD $[***] (the “Cap”). The maximum aggregate liability of the Reinsurer to the Cedent Indemnified Persons for any and all Indemnifiable Losses under Section 7.2(b)(i) and Section 7.2(b)(ii) (other than Indemnifiable Losses arising out of any intentional breach of any agreement or covenant of the Reinsurer) shall not exceed the Cap.
(b)    The maximum aggregate liability of the Cedents to all the Reinsurer Indemnified Persons for any and all Indemnifiable Losses under Section 7.2(a) (including any Indemnifiable Losses subject to the Cap, any Indemnifiable Losses under Section 7.2(a)(ii) arising out of any breach of any agreement or covenant of a Cedent and any Indemnifiable Losses under Section 7.2(a)(iii))7.2(a) shall not exceed USD $[***], and in no event shall the aggregate liability of a Cedent under this Article VII exceed the portion of the Reinsurance Premium reasonably allocable to such Cedent. The maximum aggregate liability of the Reinsurer to all the Cedent Indemnified Persons for any and all Indemnifiable Losses under Section 7.2(b) (including any Indemnifiable Losses subject to the Cap, any Indemnifiable Losses under Section 7.2(b)(ii) arising out of any breach of any agreement or covenant of the Reinsurer and any Indemnifiable Losses under Section 7.2(b)(iii)) shall not exceed USD $[***]. For the avoidance of doubt, (i) the limitations in this Section 7.3(b) shall not increase the Cap, and in no event shall the aggregate liability
36


of the indemnifying Party for Indemnifiable Losses subject to the Cap exceed the Cap, and (ii) any amounts paid in respect of Indemnifiable Losses subject to the Cap shall count toward the limitations set forth in this Section 7.3(b).
(c)The limitations set forth in Section 7.3(a) and Section 7.3(b) shall not apply in the case of fraud or willful or intentional misconduct by the indemnifying Party.
(d)Except with respect to Taxes, an Indemnitee, whether a Reinsurer Indemnified Person or a Cedent Indemnified Person, shall use commercially reasonable efforts to mitigate or prevent the amount of its Indemnifiable Losses upon and after becoming aware of any facts or circumstances that would reasonably be expected to result in any Indemnifiable Losses that are indemnifiable hereunder.
(e)No Reinsurer Indemnified Person or Cedent Indemnified Person shall be entitled to indemnification with respect to any particular Indemnifiable Loss solely to the extent such Indemnifiable Loss can objectively be shown to have been specifically provided for or reserved against in the calculation of the Reinsurance Premium as set forth in the Final Closing Statement. For the avoidance of doubt, subject to the other limitations set forth in this Section 7.3, an indemnifying Party shall be liable for any and all such Indemnifiable Losses in excess of such amount provided for or reserved against in the calculation of the Reinsurance Premium as set forth in the Final Closing Statement.
(f)    Any liability for indemnification under this Agreement shall be determined without duplication of recovery by reason of the state of facts giving rise to such liability constituting a breach of more than one representation, warranty, covenant or agreement herein. For the avoidance of doubt, no Party shall be entitled to collect indemnification with respect to the same underlying subject matter more than once. Notwithstanding anything to the contrary contained in this Agreement, no Reinsurer Indemnified Person or Cedent Indemnified Person shall be entitled to indemnification with respect to any particular Indemnifiable Loss to the extent the related liability or obligation has been specifically accounted for in connection with an adjustment under Section 2.4.

(g)    In the event a claim or any Action for indemnification under this Article VII has been finally determined, the amount of such final determination shall be paid (i) if the Indemnitee is a Reinsurer Indemnified Person, by the applicable Cedent to the Reinsurer Indemnified Person and (ii) if the Indemnitee is a Cedent Indemnified Person, by the Reinsurer to the Cedent Indemnified Person, in each case on demand by wire transfer of immediately available funds to an account designated by the Cedents or the Reinsurer, as applicable. A claim or an Action, and the liability for and amount of damages therefor, shall be deemed to be “finally determined” for purposes of this Article VII when the Parties have so determined by mutual agreement or, if disputed, when a final non-appealable Order has been entered into with respect to such claim or Action.
37


(h)    Subject to Section 2.4 and Section 9.13 and except in the case of fraud, the Parties acknowledge and agree that their sole and exclusive remedy with respect to any and all claims under or arising out of this Agreement, including for any breach or non-fulfillment of any representation, warranty, covenant or agreement in this Agreement, shall be pursuant to the indemnification provisions set forth in this Article VII. In furtherance of the foregoing, each Party hereby irrevocably waives, to the fullest extent permitted under Applicable Law, any and all rights, claims and causes of action whatsoever (other than claims for fraud) for any breach or non-fulfillment of any representation, warranty, covenant or agreement in this Agreement it may have against the other Party arising under or based upon any Applicable Law, including rescission, except pursuant to the indemnification provisions set forth in this Article VII and the remedies of injunction and specific performance to the extent available under Section 9.13.
Section 7.4.    Procedures for Third Party Claims.
(a)If any Indemnitee receives notice of assertion or commencement of any Third Party Claim against such Indemnitee in respect of which an Indemnitor may be obligated to provide indemnification under this Agreement, the Indemnitee shall give such Indemnitor prompt written notice (but in no event later than thirty (30) calendar days after becoming aware) thereof and such notice shall include a reasonable description of the claim and relevant documents relating to the claim and, to the extent reasonably capable of being estimated, an estimate of the Indemnifiable Loss and shall reference the specific sections of this Agreement that form the basis of such claim; provided that no delay on the part of the Indemnitee in notifying any Indemnitor shall relieve the Indemnitor from any obligation hereunder unless (and then solely to the extent) the Indemnitor is actually prejudiced by such delay (except that the Indemnitor shall not be liable for any unreasonable expenses incurred during the period in which the Indemnitee failed to give such notice). Thereafter, the Indemnitee shall deliver to the Indemnitor, within five (5) calendar days after the Indemnitee’s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim.
(b)    The Indemnitor shall be entitled to participate in the defense of any Third Party Claim and, if it so chooses, to assume the defense thereof with counsel selected by the Indemnitor. If the Indemnitor elects to assume the defense and investigation of such Third Party Claim, it shall, no later than thirty (30) calendar days following its receipt of the notice, notify the Indemnitee in writing of its assumption of the defense of such Third Party Claim. Such assumption of defense shall not be deemed to be an admission or assumption of liability by the Indemnitor. If the Indemnitor assumes such defense, the Indemnitee shall have the right to participate in the defense thereof and to employ counsel separate from the counsel employed by the Indemnitor, but the fees and expenses of such counsel, and any other legal expenses incurred by the Indemnitee, shall not be the expense of the Indemnitor unless (i) employment of such counsel has been specifically authorized in writing by the Indemnitor, (ii) in the reasonable opinion of counsel to the Indemnitee, a conflict or potential conflict exists between the Indemnitee and the Indemnitor that would
38


make it inappropriate for the same counsel to represent both the Indemnitee and the Indemnitor or (iii) one or more defenses are available to the Indemnitee that are not available to the Indemnitor and the Indemnitor’s counsel has unreasonably declined to pursue such defenses. The Indemnitor shall be liable for the reasonable fees and expenses of counsel employed by the Indemnitee for any period during which the Indemnitor has not assumed the defense thereof (other than unreasonable expenses accrued during any period in which the Indemnitee shall have not yet given notice of the Third Party Claim as provided above). If the Indemnitor chooses to defend any Third Party Claim, all of the Parties hereto shall, and shall cause their respective Affiliates to, cooperate in the defense thereof. Such cooperation shall include the retention and (upon the Indemnitor’s request) the provision to the Indemnitor of non-privileged records and information that are relevant to such Third Party Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Whether or not the Indemnitor shall have assumed the defense of a Third Party Claim, the Indemnitee shall not admit any liability with respect to, or pay, settle, compromise, or discharge, such Third Party Claim without the Indemnitor’s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed). If the Indemnitor has assumed the defense of a Third Party Claim, the Indemnitor may only pay, settle, compromise, or discharge a Third Party Claim with the Indemnitee’s prior written consent (which consent shall not be unreasonably withheld, conditioned, or delayed); provided that the Indemnitor may pay, settle, compromise, or discharge such a Third Party Claim without the written consent of the Indemnitee if such settlement (i) includes a written release of the Indemnitee from all liability in respect of such Third Party Claim, (ii) does not subject the Indemnitee to any injunctive relief or other equitable remedy, and (iii) does not include a statement or admission of fault, culpability, or failure to act by or on behalf of the Indemnitee. If the Indemnitor submits to the Indemnitee a bona fide settlement offer that satisfies the requirements set forth in the proviso of the immediately preceding sentence and the Indemnitee refuses to consent to such settlement, then thereafter the Indemnitor’s liability to the Indemnitee with respect to such Third Party Claim shall not exceed the settlement amount included in such settlement offer, and the Indemnitee shall either assume the defense of such Third Party Claim or pay the Indemnitor’s reasonable attorney’s fees and other out-of-pocket costs incurred thereafter in continuing the defense of such Third Party Claim.

Section 7.5. Direct Claims. Any claim by an Indemnitee on account of an Indemnifiable Loss that does not result from a Third Party Claim shall be asserted by prompt written notice to the Indemnitor describing such claim in reasonable detail and, to the extent reasonably capable of being estimated, the amount of such Indemnifiable Loss; provided that no delay on the part of the Indemnitee in notifying any Indemnitor shall relieve the Indemnitor from any obligations hereunder unless (and then solely to the extent) the Indemnitor is actually prejudiced by such delay (except that the Indemnitor shall not be liable for any unreasonable expenses incurred during the period in which the Indemnitee failed to give such notice). The Indemnitor will have a period of thirty (30) calendar days within which to respond in writing to such claim. If the Indemnitor does not so respond within such thirty (30) calendar day
39


period, the Indemnitor will be deemed to have rejected such claim, in which event the Indemnitee will be entitled to pursue such remedies as may be available to the Indemnitee under this Agreement.
Section 7.6. Certain Other Matters. Upon making any Indemnity Payment, Indemnitor will, to the extent of such Indemnity Payment, be subrogated to all rights of Indemnitee against any third Person (other than any Tax authority) in respect of the Indemnifiable Loss to which the Indemnity Payment related. Without limiting the generality or effect of any other provision hereof, each such Indemnitee and Indemnitor will duly execute upon request all instruments reasonably necessary to evidence and perfect the above-described subrogation rights.

ARTICLE VIII

TERMINATION

Section 8.1.    Termination of Agreement. This Agreement may be terminated at any time
prior to the Closing:
(a)by the Cedents or the Reinsurer in writing, if there shall be any Order that prohibits or restrains any Party from consummating the transactions contemplated hereby, and such Order, injunction or decree shall have become final and non-appealable; provided that the Party seeking to terminate this Agreement pursuant to this Section 8.1(a) shall have performed in all material respects its obligations under this Agreement, acted in good faith, and, if binding on such Party, used reasonable best efforts to prevent the entry of, and to remove, such Order in accordance with its obligations under this Agreement;
(b)by the Cedents or the Reinsurer in writing, if the Closing has not occurred on or prior to June 30, 2027 (as it may be extended pursuant to this Section 8.1(b), the “Deadline Date”); provided that no Party may terminate pursuant to this Section 8.1(b) if the failure of the Closing to occur is the result of a material breach by such Party of this Agreement; provided, further, that, if on the date that would have been the Deadline Date the conditions set forth in Section 6.1(a) are the only condition in Article VI (other than those conditions that by their terms are to be satisfied at the Closing) that shall not have been satisfied or waived on or before such date, either Party may extend the Deadline Date upon delivering written notice to the other Party pursuant to Section 9.2 to a date and time reasonably agreed by the Parties that is not later than 5:00 p.m., Eastern Time, on December 30, 2027;
(c)by either the Cedents or the Reinsurer (but only so long as the Cedents or the Reinsurer, as applicable, is not in material breach of its obligations under this Agreement) in writing, if a breach of any provision of this Agreement that has been committed by the other Party would cause the failure of any mutual condition to Closing or any cond ition to Closing for the benefit of the non-breaching Party and such breach is not subsequently waived by the non-breaching Party or capable of being cured or is not cured within thirty (30) calendar days after the breaching Party receives written notice from the non-breaching Party that the non-breaching Party intends to terminate this Agreement pursuant to this Section 8.1(c); or
40


(d)    by mutual written consent of the Cedents and the Reinsurer.

Section 8.2. Effect of Termination. If this Agreement is terminated pursuant to Section 8.1, this Agreement shall become null and void and of no further force and effect without liability of either Party (or any Representative of such Party) to the other Party; provided that no such termination shall relieve a Party from liability for any breach of this Agreement prior to such termination. Notwithstanding the foregoing, Section 1.1, this Section 8.2 and Article IX shall survive termination hereof pursuant to Section 8.1. If this Agreement is terminated pursuant to Section 8.1, (a) each Party shall return or destroy, at its sole discretion, all documents received from the other Party, its Affiliates, and its Representatives relating to the transactions contemplated hereby, whether obtained before or after the execution hereof, and (b) all confidential information received by the Reinsurer with respect to the Cedents shall be treated in accordance with the Confidentiality Agreement, which shall remain in full force and effect notwithstanding the termination of this Agreement.
ARTICLE IX GENERAL PROVISIONS
Section 9.1. Fees and Expenses. Each Party shall, except as otherwise provided in this
Agreement or the other Transaction Agreements, pay its own Transaction Expenses incidental to preparing for, entering into, and carrying out the Transaction Agreements and the consummation of the transactions contemplated hereby and thereby.
Section 9.2. Notices. Notices and other communications required or permitted to be given under this Agreement shall be effective if in writing and (i) mailed by United States registered or certified mail, return receipt requested; (ii) delivered by overnight express mail; or (iii) delivered by electronic mail (unless the sender of such electronic mail receives a notice that such electronic mail is undeliverable or otherwise has not been received by the intended recipient(s)) to:
if to the Reinsurer or Guarantor:
RiverStone International Bermuda Limited Dorchester House, First Floor
7 Church Street
Hamilton, HM11, Bermuda
Attention: David Rocke, Chief Executive Officer
Email: [***]

with a copy (which shall not constitute notice) to:

41


RiverStone Management Limited
Park Gate
161-163 Preston Road
Brighton, United Kingdom, BN1 6AU Attention: Fraser Henry, General Counsel
Email: [***]

with a copy (which shall not constitute notice) to:
RiverStone International Limited Dorchester House, First Floor
7 Church Street
Hamilton, HM11, Bermuda
Attention: David Rocke, Chief Executive Officer
Email: [***]

with a copy (which shall not constitute notice) to:
RiverStone International
22 Bishopsgate
London, United Kingdom, EC2N 4BQ Attention: Mike Cain
Email: [***]
with a copy (which shall not constitute notice) to:
Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West
New York, NY 10001
Attention: Elena M. Coyle
Email: [***]
if to the Cedents:
SiriusPoint America Insurance Company 285 Fulton Street, Suite 47J
One World Trade Center New York, NY 10007
Attn: Linda S. Lin, Chief Legal Officer
Email: [***]; [***]
SiriusPoint Bermuda Insurance Company Ltd. Point Building
3 Waterloo Lane
42


Pembroke, HM 08 Bermuda
Attn: Linda S. Lin, Chief Legal Officer
Email: [***]; [***]

with a copy (which shall not constitute notice) to:
Mayer Brown LLP
1221 Avenue of the Americas
New York, New York 10020-10011
Attention: Vikram Sidhu
Email: [***]
Either Party may change the names or addresses where notice is to be given for such Party by providing notice to the other Party of such change in accordance with this Section 9.2.
Section 9.3. Entire Agreement. This Agreement (including the Exhibits and Schedules hereto), the other Transaction Agreements and any other documents delivered pursuant hereto or thereto, constitute the entire agreement among the Parties and their respective Affiliates with respect to the subject matter hereof and thereof and supersede all prior negotiations, discussions, writings, agreements and understandings, oral and written, among the Parties with respect to the subject matter hereof and thereof.
Section 9.4. Waiver and Amendment. This Agreement may be amended, superseded, canceled, renewed or extended, and the terms hereof may be waived, only by an instrument in writing signed by the Parties hereto, or, in the case of a waiver, by the Party waiving compliance. No delay on the part of any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other such right, power or privilege. The failure of any Party to insist on compliance with any obligation contained in this Agreement or to exercise any right or remedy hereunder shall not constitute a waiver of any right or remedy contained herein nor stop any Party from thereafter demanding full and complete compliance nor prevent any Party from exercising such right or remedy in the future. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.
Section 9.5. Successors and Assigns. The rights and obligations of the Parties under this Agreement shall not be subject to assignment without the prior written consent of the other Parties, and any attempted assignment without the prior written consent of the other Parties shall be invalid ab initio. The terms of this Agreement shall be binding upon, inure to the benefit of and be enforceable by and against the successors and permitted assigns of the Parties.
43


Section 9.6. Headings. The headings of the Sections and the Table of Contents have been inserted for convenience of reference only and shall not be deemed to constitute a part of this Agreement.
Section 9.7.    Dispute Resolution.
(a)    Prior to initiating arbitration pursuant to this Section 9.7, the Parties shall first promptly refer the dispute to their respective senior executives, each at the level of Chief Executive Officer, Chief Financial Officer, or equivalent, for resolution. Such senior executives shall meet, in person or by teleconference, within fifteen (15) Business Days of such referral and shall attempt in good faith to resolve the dispute within thirty (30) Business Days of the initial referral. If the dispute is not resolved within such thirty (30) Business Day period, either Party may then initiate arbitration.
(b)    Except as set forth in Section 2.4 and subject to the terms and conditions of Section 9.7(a), any dispute or difference arising out of or relating to this Agreement, the performance of the duties and obligations arising under the Agreement, including the formation or validity thereof, or its termination, and including any dispute regarding the applicability, interpretation, scope or enforceability of this arbitration provision, shall be administered by AIDA Reinsurance and Insurance Arbitration Society —US (“ARIAS·US”) and settled by binding arbitration in accordance with the ARIAS·US Rules for the Resolution of U.S. Insurance and Reinsurance Disputes, and each Party agrees that it hereby waives its right to seek remedies in court, including the right to a jury trial. If more than one arbitration is initiated with respect to any of the Transaction Agreements and if reasonably necessary given the subject matter of the disputes or differences relating to such arbitration proceedings, all such arbitration proceedings shall be consolidated into a single arbitration proceeding and administered under the first -initiated arbitration proceeding and shall occur in New York City, New York or another location if mutually agreed. Subject to any express provisions of this Section 9.7, the arbitration will be administered in accordance with the procedures of ARIAS·US required selections process. By agreeing to arbitration, the Parties do not intend to deprive any court of its jurisdiction to (i) issue any pre-arbitral injunction, pre-arbitral attachment or other temporary or interim relief in aid of arbitration or (ii) grant injunctive relief pursuant to Section 9.7(h).
(c)    The arbitration panel will consist of two (2) disinterested party-appointed arbitrators and an umpire. Arbitration shall be initiated by the delivery of a written notice of demand for arbitration by one (1) Party to the other Party sent by registered mail or its equivalent. Such notice of demand shall set out the reason for the request for arbitration.
(d)The Cedents, on the one hand, and the Reinsurer, on the other hand, shall each choose an arbitrator and the two (2) so appointed shall then appoint an umpire. If either Party refuses or neglects to appoint an arbitrator within thirty (30) calendar days after a request by the other to do so, the other Party may appoint both
44


arbitrators. The two (2) arbitrators shall then agree on an impartial umpire within thirty (30) calendar days of their appointment. If the two (2) arbitrators do not agree on a third arbitrator within thirty (30) days of their appointment, the third arbitrator shall be chosen in accordance with the procedures for selecting the third arbitrator in force on the date the arbitration is demanded, established by ARIAS·US. The arbitrators and umpire shall be active or retired directors or officers of insurance or reinsurance companies and disinterested in the Cedents, the Reinsurer (or the Parties’ Affiliates) and the outcome of the arbitration, and no arbitrator or umpire shall, have, or within the past five (5) years have had, any direct or indirect affiliation, financial interest, or professional relationship with any Party, including but not limited to: officers, directors, employees, agents, consultants, lawyers and other professional advisors, or any of their respective affiliates. Umpire candidates shall complete disclosure statements at the request of a Party.
(e)    The arbitration hearings shall be held in New York City, New York or another location if mutually agreed. Within twenty (20) calendar days after all arbitrators and the umpire have been appointed, the panel shall meet and determine time periods for briefs, discovery procedures and schedules of hearings. Each Party shall submit its case to the arbitration panel within sixty (60) calendar days of the appointment of the umpire or within such longer periods as may be agreed by the Parties or directed by the arbitration panel. Ex parte communication with any arbitrator is prohibited following the appointment of the arbitrators. The arbitrators shall act as a neutral panel with respect to the issues before them. The panel shall be relieved of all judicial formality and shall not be bound by the strict rules of procedure and evidence. The Parties shall instruct the panel to issue a written decision as promptly as possible after the hearings. Judgment upon an award may be entered in any court having jurisdiction thereof.
(f)    Each Party shall pay the fees and expenses of its own arbitrator. The Parties shall equally divide the fees and expenses of the umpire and other expenses of the arbitration, unless such fees and expenses are otherwise allocated by the arbitration panel. The arbitration panel is precluded from awarding punitive, treble or exemplary damages, however denominated; provided that in the event the relief sought by a Party includes indemnification for punitive, treble or exemplary damages paid or incurred by that Party, such amounts may be included in any award rendered by the panel. The panel shall have the power to award reasonable attorneys’ fees to either Party, including fees incurred in connection with the arbitration or any litigation commenced to stay or dismiss arbitration.
(g)    Except as expressly permitted by this Agreement, no Party will commence or voluntarily participate in any Action concerning a dispute, except (x) for enforcement pursuant to the Federal Arbitration Act, 9 U.S.C. §§ 1 et seq., (y) to restrict or vacate an arbitral decision based on the grounds specified under Applicable Law, or (z) for interim relief as provided in subsection (h) below.
(h)    Notwithstanding any other provision to the contrary herein, each Party acknowledges that the breach of certain obligations may cause irreparable
45


injury and damages, which may be difficult to ascertain. Without regard to subsection (g) above, each Party immediately shall be entitled to seek injunctive relief with respect to such breaches by the other Party and without the requirement of posting a bond. This provision shall not in any way limit such other remedies as may be available to any Party at law or in equity.
Section 9.8. Governing Law. This Agreement and any dispute arising hereunder shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to such state’s principles of conflict of laws that could compel the application of the laws of another jurisdiction.
Section 9.9.    Service of Suit.
(a)Nothing in this Section 9.9 will be construed to override the provisions of Section 9.7. This Section 9.9 is intended as an aid to compelling arbitration, or enforcing such arbitration, or arbitral award, and not as an alternative to Section 9.7 for resolving disputes arising out of this Agreement.
(b)    Solely for purposes of (x) for enforcement pursuant to the Federal Arbitration Act, 9 U.S.C. §§ 1 et seq., (y) to restrict or vacate an arbitral decision based on the grounds specified under Applicable Law, or (z) for interim relief as provided in Section 9.7(h), each of the Parties hereby irrevocably and unconditionally (i) submits, for itself and its property, to the exclusive jurisdiction and venue of the federal courts of the United States located in the Southern District of New York (or, if such courts decline jurisdiction, the state courts of the State of New York sitting in the Borough of Manhattan) (“New York Courts”), (ii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any action that may be based upon, arising out of or relating to this Agreement or the negotiation, execution and delivery or performance of this Agreement in the New York Courts, including any objection based on its place of incorporation or domicile, (iii) waives, to the fullest extent permitted by Applicable Law, the defense of an inconvenient forum to the maintenance of such action in any New York Court and (iv) agrees that a final judgment in any such action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Applicable Law. Each of the Parties consents and agrees that service of process, summons, notice or document for any Action permitted hereunder may be delivered by registered mail addressed to it at the applicable address set forth in Section 9.2 or in any other manner permitted by Applicable Law.
Section 9.10. Third Party Beneficiaries. Except as set forth in 0 with respect to the Reinsurer Indemnified Persons and the Cedent Indemnified Persons, this Agreement is not intended to confer upon any Person other than the Parties any rights or remedies.
Section 9.11. Counterparts. This Agreement may be executed by the Parties in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same
46


instrument binding upon all of the Parties notwithstanding the fact that all Parties are not signatory to the original or the same counterpart. Each counterpart may consist of a number of copies hereof each signed by less than all, but together signed by all of the Parties. Each counterpart may be delivered by email (with PDF attachment), DocuSign or other electronic transmission, which shall be deemed delivery of an originally executed document.
Section 9.12. Severability. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms and provisions of this Agreement in any other jurisdiction, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. If any provision of this Agreement is so broad as to be unenforceable, that provision shall be interpreted to be only so broad as is enforceable. In the event of such invalidity or unenforceability of any term or provision of this Agreement, the Parties shall use their commercially reasonable efforts to reform such terms or provisions to carry out the commercial intent of the Parties as reflected herein, while curing the circumstance giving rise to the invalidity or unenforceability of such term or provision.

Section 9.13. Specific Performance. The Parties agree that irreparable damage would occur and that the Parties would not have any adequate remedy at law in the event that any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached and that money damages or other legal remedies would not be an adequate remedy for any such failure to perform or breach. It is accordingly agreed that, without posting bond or other undertaking, the Parties shall be entitled to seek injunctive or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the New York Courts in accordance with Section 9.7(h) and Section 9.9(b), this being in addition to any other remedy to which they are entitled at law or in equity. In the event that any such action is brought in equity to enforce the provisions of this Agreement, no party will allege, and each party hereby waives the defense or counterclaim, that there is an adequate remedy at law. The parties further agree that (a) by seeking any remedy provided for in this Section 9.13, a Party shall not in any respect waive its right to seek any other form of relief that may be available to such party under this Agreement and (b) nothing contained in this Section 9.13 shall require any Party to institute any action for (or limit such Party’s right to institute any action for) specific performance under this Section 9.13 before exercising any other right under this Agreement.
Section 9.14. Incontestability. In consideration of the covenants and agreements contained herein, each Party hereby agrees that this Agreement, and each and every provision hereof, is and shall be enforceable by and between them
47


according to its terms, and each party hereby agrees that it shall not contest in any respect the validity or enforceability hereof.
Section 9.15. Currency. All references to “dollars” or “$” shall mean United States dollars and all financial data required to be provided pursuant to the terms of this Agreement shall be expressed in United States dollars. All payments and all settlements of account between the Parties shall be in United States currency unless otherwise agreed by the Parties. For purposes of determining the Section A Interim Paid UNL, the Section B Interim Paid UNL, the Reinsurance Premium, the Aggregate Limit, the Sub-Limit and any other amount expressed in United States dollars under this Agreement, any amount paid or denominated in a currency other than United States dollars shall be converted into United States dollars as follows: (i) amounts paid in a currency other than United States dollars shall be converted into United States dollars at the rate of exchange used by the Cedents in recording such payment in their books and records on the date of payment; and (ii) reserves and other unpaid amounts denominated in a currency other than United States dollars shall be converted into United States dollars at the rates of exchange used by the Cedents in preparing their quarterly financial statements as of the most recent quarter end.
Section 9.16. Construction.
(a)As used in this Agreement, unless clearly indicated to the contrary, references to the following terms have the meanings indicated:
(i)to the Preamble or to the Recitals, Sections, Articles, Exhibits or Schedules are to the Preamble or a Recital, Section or Article of, or an Exhibit or Schedule to, this Agreement;
(ii)to any Contract (including this Agreement) or “organizational document” are to the Contract or organizational document as amended, modified, supplemented or replaced from time to time;
to any Applicable Law are to such Applicable Law as amended, modified, supplemented or replaced from time to time and all rules and regulations promulgated thereunder, and to any section of any Applicable Law include any successor to such section;

(iii)to any Governmental Authority include any successor to the Governmental Authority and to any Affiliate include any successor to such Affiliate;
(iv)to any “copy” of any Contract or other document or instrument are
to a true and correct copy thereof;
(v)to “hereof,” “herein,” “hereunder,” “hereby,” “herewith” and words of similar import refer to this Agreement as a whole and not to any particular Article, Section or clause of this Agreement, unless otherwise clearly indicated to the contrary;
48


(vi)to the “date of this Agreement,” “the date hereof” and words of
similar import refer to October 30, 2026; and
(vii)to “this Agreement” includes the Exhibits and Schedules (including the Reinsurer Disclosure Schedule and the Cedents Disclosure Schedule) to this Agreement.
(b)Unless otherwise indicated, any reference herein to “days” (as opposed to “Business Days”) shall be deemed to mean calendar days. With respect to any determination of any period of time, unless otherwise set forth herein, the word “from” means “from and including” and the word “to” means “to but excluding.”
(c)Unless otherwise indicated, any reference herein to a “consent” shall be
deemed to mean prior written consent.
(d)Unless otherwise indicated, any reference herein to “notice” shall be
deemed to mean prior written notice.
(e)Except as otherwise provided herein, references to “written” or “in writing”
include in electronic form.
(f)Any reference herein to “including” and words of similar import shall mean “including without limitation,” unless otherwise specified. Unless the context otherwise requires, the terms “neither,” “nor,” “any,” “either” and “or” are not exclusive.
(g)Any fact or item disclosed in any section of each of the Reinsurer Disclosure Schedule or the Cedents Disclosure Schedule (together, the “Disclosure Schedules”) shall be deemed disclosed in all other sections of such Disclosure Schedules to the extent the applicability of such fact or item to such other sections of such Disclosure Schedules is reasonably apparent. Disclosure of any item in the Reinsurer Disclosure Schedule or the Cedents Disclosure Schedule, as the case may be, shall not be deemed an admission that such item represents a material item, fact, exception of fact, event, or circumstance or that occurrence or non-occurrence of any change or effect related to such item would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(h)    The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

(i)    Whenever the singular is used herein, the same shall include the plural, and whenever the plural is used herein, the same shall include the singular, where appropriate. All pronouns and variations of pronouns will be deemed to refer to the feminine, masculine or neuter, singular or plural, as the identity of the Person or thing referred to may require. References to any Person include such Person’s predecessors or successors, whether by merger, consolidation, amalgamation,
49


reorganization or otherwise. Where a word or phrase is defined herein, each of its other grammatical forms shall have a corresponding meaning. The word “will” shall be construed to have the same meaning and effect as the word “shall”.
(j)    All time periods within or following which any payment is to be made or act is to be done shall be calculated by excluding the date on which the period commences and including the date on which the period ends and by extending the period to the first succeeding Business Day if the last day of the period is not a Business Day.
(k)    This Agreement has been jointly negotiated and drafted by the Parties and shall not be construed by any Governmental Authority or other Person against either Party by virtue of the fact that such Party was the drafting Party and no presumption, burden of proof or rule of strict construction shall arise favoring or disfavoring any party by virtue of its authorship of any provision of this Agreement.
(l)    Whenever any cash amount is payable hereunder, such amount shall be paid to the Person entitled to receive such payment by wire transfer of immediately available funds to one or more accounts specified in writing by the recipient.
(m)    Any statement that a document has been “delivered,” “provided” or “made available” to the Reinsurer means that such document has been uploaded to the Data Room, or delivered by email to the Reinsurer or its advisors, not later than one (1) Business Day prior to the date of this Agreement.
(n)    No summary of this Agreement prepared by or on behalf of any Party shall affect the meaning or interpretation of this Agreement.
(o)    Where specific language is used to clarify by example a general statement herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.
(p)    All capitalized terms used without definition in the Exhibits and Schedules (including the Reinsurer Disclosure Schedule and the Cedents Disclosure Schedule) to this Agreement shall have the meanings ascribed to such terms in this Agreement.
Section 9.17. Certain Limitations.
(a)    Notwithstanding anything to the contrary contained herein, the other Transaction Agreements, the Cedents Disclosure Schedule, or any of the Schedules or Exhibits hereto or thereto, the Reinsurer acknowledges and agrees that neither the Cedents nor any of their Affiliates, nor any Representative of any of them, makes or has made, and the Reinsurer has not relied on, any inducement or promise to the Reinsurer except as specifically made in this Agreement or any representation or warranty to the Reinsurer, oral or written, express or implied, other than as expressly made by each Cedent in Article III or any Ancillary Agreement. Each of the Cedents expressly disclaims, and the Reinsurer expressly disclaims any reliance on, and shall
50


cause its Affiliates and any of its Affiliates’ respective Representatives to expressly disclaim any reliance on, any and all representations and warranties, whether express or implied, other than those contained in Article III or any Ancillary Agreement. Without limiting the foregoing, other than as expressly set forth in Article III, no Person has made any representation or warranty to the Reinsurer with respect to the Subject Business or any other matter, including with respect to (i) the probable success or profitability of the Subject Business after the Closing or (ii) any information, documents or materials made available to the Reinsurer, its Affiliates or their respective Representatives in the Data Room or otherwise in connection with the transactions contemplated by this Agreement. With respect to any estimation, valuation, appraisal, projection, or forecast (including any confidential information memoranda prepared by or on behalf of the Cedents in connection with the transactions contemplated by this Agreement), the Reinsurer acknowledges that: (i) there are uncertainties inherent in attempting to make such estimations, valuations, appraisals, projections, and forecasts; (ii) it is not acting and has not acted in reliance on any such estimation, valuation, appraisal, projection, or forecast; and (iii) such estimations, valuations, appraisals, projections, and forecasts, in and of themselves, are not and shall not be deemed to be representations or warranties of a Cedent or any of its Affiliates.
(b)Except for the representations and warranties contained in Article IV and the Ancillary Agreements, neither the Reinsurer, the Administrator, the Guarantor nor their Affiliates, nor any of its or their respective Representatives, makes or has made, and none of the Cedents or their Affiliates, nor any of its or their respective Representatives relies or has relied upon, any other representation or warranty on behalf of the Reinsurer, the Administrator or the Guarantor. The Reinsurer, the Administrator and the Guarantor each expressly disclaims, and each Cedent expressly disclaims any reliance on, and shall cause its Affiliates and any of its Affiliates’ respective Representatives to expressly disclaim any reliance on, any and all representations and warranties, whether express or implied, other than those contained in Article IV or any Ancillary Agreement.
(c)Neither Cedent makes any express or implied representation or warranty hereby or otherwise under this Agreement or the transactions contemplated hereunder (i) as to the future experience, success or profitability of the Subject Business, whether or not conducted in a manner similar to the manner in which such business was conducted prior to the Closing, (ii) that the reserves held in connection with the Subject Business or the assets supporting such reserves have been or will be adequate or sufficient for the purposes for which they were established or (iii) except as set forth in Section 3.8, that such reserves were calculated, established or determined in accordance with any actuarial, statutory or other standard .
(d)The Reinsurer further acknowledges and agrees that it has made its own inquiry and investigation into and, based thereon, has formed an independent judgment concerning the Subject Business. Notwithstanding anything to the contrary contained herein, nothing in this Section 9.17 is intended to, or shall, limit any claim for fraud.
51


IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their respective duly authorized officers, all as of the date first written above.


SIRIUSPOINT AMERICA INSURANCE COMPANY

By:     /s/ Scott Egan    
Name: Scott Egan
Title: CEO

By:     /s/ Linda Lin    
Name: Linda Lin
Title: Chief Legal Officer

SIRIUSPOINT BERMUDA INSURANCE COMPANY LTD.


By:     /s/ Justin Brenden    
Name: Justin Brenden
Title: Deputy Chief Financial Officer

[ ]

RIVERSTONE INTERNATIONAL BERMUDA LIMITED

By:     /s/ David Rocke    
Name: David Rocke
Title: Director


(SOLELY FOR PURPOSES OF SECTION 5.12, SECTION 9.2, SECTION 9.7 THROUGH SECTION 9.9 AND SECTION 9.17)

RIVERSTONE INTERNATIONAL LIMITED

By: /s/ David Rocke    
Name: David Rocke
Title: Director

[Signature Page to Master Agreement]

Exhibit 31.1
SiriusPoint Ltd.
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) OF THE EXCHANGE ACT, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Scott Egan, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of SiriusPoint Ltd.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and



(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 5, 2026
/s/ Scott Egan
Scott Egan
Chief Executive Officer
(Principal Executive Officer)





Exhibit 31.2
SiriusPoint Ltd.
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) OF THE EXCHANGE ACT, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jim McKinney, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of SiriusPoint Ltd.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and



(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 5, 2026
/s/ Jim McKinney
Jim McKinney
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)




Exhibit 32.1
SiriusPoint Ltd.
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Scott Egan, Chief Executive Officer of SiriusPoint Ltd. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal period ended September 30, 2026 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 5, 2026
/s/ Scott Egan
Scott Egan
Chief Executive Officer
(Principal Executive Officer)



Exhibit 32.2
SiriusPoint Ltd.
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Jim McKinney, Chief Financial Officer of SiriusPoint Ltd. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)    the Quarterly Report on Form 10-Q of the Company for the fiscal period ended September 30, 2026 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 5, 2026
/s/ Jim McKinney
Jim McKinney
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)